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 ABSTRACT 
Cyclin D1 and its kinase partner Cdk4 form a complex which is well known for its nuclear role 
regulating the cell cycle. In addition, non-canonical functions of cyclin D1 are related to 
transcription, DNA damage repair, differentiation and metabolism. Also, our group has 
demonstrated a cytoplasmic role of cyclin D1 in cell invasion and metastasis through the 
phosphorylation of paxillin. Cyclin D1 knockout mice show neurological deficiencies. Cyclin D1 
has been found at the cytoplasm of differentiated neurons, and is required for NGF-induced 
neurite outgrowth in PC12 cells. Hence, we have aimed to explore cyclin D1 cytoplasmic 
functions in neurons. Here we show that cytoplasmic cyclin D1-Cdk complexes are important for 
early neurite outgrowth in embryonic cortical neurons. Overexpression of cytoplasmic cyclin D1 
or Cdk4 promotes axon and neurite outgrowth, while downregulation of endogenous cyclin D1 
inhibits neuritogenesis in cultured cortical neurons. Our data point to paxillin as a downstream 
effector of cyclin D1 in this process since a non-phosphorylatable mutant of paxillin results in a 
decrease in axon and neurite lengths.  
We have also focused on the regulation of type A GABA receptors by cyclin D1. GABA is the 
main inhibitory neurotransmitter in the mammalian brain, exerting its actions by binding and 
activating the so-called GABA receptors. Ionotropic GABAAR function and abundance are often 
regulated by phosphorylation at the intracellular loop of its subunits. Here we describe that cyclin 
D1 directly interacts with the α4 and β3 subunits of GABAA receptors, and co-
immunoprecipitates and colocalizes with the α4 subunit at the hippocampus of adult mice. 
Moreover, we prove that the cyclin D1-Cdk4 complex phosphorylates α4 at residues T423 and 
S431, and that cyclin D1 or a phosphomimetic allele of α4 prevent GABAAR run-down in HEK 
tsA201. Finally, the inhibition of cyclin D-Cdk4/6 complexes by Palbociclib reveals that these 
complexes are necessary for maintaining GABA-tonic currents and miniature inhibitory 
postsynaptic currents in hippocampal slices. 
Taken together, our results strongly suggest new roles for cytoplasmic cyclin D1 in the central 
nervous system, regulating early neuritogenesis and neuronal activity through GABAA receptors. 
This may shed light on the neurological phenotype of the cyclin D1 knockout mice and be 
relevant for several mental disorders wherein dysregulation of GABA inhibitory functions may be 
a determining factor. 
 RESUMEN 
Ciclina D1 y la quinasa Cdk4 forman un complejo con una función nuclear bien definida, 
regulando el ciclo celular. Por otro lado, ciclina D1 ejerce funciones no canónicas relacionadas 
con la transcripción, la reparación del ADN, la diferenciación y el metabolismo. En nuestro grupo 
hemos demostrado que ciclina D1 en el citoplasma regula la invasión celular y la metástasis a 
través de la fosforilación de paxilina. Los ratones knockout de ciclina D1 presentan deficiencias 
neurológicas. Ciclina D1 se ha encontrado en el citoplasma de neuronas diferenciadas y es 
necesaria para el crecimiento de neuritas inducido por NGF en células PC12. Así pues, nos hemos 
propuesto explorar las funciones de ciclina D1 citoplasmática en neuronas. Aquí mostramos que 
los complejos ciclina D1-Cdk son importantes para el crecimiento inicial de neuritas en neuronas 
corticales embrionarias. La sobreexpressión de ciclina D1 o Cdk4 promueve el crecimiento del 
axón y las neuritas, mientras que una disminución de los niveles de ciclina D1 endógena inhibe la 
neuritogénesis en neuronas corticales en cultivo. Nuestros resultados apuntan a paxilina como 
efector downstream de ciclina D1 en este proceso, puesto que el mutante no fosforilable de 
paxilina produce una disminución de la longitud del axón y de las neuritas.  
También, nos hemos centrado en la regulación de los receptores de GABA tipo A por parte de 
ciclina D1. GABA es el principal neurotransmisor inhibitorio del cerebro de los mamíferos, 
ejerciendo su acción a través de su unión a los receptores de GABA. Tanto la función como la 
abundancia de los receptores GABAA ionotrópicos a menudo son reguladas por la fosforilación 
del bucle intracelular de sus subunidades. Aquí describimos que ciclina D1 interacciona 
directamente con las subunidades α4 y β3 de los GABAARs, y que colocaliza y co-
inmunoprecipita con la subunidad α4 en el hipocampo de ratón adulto. Además, hemos 
demostrado que el complejo ciclina D1-Cdk4 fosforila α4 en los residuos T423 y S431 y que tanto 
ciclina D1 como un alelo fosfomimético de α4 previenen la pérdida de funcionalidad (run-down) 
de los GABAAR en células HEK tsA201. Finalmente, la inhibición de los complejos ciclina D-
Cdk4/6 mediante Palbociclib revela que estos complejos son necesarios para mantener las 
corrientes tónicas de GABA así como las corrientes postsinápticas miniatura en el hipocampo. 
Globalmente, nuestros resultados sugieren nuevos roles de ciclina D1 citoplasmática en el sistema 
nervioso central, regulando la neuritogénesis y la actividad neuronal a través de los receptores tipo 
A de GABA. Esto podría esclarecer el fenotipo del ratón carente de ciclina D1 y ser relevante 
para comprender diferentes trastornos mentales en los que la desregulación de la 
inhibición GABAérgica es un factor determinante. 
 RESUM 
Ciclina D1 i la quinasa Cdk4 formen un complex que és regularment conegut pel seu paper dintre 
del nucli regulant el cicle cel·lular. D’altra banda, ciclina D1 exerceix funcions no canòniques 
relacionades amb la transcripció, la reparació de l’ADN, la diferenciació i el metabolisme. En el 
nostre grup hem demostrat que ciclina D1 en el citoplasma regula la invasió cel·lular i la 
metàstasi a través de la fosforilació de paxilina. Els ratolins knockout de ciclina D1 presenten 
deficiències neurològiques. Ciclina D1 s’ha trobat al citoplasma de neurones diferenciades i és 
necessària per al creixement de neurites induït per NGF en cèl·lules PC12. Així doncs, ens hem 
proposat explorar les funcions de ciclina D1 citoplasmàtica en neurones. Aquí demostrem que els 
complexos ciclina D1-Cdk són importants per al creixement inicial de neurites en neurones 
corticals embrionàries. La sobreexpressió de ciclina D1 o Cdk4 promou el creixement de l’axó i 
les neurites, mentre que una disminució dels nivells de ciclina D1 endògena inhibeix la 
neuritogènesi en neurones corticals en cultiu. Els nostres resultats assenyalen paxilina com a 
efector downstream de ciclina D1 en aquest procés ja que el mutant no fosforilable de paxilina 
comporta una disminució de les longituds de l’axó i les neurites.  
També ens hem centrat en la regulació dels receptors de GABA tipus A per part de ciclina D1. 
GABA és el principal neurotransmissor inhibitori del cervell dels mamífers, exercint les seves 
accions a través de la seva unió als receptors de GABA. Tant la funció com l’abundància dels 
receptors ionotròpics GABAA sovint són regulades per la fosforilació del bucle intracel·lular de 
les seves subunitats. Aquí descrivim que ciclina D1 interacciona directament amb les subunitats 
α4 i β3 dels GABAARs, i que colocalitza i coimmunoprecipita amb la subunitat α4 a l’hipocamp 
de ratolí adult. A més, hem demostrat que el complex ciclina D1-Cdk4 fosforila α4 en els residus 
T423 i S431, i que, tant ciclina D1 com un al·lel fosfomimètic d’α4 prevenen la pèrdua de 
funcionalitat (run-down) dels GABAAR en cèl·lules HEK tsA201. Finalment, la inhibició dels 
complexos ciclina D1-Cdk4/6 mitjançant Palbociclib revela que aquests complexos són necessaris 
per a mantenir els corrents tònics de GABA així com els corrents postsinàptics miniatura en 
l’hipocamp. 
Globalment, els nostres resultats suggereixen nous papers de ciclina D1 citoplasmàtica en el 
sistema nerviós central, regulant la neuritogènesi i l’activitat neuronal a través dels receptors tipus 
A de GABA. Això podria aclarir el fenotip del ratolí mancat de ciclina D1 i ser rellevant per a 
comprendre diferents trastorns mentals en els que la desregulació de la inhibició GABAèrgica 
n’és un factor determinant. 
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1. INTRODUCTION 
1.1 Cyclins and cyclin dependent kinases 
Cyclins are a family of proteins that regulate the progression through the different stages of the 
cell cycle by forming complexes with catalytic subunits, termed cyclin dependent kinases 
(CDKs), which are serine/threonine kinases. In the cell cycle, the function of these cyclin-CDK 
complexes is to ensure the proper control of both DNA replication and chromosomal segregation 
(Bendris et al. 2015). For instance, the formation of heterodimeric cyclin D-Cdk4/6 complexes 
regulate the entrance to the cell cycle that activates cyclin E-Cdk2 (or Cdk1 to a lesser extend) 
and cyclin A which promote the phosphorylation of various targets that contribute to the cell cycle 
progression. Alternatively, cyclin C-Cdk3 participate in the transition from G0 to G1. To date, 29 
cyclins and 20 CDKs have been described in humans, although not all of them are involved in cell 
cycle control (Malumbres 2011), and there is some degree of redundancy among cyclins and 
among CDKs. Actually, in mammals, the only CDK that seems to be essential is Cdk1 
(Hochegger et al. 2008). The activity of CDKs varies during the cell cycle due to activating 
phosphorylation and the transient interactions with specific cofactors such as cyclins and CDKs 
inhibitors (CKIs). In this sense, cyclins play a role in activating CDKs while CKIs inhibit them 
(Bendris et al. 2015).  
1.1.1. D-type cyclins are essential 
The progression through the cell cycle in mammals is orchestrated by D-type cyclins. This family 
of homologous proteins (D1, D2 and D3) (Charles J. Sherr 1995) associate with Cdk4 or Cdk6 
(Cdk4/6) to form a complex that phosphorylates target proteins (Paternot et al. 2006). D-type 
cyclin expression is tissue specific (Matsushime et al. 1991) and for this reason, the ablation of 
each cyclin D produces deficits in a tissue specific manner. For instance, CCND1 knockout (KO) 
mice are smaller than wild type (WT) mice and also they develop retina and mammary gland 
abnormalities during gestation and are born with neurological deficiencies (Fantl et al. 1995; 
Sicinski et al. 1995), while CCND2 KO mice show female sterility as well as cerebral and 
lymphocyte proliferation deficiencies (Sicinski et al. 1996; Huard et al. 1999; Lam et al. 2000), 
and  mice lacking CCND3 present defects in T lymphocytes maturation (Sicinska et al. 2003). 
Mice lacking all three D-type cyclins developed normally until half gestation with all organs 
developed as in WT, demonstrating that D-type cyclin deficit does not affect cellular proliferation. 
Nevertheless, these mice die before birth due to anemia and coronary deficits because of the 
essential role of cyclins D in the expansion of hematopoietic stem cells (Kozar et al. 2004).  
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Reassuringly, the CDK4/6 KO mouse presents a similar phenotype (Malumbres et al. 2004). 
Thus, D-type cyclins display some degree of redundancy in specific functions that are essential 
during development, but there are also cell types able to proliferate almost normally in the 
absence of these cyclins. For instance, fibroblasts of mice lacking cyclins D proliferate similar to 
WT even though they need more mitogenic signals to reenter the cell cycle (Kozar et al. 2004).   
1.1.2. Canonical function of cyclin D1 
The most studied D-type cyclin is cyclin D1 (Ccnd1) since it is amplified in many tumors of 
different types and origin (Beroukhim et al. 2010). Ccnd1, together with Cdk4/6, controls the 
transition from G1 to S phase in the cell cycle, establishing a point of no return called the 
Restriction point, where cells commit to a new round of cell division (Figure 1). Under mitogenic 
signals and nutrient availability, Ccnd1 expression is induced and Ccnd1-Cdk4/6 complexes are 
activated and phosphorylate the retinoblastoma protein (Rb). The classical view of how cell cycle 
entry takes place assumes that Ccnd1-Cdk4 inactivates Rb by progressive multiphosphorylation.  
 
Figure 1: Multiple roles of cyclin D1. Cyclin D1 acts at the Restriction point of the cell cycle. Under 
mitogenic stimuli, Ccnd1 forms a heterodimer with Cdk4/6 that is able to initiate the phosphorylation of the 
retinoblastoma protein (Rb) that was retaining E2F transcription factor. Once released, E2F is able to trigger 
the transcription of genes necessaries for S phase such as cyclin E. The activation of cyclinE-Cdk2 complex 
gives rise to a positive feedback. Ccnd1-Cdk4/6 complex also contributes to the cell cycle progression by 
retaining Cip/kip, which are Cdk inhibitors. Non-canonical functions of Ccnd1 include: inhibition of 
mitochondrial metabolism, regulation of transcription factor activity, enhancement of DNA repair and 
induction of cell migration and invasion. At late G1 phase, Ccnd1 is phosphorylated by GSK3, exported to 
the cytoplasm and degraded in the proteasome. Adapted from: Sherr 1999.  
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Hypophosphorylated Rb still interacts with the E2F transcription factor and prevents the 
expression of many genes necessary for cell cycle entry. Eventually, when Ccnd1-Cdk4-induced 
phosphorylation of Rb reaches a threshold, E2F is partially released from its inhibition and some 
E2F target genes get expressed, at least to some extent. One of these genes is cyclin E, which 
together with Cdk2 completes the phosphorylation of Rb at late G1 phase to produce an inactive 
hyperphosphorylated Rb, thereby allowing the full expression of a transcriptional program driven 
by E2F that leads to DNA replication (S phase)  (Dulić et al. 1992; Kato et al. 1993). Although 
this constitutes a widely accepted model of G1 cell cycle progression in mammals, it has been 
brought into question by recent studies (Narasimha et al. 2014; Sanidas et al. 2019) that 
demonstrate that Ccnd1-Cdk4 can only monophosphorylate Rb at any of 14 residues, giving rise 
to 14 different monophosphorylated forms of the protein. 
Moreover, Ccnd–Cdk4/6 complexes also contribute to the progression to S phase by sequestering 
members of the Cip/Kip (CDK interacting protein/Kinase inhibitory protein) family of CKIs 
(Sherr and Roberts 1999). These inhibitors do not inhibit Ccnd-Cdk4/6 complexes –in fact they 
are required for their proper functionality- but do inhibit cyclin E and cyclin A in complex with 
Cdk2. 
1.1.3. Non-canonical functions of cyclin D1 
Besides its well-known function as a cell cycle regulator, Ccnd1 has been involved in some other 
processes such as the induction of cell migration and invasion, inhibition of mitochondrial 
metabolism, regulation of transcription factor activity, and enhancement of DNA repair (Hydbring 
et al. 2016). Concerning the function of Ccnd1 as a regulator of transcription factor activity, both 
kinase-dependent and -independent roles have been described. Ccnd-Cdk4/6 complexes activate 
the forkhead transcription factor protein (FOXM1) which further regulates the transcription of 
several cell cycle regulators. Also, Ccnd1–Cdk4 complexes phosphorylate the methylosome 
protein 50, thus increasing the activity of the chromatin modifier PRMT5 (protein Arg N-
methyltransferase 5), involved in neoplastic growth. Besides, Ccnd1 has direct roles in 
transcription that do not implicate kinase activity of Cdks. For instance, Ccnd1 can directly bind 
to and inhibit histone acetyltransferases like CREB-binding protein (CBP) avoiding their binding 
to promoters of target genes such as the peroxisome proliferator-activated receptor- (PPAR). 
Moreover, Ccnd1 is involved in the process of DNA repair, even though Ccnd1 is degraded as a 
consequence of DNA damage. Specifically, Ccnd1 recruits RAD51 thus stimulating homologous 
recombination. Ccnd1 also regulates mitochondrial metabolism. Studies done in transgenic 
CCND1 KO mice showed an important role of Ccnd1 as an inhibitor of mitochondrial biogenesis 
and activity since it phosphorylates and inhibits the nuclear respiratory factor 1 (NRF1) which is 
an inducer of the expression of nuclear-encoded mitochondrial genes (Wang et al. 2006). Also, 
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Sakamaki and co-workers demonstrated in Ccnd1-induced mammary tumors that Ccnd1 
overexpression promotes inhibition of mitochondrial activity while the silencing of Ccnd1 
promotes mitochondrial metabolism (Sakamaki et al. 2006).  
One of the non-canonical functions of Ccnd1, particularly relevant to this work, is its role in cell 
migration (reviewed in Pestell 2013; Hydbring et al. 2016). It has been postulated that Ccnd1 
governs cell adhesion and migration in different cells, including bone-marrow derived 
macrophages, fibroblasts and mammary gland epithelial cells. Indeed, Ccnd1 ablation in both 
fibroblasts and macrophages leads to defects in cell motility and invasion as well as cell matrix 
adhesion (Neumeister 2003; Li et al. 2006b). Genetic complementation experiments showed that 
Ccnd1 rescued the cell migration phenotype of CCND1 KO cells only when a productive complex 
with Cdk4 formed (Li et al. 2006a, c). These authors showed that Ccnd1 promotes fibroblasts 
migration through the inhibition of the thrombospondin 1 and RHO kinase (ROCK) signaling 
pathways (Li et al. 2006b). Besides, Ccnd1 negatively regulates the transcription of E3 ubiquitin 
ligase factor SKP2 (S-phase kinase-associated protein 2) to enhance cell migration (Li et al. 
2006a). Put together, these results suggest that cyclin D1 mediates cell adherence and migration 
through its function in the nucleus as a transcriptional regulator of genes involved in controlling 
those processes. 
Yet, because Ccnd1 interacts with different substrates in the cytoplasm such as filamin A, 
PACSIN2, RhoA, Ral GTPases and paxillin (Pxn), it is thought to play an active role in this 
compartment regulating cell migration and adhesion (Alhaja et al. 2004; Zhong et al. 2010; 
Fernández et al. 2011; Meng et al. 2011; Li et al. 2014; Fusté et al. 2016). For instance, Ccnd1 
can bind to and promote the phosphorylation of filamin A, which is a member of the actin-binding 
filamin protein family favoring cell migration (Zhong et al. 2010). Also, Ccnd1 negatively 
regulates RhoA function to promote cell migration in a manner that in cells lacking CCND1 there 
is an increase in RhoA activity that eventually leads to diminished cellular motility. Besides, 
during keratinocyte differentiation, Ccnd1 interacts with exocyst proteins such as SEC6, 1 
integrin and RALA. The overexpression of Ccnd1 in keratinocytes results in a reduction of 1 
integrin in the membrane and loss of cell adhesion to the matrix.  
Moreover, Fusté et al demonstrated that Ccnd1 controls not only cell adhesion and migration but 
also metastases, by way of activated Ccnd1-Cdk4/6 – Pxn – Rac1 axis (Fusté et al. 2016) since 
Ccnd1 knockdown cells show both reduced phosphorylated Pxn at serine 83 and reduced Rac1 
activation in the membrane thus leading to diminished cell metastatic potential. By contrast, 
phospho-pxn expression in Ccnd1-deficient cells restores metastases. 
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1.1.4. Regulation of cyclin D1 expression 
Because of the relevant role of Ccnd1 in cell cycle regulation, a stringent modulation of its 
function is mandatory (Charles J. Sherr 1995; Sherr 1996; Sherr et al. 2004). On the one hand, 
Ccnd1 expression is induced by mitogenic signals, both from soluble growth factors and from 
interactions with the extracellular matrix (ECM) (Assoian and Klein 2008). On the other hand, 
anti-proliferative stimuli repress Ccnd1 expression. For instance, growth factors modulate both 
the activity and localization of GSK3 through Ras/PI3K/Akt pathway in a manner that when 
growth factors are present, Akt phosphorylates and inhibits GSK3 (Cross et al. 1995; Dudek et 
al. 1997). This is important because GSK3 phosphorylates Ccnd1 at threonine T286 in the C-
terminus of the protein (Diehl et al. 1998), allowing Ccnd1 nuclear export, its polyubiquitination 
and degradation. During G1 phase, GSK3 mostly cytoplasmic but during G1/S transition, 
GSK3 is translocated to the nucleus, where it phosphorylates Ccnd1 allowing its export to the 
cytoplasm by the nuclear exportin CRM1 (Alt et al. 2000). Accordingly, the non-phosphorylatable 
mutant T286A as well as Ccnd1b (an alternative splicing mutant lacking the last 33 amino acids 
of the C-terminus) (Knudsen 2006) are more stable and they localize at the nucleus since they 
cannot be phosphorylated by GSK3 (Diehl et al. 1997) nor exported by CRM1 (Alt et al. 2000). 
Once at the cytoplasm, Ccnd1 is polyubiquinated and recognized for degradation by the 26S 
proteasome. Alt and co-workers showed the relevance of the correct Ccnd1 nuclear exportat since 
the constitutive overexpression of the Ccnd1 T286A mutant in mouse fibroblasts produces 
cellular transformation and has markedly enhanced oncogenic potential in immunodeficient mice 
(Alt et al. 2000). Besides, some studies found somatic mutations of this residue in endometrial and 
esophageal cancers (Moreno-Bueno et al. 2003; Benzeno et al. 2006)  
CCND1 gene expression however, is tightly regulated by multiple transcription factors (reviewed 
in Klein and Assoian 2008). CCND1 transcription is enhanced by mitogenic growth factors since 
CCND1 promoter contains binding sites for AP-1, which is regulated by Fos and Jun which in 
turn are activated by the canonical Ras-Raf-MEK-ERK pathway under mitogenic signaling. In 
addition, Ras activation by growth factors induces Sp-1 mediated CCND1 gene expression. 
Similarly, Rac and NF-B stimulated by mitogenic signals are also strong enhancers of CCND1 
expression, and cytokines are also capable of inducing CCND1 gene expression via the JAK-
STAT pathway. Importantly, proteins of the ECM such as collagen, fibronectin and vitronectin 
can trigger focal adhesion kinase (FAK) upon integrin clustering and further promote CCND1 
expression through different transcription factors.  
On the other hand, CCND1 expression is inhibited by several transcription factors in a process 
that is of high relevance for cell differentiation in certain cell lineages. Actually, Ccnd1 
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transcriptional repressors are cell-type-specific. For example, jumonji (Jmj; JARID2) repression 
of CCND1 is necessary for neurogenesis in the mouse hindbrain and cardiac morphogenesis while 
in epithelial cells SIP1 downregulates CCND1 inducing an epithelial-mesenchymal transition. 
Apart from controlling cell differentiation, the repression of CCND1 is very important to avoid 
unwanted cell proliferation.  
1.1.5. Phenotype of cyclin D1 knockout mice  
The phenotype of mice lacking CCND1 was studied parallelly by Fantl and Sicinski (Fantl et al. 
1995; Sicinski et al. 1995). Sicinski and co-workers did not observe embryonic lethality while 
Fantl and co-workers saw a modest but statistically significant reduction in the number of Ccnd1 
KO animals born as compared to the expected value (18% vs 25%), suggesting some degree of 
embryonic lethality. This difference may be attributed to the different genetic backgrounds used. 
Both studies reported that lack of Ccnd1 gave rise to smaller than normal animals, produced 
severe developmental defects in the retina, and a failure to undergo the massive proliferation of 
the mammary epithelium that takes place during pregnancy. Interestingly, Sicinski and co-
workers also observed an abnormal limb reflex phenotype in Ccnd1 KO mice, indicative of a 
neurological impairment. 
1.1.6. Cyclin D1 in neurons 
Neurons are generated from cells of the neural tube in a process known as neurogenesis. In the 
central nervous system (CNS), progenitor cells may undergo two different divisions: proliferative 
and differentiative. In the symmetric proliferative division, a progenitor cell divides generating 
two progenitors that maintain cycling capacity. By contrast, in the differentiative division at least 
one daughter cell stops dividing and differentiates into a neuron (Dehay and Kennedy 2007; 
Knoblich 2008). It is ill-defined what makes a cell to follow one of these alternatives, but there 
appears to be a correlation between the length of G1 phase and the final output. Thus, regulators 
of G1 phase such as cyclins D may play an important role in neurogenesis (Lange et al. 2009; 
Pilaz et al. 2009; Najas et al. 2015). Once generated, neurons must undergo specialization 
according to its final location and function. A morphological characteristic of neuronal 
differentiation is the growth of prolongations (neuritogenesis) from the main cell body (soma), the 
neurites and the axon, that will allow the neuron to communicate with other cells. Proper 
generation and extension of neurites and axons in time and orientation is critical for neuronal 
connectivity and, as a consequence, for brain function (see below). Interestingly, a role for Ccnd1 
in neuritogenesis has been reported as its downregulation by shRNA prevents the NGF-induced 
neuritogenesis in PC12 cells (Marampon et al. 2008). 
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Cytoplasmic sequestration of Ccnd1 in neurons has been proposed as a survival mechanism for 
differentiated cells (Sumrejkanchanakij et al. 2003). In this case, it is the inhibition of Ccnd1 
nuclear import, rather than the acceleration of nuclear export, what prevents the nuclear 
accumulation of Ccnd1 and, in this manner, prevents neuronal death. Importantly, both mRNA 
and protein levels of Ccnd1 are increased after exposure to stress conditions in in vitro and in vivo 
models of neurodegeneration (Osuga et al. 2000; Di Giovanni et al. 2005; Byrnes et al. 2007). 
Similarly, Ccnd1 expression levels are elevated subsequent to glutamate- or kainate- induced 
neurotoxicity (Koeller et al. 2008; Negis and Karabay 2016). Actually, hippocampal neurons 
from Ccnd1+/- mice presented reduced cytotoxicity after kainate exposure compared to those from 
WT mice (Koeller et al. 2008). In addition, overexpression of cytoplasmic Ccnd1 in in utero 
electroporated cells resulted in an increase in migration (Rocandio 2018). Besides, cytoplasmic 
Ccnd1 has been detected in important adhesion sites of the radial glia fiber, suggesting that it 
plays a role in brain development (Rocandio 2018). In fact, Ccnd1 deficiency during radial 
migration leads to defects in the organization of layer V at postnatal ages that could be 
responsible for the abnormal limb reflex and leg clasping movements present in Ccnd1 KO mice 
(Urbánek et al. 1994; Sicinski et al. 1995; Rocandio 2018).  
1.2 Paxillin 
Paxillin is a 68 kDa protein with multiple domains that is a structural and regulatory component 
of focal adhesions (FAs), the macromolecular structures connecting the cytoskeleton and the 
extracellular matrix (ECM). Pxn actively mediates cell signaling and participates in FA assembly 
(Brown and Turner 2004) functioning as an adaptor protein that facilitates the interaction between 
different molecules such as kinases, other adaptor proteins, nucleotide exchange factors and 
cytoskeleton proteins (Brown et al. 1996). Notably, Pxn interacts with several proteins involved in 
the regulation of various processes such as cell motility, cell survival, actin cytoskeleton 
organization, cell proliferation, embryonic development, wound healing and immunity (Schaller 
2001). 
Paxillin knockout mouse is embryonic lethal, and in vitro cultured Pxn-deficient MEFs has altered 
processes of fibronectin signaling such as inadequate FA formation and an inefficient distribution 
of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase that is a key mediator of integrin 
signaling. The shortage of phosphorylation by FAK leads to reduced spreading capacity, loss of 
lamellipodia and decreased rates of cell migration (Hagel et al. 2002).  
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1.2.1. Paxillin regulation by phosphorylation 
Paxillin contains multiple phosphorylation sites that are critical for its localization and functions, 
and that are the targets of a wide variety of kinases and phosphatases. Even though tyrosines 31 
and 118 are the main phosphorylation sites, several serine/threonine kinases phosphorylate 
residues at the N-terminal half of the protein during cell migration, thus controlling its function 
and also proteasomal degradation. Amongst these kinases, JNK (JUN N-terminal kinase) 
phosphorylates Pxn at Ser178, a critical step in cell migration (Zeid et al. 2006; Huang et al. 
2008). Phosphorylation at Ser273 by the p21-activated kinase (PAK) participates in the regulation 
of cell adhesion through Rac activation (Nayal et al. 2006). Also, Pxn has been shown to be 
phosphorylated by GSK3 at Ser130 and by Raf/MEK/ERK at Ser126 (Woodrow et al. 2003). By 
contrast, phosphorylation at serine residues in the C-terminal domains of the protein has been 
suggested to govern Pxn localization at FAs. For instance, phosphorylation at Ser272 blocks the 
nuclear export of Pxn, leading to its accumulation in the nucleus where it enhances androgen 
receptor and ERK-mediated transcription (Dong et al. 2009; Ma and Hammes 2018).  
1.2.2. Focal adhesions 
Adhesion of cells to the ECM is a key step in processes such as cell migration through tissues, 
cell differentiation and proliferation, embryonic development, immunology and tissue repair 
(Gumbiner 1996). The attachment of cells to ECM components is mediated by cell-surface 
proteins called integrins, which are transmembrane proteins formed by a heterodimer of an  and 
a  subunit, with a large extracellular domain and a cytoplasmic portion. Although integrins lack 
intrinsic enzymatic activity in their cytoplasmic domain, interaction with the ECM promotes their 
dimerization and the recruitment of structural and regulatory proteins to the FA (Figure 2). At 
present, 24 distinct heterodimers have been characterized in mammals from the combination of 18 
different  subunits and 8  subunits (Van der Flier and Sonnenberg 2001; Hynes 2002; Luo et al. 
2007). Each integrin is capable of recognizing a distinct ligand of the ECM. As such, integrins on 
the surface of a cell act as sensors for the ECM environment (Hynes 2002). The adaptor/scaffold 
proteins in FAs mediate the interaction with the actin cytoskeleton thereby connecting cells firmly 
to the ECM. On the other hand, signaling proteins in FAs mediate cytoskeleton dynamics, FA 
formation and cell contraction through the actin-myosin filaments (Burridge et al. 1992; Geiger et 
al. 2001; Zaidel-Bar et al. 2006). This generates enough force to alter cell morphology and to 
move the cell body during migration. Upwards of 125 proteins have been reported to take part in 
FAs (Turner 2000; Zaidel-Bar et al. 2007), and among them Pxn serves as a scaffold protein to 
facilitate the functional integration of multifold components of the complex (Deakin and Turner 
2008).  
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A correct FA assembly and recycling is crucial for cell adherence and motility (Geiger et al. 
2001; Parsons et al. 2010). The activity of these complexes is often regulated by the 
phosphorylation of the clustered proteins forming the FA such as Pxn, Src and FAK (Webb et al. 
2004; Li et al. 2005). FA dynamics is believed to be controlled by small GTPases like Rac and 
Rho, one controlling the early formation of FA and the other the maturation of the complex, 
respectively (Wozniak et al. 2004). The dysregulation of FAs can lead to pathological conditions. 
For instance, Pxn is upregulated at both RNA and protein levels in many human cancers, thus 
acting as an oncogene in malignancy progression (Jagadeeswaran et al. 2008; Kim et al. 2012; 
Sen et al. 2012; Chen et al. 2013; Wu et al. 2014; Huang et al. 2015; Li et al. 2015).  
 
Figure 2: Focal adhesions serve as a link between the ECM and the actin cytoskeleton. Cells adhere to 
the ECM through -integrin heterodimers, which result activated and recruit cytoplasmic proteins, 
including Pxn, to the plasma membrane. In this structure, Pxn acts as scaffold protein. Adapted from: 
Deakin and Turner 2008.   
1.2.3. Paxillin in the central nervous system 
The generation of neurites or neuritogenesis is a process common to all neurons. It begins with the 
formation of an initial budding in the neuronal sphere, followed by the sprouting of cell 
projections (neurites) from this and other buds on the cell surface, and the polarized growth of 
these cell extensions to become axons or dendrites (Da Silva and Dotti 2002). Polarized growth 
takes place at the distant tip of the neurite, a region called the growth cone. It is the interaction 
between membrane proteins and the ECM during cell adhesion that makes possible the formation 
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of lamellipodia adjacent to the leading edge of the growth cone (Da Silva and Dotti 2002; 
Thoumine 2008). The progression of this growth cone is based on two processes. First, there is a 
retrograde flow of actin generated by actin polymerization at the leading extremity combined with 
actin depolymerization in the central region and myosin rending on actin filaments in lamellipodia 
(Diefenbach et al. 2002). This results in a mechanical tension that will drive neurite outgrowth 
(Schaefer et al. 2008). Second, cell adhesion molecules contact with the ECM and adjacent cells 
and coordinate migration speed. FA proteins facilitate the signaling across the membrane and lead 
to cell migration and neuritogenesis (Milner and Campbell 2002). In fact, integrin-mediated 
adhesions are essential for neurite outgrowth (Rhee et al. 2000; Ivankovic-Dikic et al. 2000) and 
inhibition of Pyk2/FAK is sufficient to block neuritogenesis induced by ECM (Ivankovic-Dikic et 
al. 2000). Mechanisms controlling neuronal migration and neurite extension must be well 
coordinated since the final morphology, functionality and connectivity of the neuron will depend 
on this (Hatten 2002; Solecki et al. 2006). Consequently, defects on these processes may cause 
several pathologies such as mental retardation, epilepsy or learning deficiencies (Marin and 
Rubenstein 2003).  
Although the CNS is the tissue with lower Pxn expression levels, Pxn plays a critical role in 
neuritogenesis. In particular, Pxn acts both by linking extracellular receptors to the actin 
cytoskeleton and also by regulating Rho-GTPase signaling (Brown and Turner 2004). Pxn 
phosphorylation is necessary for cell spreading and neurite formation, both characteristics of the 
morphological phenotype of a differentiated neuron, and Pxn levels are increased in differentiated 
neurons in comparison with undifferentiated cells (Leventhal and Feldman 1996). Importantly, 
Pxn deficiency disrupts neuronal positioning and neuronal migration in post-mitotic neurons 
(Rashid et al. 2017). Several studies implicate Pxn phosphorylation in neurite outgrowth in 
different cell types. For instance, laminin-induced neurite outgrowth depends on the 
phosphorylation of both FAK and Pxn mediated by the AKT/GSK3 pathway (Chen et al. 2009). 
Besides, Pxn plays a key role in cell migration in the central and peripheral nervous system during 
development. Phosphorylation of Pxn at S178 by JNK regulates Schwann cell migration 
(Miyamoto et al. 2012). In oligodendrocytes (OLs), S244 phosphorylation by Cdk5 following 
induction of OLs differentiation suggests that Pxn may also be involved in OL differentiation and 
myelination through Cdk5 phosphorylation (Miyamoto et al. 2007). In vitro studies in PC12 cells 
show that Pxn promotes neurite outgrowth induced by NGF and EGF. In particular, mutation of 
S85 in Pxn, a known phosphorylation target of p38MAPK, dramatically reduces NGF-induced 
neuritogenesis (Huang et al. 2004). Additionally, Nemo-like kinase phosphorylation of Pxn S126 
and microtubule-associated protein-1B (MAP1B) have been proposed as a downstream 
mechanism of NGF control of cytoskeleton dynamics and neurite extension (Ishitani et al. 2009).  
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1.2.4. Rho GTPases 
The Rho family of small GTPases is a subfamily of the superfamily of Ras GTPases that in 
mammals is composed by some 20 members, among which Cdc42, Rac1 and RhoA are the best 
characterized. These GTPases are involved in the control of different processes such as the actin 
cytoskeleton and FA organization, cell motility, gene transcription and cell cycle progression 
(Ridley 2015). Some members of this family are necessary for the metastatic potential of tumor 
cells in vivo (Burbelo et al. 2004). The activity of Rho GTPases is tightly regulated by nucleotide 
exchange, with an inactive form bound to GDP, and an active one bound to GTP. The alternation 
between these two states is controlled by guanine nucleotide exchange factors (GEFs), GTPase-
activating proteins (GAPs), and GDP-dissociation inhibitors (GDIs). GEFs activate GTPases by 
facilitating the exchange of GDP for GTP. GAPs stimulate GTPase activity, promoting GTP 
hydrolysis into GDP, thus inactivating the GTPase, and GDIs inhibit the dissociation of GDP 
from the protein, avoiding its exchange for GTP (Hoffman and Cerione 2002). These GTPases 
can be activated by extracellular signals like EGF or insulin, which control Rac activity and 
generate lamellipodia and membrane ruffles. On the other hand, Cdc42 activation leads to the 
formation of filopodia while RhoA promotes cell migration by regulating the adhesion of the cell 
(Ridley 2001a, b; Raftopoulou and Hall 2004). 
1.3 GABAergic neurotransmission 
Gamma-Aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the CNS. 
GABA is released by up to 40% of neurons to activate chloride channels generally leading to the 
inhibition of firing (Bowery and Smart 2006). GABAergic neurons are found all through the 
brain, especially in the hippocampus, thalamus, cerebral cortex, substantia nigra, striatum and 
cerebellum (Fritschy and Brünig 2003). Since it is present in large amounts in the brain and 
distributed in a cellular-specific manner, GABA has multiple roles in the CNS. For example, 
GABA is involved in physiological mechanisms like feeding and sexual behavior, mood, 
aggression, locomotor activity, pain sensitivity, cardiovascular regulation and thermoregulation 
(Matsumoto 1989). The abnormal function of the GABAergic neurotransmission can lead to 
several disorders such as epilepsy, anesthesia, anxiety, stress, schizophrenia, neurodegenerative 
diseases and disorders in memory, sleep, stress and cardiovascular and neuroendocrine function 
(Wong et al. 2003). Consequently, many drugs target GABA receptors including benzodiazepines, 
barbiturates, ethanol, anesthetics and neuroactive steroids (Froestl 2011), 
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1.3.1. GABA synthesis, reuptake and degradation 
GABA is a glutamate derivate synthetized by the enzyme glutamate decarboxylase (GAD) and 
found exclusively in GABAergic neurons. There are two enzyme isoforms, GAD65 and GAD67, 
which differ in their cerebral and cellular distribution. While GAD65 is mainly found at neuronal 
terminals, GAD67 is spread all through the cell and it is used as a marker for GABAergic 
neurons. Once synthetized, GABA is introduced in secretory vesicles by means of the vesicular 
transporter vGAT and further released out of the cell in a Ca2+ dependent manner following 
presynaptic neuron depolarization. The release of GABA vesicles can be modulated by 
autoreceptors of GABA located presynaptically, which results in a negative feedback; or by the 
hyperpolarization of the GABAergic neuron by another GABAergic neuron. Released GABA 
binds to and acts on postsynaptic receptors. Further, and as a mechanism for cessation of the 
GABAergic transmission, GABA is captured by Na+/Cl- GABA transporters (GAT1-3 and BGT1) 
in astrocytes or GABAergic neurons. In astrocytes, GABA is degraded by GABA transaminase 
while GABAergic neurons can reuse it as a neurotransmitter (Martin and Rimvall 1993; Madsen 
et al. 2007).  
1.3.2. GABA receptor types 
GABA exerts its effects activating two different types of GABA receptors. GABAA receptors 
(GABAAR) are pentameric ligand-gated ion channels (pLGIC) whereas GABAB receptors are 
metabotropic (Olsen and Sieghart 2008). They were first distinguished and named on the basis of 
sensitivity to bicuculline and baclofen respectively. However, their classification has been 
confounded by the finding of ionotropic receptors that are insensitive to both bicuculline and 
baclofen. These are GABAc receptors, nowadays belonging to the GABAA receptor family. 
Ionotropic type A receptors are the major inhibitory receptors in the CNS and are selectively 
permeable to Cl- (and HCO3-). When activated by GABA binding, they commonly allow the rapid 
influx of anions into the cell leading to hyperpolarization of the plasmatic membrane and 
consequently to the inhibition of the neurotransmission (Farrant and Kaila 2007). On the other 
hand, GABAB receptors are coupled to G proteins and their mechanism of action depends on 
which G protein(s) it is coupled to. Finally, the structure, pharmacology and physiology of 
GABAc receptors is different from other GABAAR although they preserve the main functional 
properties such as Cl- permeability. They are almost exclusively found in the retina (Albrecht and 
Darlison 1995).  
The main action of GABA is mediated by pLGIC or type A receptors. GABAAR belongs to the 
Cys-loop superfamily of LGICs along with other receptors such as the nicotinic acetylcholine 
receptors (nAChRs) (Corringer et al. 2000), glycine receptors (GlyRs) (Breitinger and Becker 
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2002), type-3 5-hydroxytrypamine receptors (5-HT3R) (Lummis 2012) and the Zn2+-activated 
cation channel (ZAC) (Davies et al. 2003). They are called Cys-loop receptors because they 
contain a conserved structural motif formed by a disulphide bridge in the extracellular domain 
(ECD). Cys-loop receptors are heteropentameric structures that form an ion-permeable central 
pore. Upon agonist binding, there is a conformational change in the receptor complex with the 
consequent ion channel opening. In most mature neurons, this generates a net inward flow of 
anions and the consequent hyperpolarizing postsynaptic response known as inhibitory 
postsynaptic potential (IPSP). This phenomenon occurs following release of GABA from 
presynaptic vesicles. The high concentration of GABA briefly stimulates postsynaptic GABAAR 
resulting in an increase in membrane conductance which in turn underlies what is known as 
“phasic” inhibition (Figure 3).  
However, GABA inhibition of the CNS is not only due to the activation of postsynaptic 
GABAAR, but also due to the persistent or “tonic” stimulation of extrasynaptic GABAAR (Figure 
3). Those responses are less spatially and temporally specific and are generated by low GABA 
concentrations in the extracellular space. Hence, extrasynaptic GABAAR present higher affinity 
for GABA than postsynaptic receptors. Moreover, tonic receptors remain opened for a longer time 
upon GABA binding (Farrant and Nusser 2005). Alterations in the modulation of this tonic 
inhibition have been linked to several disease states.  
 
Figure 3: Synaptic and extrasynaptic GABAAR neuronal localization. GABAARs containing (1-3) 
subunits are mainly located at the synapse mediating phasic inhibition, whereas (4,6) and (5) 
receptors are located at extrasynaptic sites modulating tonic inhibition.  
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1.3.3. GABAA receptor subunits 
All the pLGICs show a common transmembrane topology with many residues and motifs 
conserved between members, which indicates their relevance in the structure and function of the 
receptor. Within the members of the eukaryotic Cys-loop superfamily, tertiary and quaternary 
structures are conserved (Sine and Engel 2006). Each mature subunit is approximately 450 amino 
acid residues in length and contains a very large hydrophilic amino (N)-terminal ECD containing 
agonist binding sites and the characteristic Cys-loop. Besides, they contain a transmembrane 
domain (TM) composed of four transmembrane alpha-helices (TM1-4) where the TM2 of each 
subunit forms the lining of the channel pore (Figure 4A,B).  
 
Figure 4: Schematic representation of GABAAR structure. A) Typical GABAAR subunit structure with 
a large extracellular N terminal, four transmembrane domains (TM1-4), one short intracellular loop between 
TM1-2, one short extracellular loop that links TM2-3 and one long intracellular loop between TM3-4 
susceptible to phosphorylation. B) Top view of the pentamer showing the distribution of each subunit. TM2 
of each subunit (in yellow) forms the lining of the channel pore. GABA binding site is located between  
and  subunits while benzodiazepines bind at the interface between  and . C) GABAARs are pentamers 
forming a channel that is permeable to chloride anion.  
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Between the TM3 and TM4 they contain a large intracellular loop which is susceptible to 
phosphorylation as a mechanism of regulation of the activity and trafficking of the receptor 
(GABAAR modulation via intracellular loop phosphorylation will be discussed below). Finally, 
GABAARs have two binding sites for GABA located to the / interface. Moreover, they have an 
extra binding site at the / subunit interface where benzodiazepines and other drugs bind (Figure 
4B) (Sigel and Steinmann 2012). 
In the human genome, 19 genes have been identified to encode for GABAAR subunits, including 
six  subunits, three  subunits, three  subunits, three  subunits (forming GABACR), and one 
each of the , ,  and  subunits (Barnard et al. 1998; Whiting 1999). Additionally, some 
GABAAR subunits present different forms following alternative splicing. For instance, splice 
variants are found for the 1-3, 2, 1,  2-3 and  subunits. The majority of genes coding for the 
GABAAR subunits are organized in four clusters on chromosomes 4, 5, 15 and X in the human 
genome (Darlison et al. 2005). This distribution is thought to contribute to coordinated gene 
expression.  
In this thesis, we focus on the study of the 4 and 3 subunits. For this reason, a special mention 
of them will be done in each section.  
1.3.4. GABAA receptors, structure and composition 
As mentioned above, GABAARs are formed by the assembly of five subunits (Figure 4C). 
Commonly receptors are heteropentamers formed by several types of subunits. Hence, in 
physiological conditions five subunits selected from 19 isoforms form a pentameric complex and 
surrounding a central ion channel. Furthermore, some GABAAR subunits (e.g. 3) can form 
homopentameric functional receptors in vitro (Wooltorton 1997). In fact human 3 subunit is able 
to assemble into functional homomeric channels although they have not been identified as discrete 
populations in the brain yet (Miller and Aricescu 2014). Actually, the functional properties of the 
receptors depend on both subunit composition (Sigel et al. 1990) and arrangement (Minier and 
Sigel 2004). Therefore, receptors formed by the same subunits but differently arranged will have 
distinct functional properties. Usually, GABAAR are made up of two , two  and one  or  
subunits being the most common combination in the adult brain 122 (40-60%) (Whiting et al. 
1995; Barnard et al. 1998) with the other common subunit combinations being 222 (15-20%), 
4/2 (<5%) and 6/2 (<5%) (Fritschy and Mohler 1995; Whiting et al. 1995; Sieghart and 
Sperk 2002). Also, GABAARs containing other subunit stoichiometries, like binary constructs of 
 and  subunits have been reported (Fritschy et al. 2012; Fritschy and Panzanelli 2014). 
Notably, 6 subunit is nearly exclusively expressed in granule cells in the cerebellum of the adult 
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brain forming 6 receptors (Nusser et al. 1998). The 42 is expressed in the thalamus, 
dentate gyrus and caude-putamen (Pirker et al. 2000). The 42 is expressed in the thalamic 
relay nuclei (Chandra et al. 2006), and the 43 subtype is expressed in dentate granule cells of 
the hippocampus (Liang et al. 2006). Both 42 and 43 are found in the cerebral cortex 
while 43 predominates in the striatum. Notably, 4 subunit can form functional receptors 
with x2 and x, both expressed in the thalamus and the dentate gyrus of the hippocampus, 
although they differ in their subcellular localization: being the first located synaptic and the 
second extrasynaptic (Bencsits et al. 1999). Though 4 receptors represent only 1% of the total 
subtypes (Bencsits et al. 1999), their role is highly important since they are involved in 
extrasynaptic tonic inhibition. In the cerebellum, 2/3 subunits interact with 6 and  to form 
extrasynaptic receptors (Wei et al. 2003; Scimemi 2005; Hörtnagl et al. 2013; Fritschy and 
Panzanelli 2014). Moreover, 3 subunit can be found together with 5 and 2/3 in hippocampal 
pyramidal cells (Fritschy and Mohler 1995).  
1.3.5. Cellular and subcellular localization of GABAA receptors 
The regional and subcellular localization of GABAARs is ruled by its subunit composition and 
varies all over the brain throughout development (Laurie et al. 1992; Wisden et al. 1992). Most 
subunits are present in several regions of the CNS, although 6 subunit is exclusively expressed 
in granular cells in the cerebellum of the adult brain and  subunit is nearly restricted to retina 
cells (Sieghart and Sperk 2002). Besides, GABAARs containing 1 subunit are mainly found on 
interneurons and Purkinje cells while 2 subunit-containing receptors are localized to motor 
neurons and pyramidal cells (Sieghart and Sperk 2002). Concerning 4 subunit, it is specifically 
located in the thalamus, dentate gyrus and striatum (Chandra et al. 2006) and its expression varies 
along the development. In immature and newborn granule cells, 4 is required for the assembly of 
functional GABAARs. Expression of 4 subunit expression increases in hippocampal pyramidal 
neurons at puberty, which has been proposed as a mechanism for the decline in Long-Term 
Potentiation (LTP) observed at puberty (Shen et al. 2010). Finally, in the adult brain, there is a 
decrease in the expression of the 4 subunit (Peng et al. 2004). 4 deficient cells from adult 
hippocampus present incomplete migration and altered dendritic maturation attributed to the lack 
of 4-containing GABAARs (Duveau et al. 2011). Regarding 3 subunit, it is expressed at 
different structures of the brain, including among others the cerebral cortex, hippocampus, 
cerebellum and the thalamus. Again, its expression varies at different stages of development and 
maturity. For instance, peaks are reached prenatally in the thalamus, the hippocampus and the 
cerebral cortex and further postnatally in the cerebellar cortex (Laurie et al. 1992; Nadler et al. 
1994). After each peak of expression, rapid down-regulation takes place. Along postnatal 
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maturation, the cerebral cortex and, not as much, the hippocampus present lower 3 subunit levels 
while expression in the cerebellum does not change (Laurie et al. 1992; Nadler et al. 1994). In the 
end, in mature mice, the expression of the 3 subunit is higher in the cerebellum (Purkinje and 
granule cells), the pyriform cortex and the hippocampus (Wisden et al. 1992).  
In the CNS, the subcellular localization of GABAAR has been studied by immunofluorescence 
and electron microscopy (EM). For instance,  receptors are enriched at GABA-synapses of 
postsynaptic neurons in numerous brain regions such as the cerebellum (Craig et al. 1994) 
(Nusser et al. 1995), hippocampus (Nusser et al. 1996) and neocortex (Farrant and Nusser 2005). 
Nevertheless, so far not a single receptor has been described to be uniquely found at synapses. 
Thus, even the more enriched form at synapses, the 12/32L, is also present outside the 
synapses (Nusser et al. 1995). On the other hand, -containing GABAARs do not localize at the 
synapse and exist exclusively in extrasynaptic and perisynaptic sites in hippocampal CA1 
pyramidal neurons and dentate granule cells (Wei et al. 2003; Scimemi 2005). For instance,  
subunit forms receptors with 6 and 2/3 in the cerebellum and with 4 and X in the 
hippocampus (Hörtnagl et al. 2013; Fritschy and Panzanelli 2014). In summary, 2-containing 
GABAARs (co-assembled with 1-3 and 2/3 subunits) predominantly exist at inhibitory 
synapses mediating phasic inhibition, while receptors formed by 4-6 subunits co-assembled with 
 subunit are almost exclusively found peri- and extrasynaptically and mediate tonic inhibition.  
Apart from its localization at postsynaptic neurons, GABAAR have also been found at presynaptic 
membranes on distal axons and terminals (Fritschy and Panzanelli 2014). presumably regulating 
neuronal synchronization and mediating presynaptic afferent depolarization, as well as regulating 
neurotransmitter release in some cell types (Bowery and Smart 2006).  
Outside the CNS, GABAA receptors have been found in the liver where they inhibit cell 
proliferation (Erlitzki et al. 2000). For instance, 3 subunit levels are decreased in hepatocellular 
carcinoma, which correlates with increased tumor growth (Minuk et al. 2007). In smooth airway 
muscles of the lung, GABAARs facilitate relaxation (Mizuta et al. 2008) and in several types of 
immune cells, GABAAR activation decreases cell proliferation (Alam et al. 2006; Bjurstöm et al. 
2008).  
1.3.6. Assembly and trafficking of GABAA receptors  
GABAARs serve as a chloride ion-selective channel that opens when GABA binds to its agonist 
binding site, thus increasing the chloride entrance into the cell. The membrane then 
hyperpolarizes, inhibitng the firing of new action potentials. Given the relevant role of the 
GABAergic neurotransmission for the proper CNS function, regulating the number of GABAARs 
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in the cell surface is fundamental (Figure 5). GABAARs are assembled in the endoplasmic 
reticulum (ER) in a specific process regulated by residues at the N-terminal domain in each 
subunit, which limits the possible subunit combinations (Luscher et al. 2011). Mutations in the N-
terminal domains of different subunits abolish the subunit assembly and receptor generation 
(Korpi et al. 1994; Tan et al. 2007). The assembly begins with the formation of  heterodimers 
with the assistance of ER-associated chaperones, including calnexin and binding immunoglobulin 
protein (BiP) which monitor the fidelity of protein folding and assembly (Connolly et al. 1996; 
Bradley et al. 2008). This step is of a high relevance since the depletion of either  or  subunits 
results in the loss of the corresponding receptors whereas the loss of the 2 leads to just a modest 
decrease of GABA binding sites (Gunther et al. 1995). Unassembled GABAAR subunits are 
bound to ER-chaperones that retain them until degradation (Bollan et al. 2003). Although the 
regulation of the differential subunit assembly in cells that co-express different GABAARs is still 
unknown, it is thought that is driven by the co-translation of compatible subunits. In this sense, 
the ectopic expression of 6 subunit in mouse hippocampal cells leads to an increased number of 
62 receptors located extrasynaptically whereas postsynaptic receptors decrease (Wisden et al. 
2002).  
Once assembled, GABAARs must leave the ER by exocytosis. This process is however limited by 
the constitutive degradation of both  and  subunits in the ER (Saliba et al. 2007; Bradley et al. 
2008). The chronic blockade of neural activity increases the GABAAR degradation at the ER 
(Saliba et al. 2009). The release of GABAARs is helped by the interaction between  and  
subunits with PLIC-1 (Protein that Links Integrin-associated protein with the Cytoskeleton-1), 
since PLIC-1 interacts with polyubiquitinated GABAAR subunits at the ER thus preventing ER-
associated subunit degradation and enhancing their expression at the cell surface (Bedford et al. 
2001; Saliba et al. 2008).  
Another posttranslational modification that is involved in the control of GABAAR trafficking is 
palmitoylation. In particular, the Golgi-specific DHHC zinc finger protein (GODZ, zDHHC3) 
palmitoylates 2 subunit at cytoplasmic cysteine residues facilitating the translocation of the 2-
containing receptor from ER to Golgi and enhancing the accumulation of GABAARs at inhibitory 
synapses (Keller et al. 2004). Actually, the downregulation of GODZ produces the selective loss 
of GABAARs at synapses and the corresponding decrease in the amplitude and frequency of 
mIPSCs along with whole cell currents (Fang et al. 2006). 
 
 
  
 
Figure 5: Modulation of GABAARs trafficking by phosphorylation. GABAARs are assembled in the ER, matured in the Golgi, secreted and inserted into the plasma 
membrane. Synaptic receptors reach their destination through lateral diffusion. GABAARs subunits phosphorylation by several kinases regulates their function and their 
surface expression. Dephosphorylation of these subunits activates the internalization of the GABAAR through its interaction with AP2 adapting complex. Endocyted receptors 
are transported to the endosomal system and further recycled to the cell surface or degraded in the lysosomes. Adapted from: Chuang and Reddy 2018. 
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Further, GABAARs need to be translocated from Golgi to the plasma membrane. In this process, 
the brefeldin A-inhibited GDP/GTP exchange factor 2 (BIG2) interacts with the  subunits 
through its intracellular loop and facilitates the GABAARs release from the Golgi to the plasma 
membrane (Charych et al. 2004). Besides, BIG2 is also a component of GABAARs recycling 
endosomes (Boal and Stephens 2010). Apart from BIG2, the GABAARs associated protein 
(GABARAP) interacts with all  subunits easing the translocation of GABAARs to the cell surface 
(Leil 2004). Moreover, GABARAP plays a role in rapid NMDA-induced functional plasticity of 
inhibitory synapses (Marsden et al. 2007). That is, upon NMDA receptor activation, there is an 
influx of Ca2+ that leads to a rapid accumulation of postsynaptic GABAARs with the consequent 
increase in mIPSCs. This procedure also involves Ca2+ calmodulin-dependent kinase II (CaMKII), 
which is believed to phosphorylate the residue S383 of the 3 subunit (Houston et al. 2007).  
Another important process for the correct regulation of the number of GABAARs in the cell 
surface is the endocytosis. For this, adaptor proteins like clathrin adaptor protein AP2 are 
important for their interaction with  and  subunits (Kittler et al. 2000). The AP2 binding motif 
in  subunits consists in a 10 basic amino acids sequence that includes a conserved 
phosphorylation site in the intracellular loop of 1-3 subunits (Kittler et al. 2005, 2008). 
Significantly, AP2 cannot interact with the  subunit when they are phosphorylated, i.e. AP2 
interacts with GABAARs promoting their internalization only when they are dephosphorylated. 
Consequently, neuronal perfusion with an unphosphorylated 3-derived peptide leads to an 
increase in mIPSCs and whole cell currents due to a decrease in the internalization of GABAARs 
(Kittler et al. 2005). In fact, several kinases like PKA (Protein Kinase A), PKC, Akt and CaMKII 
can control phosphorylation of  subunits and consequently, endocytosis. Thus, PKA can 
phosphorylate 1 and 3 subunits at the AP2 interaction site (McDonald et al. 1998). PKC 
phosphorylates 1, 2 and 3 (McDonald et al. 1998; Brandon et al. 2003) and reductions in the 
phosphorylation state of  subunits by PKC inhibition have been involved in the loss of 
GABAergic inhibition present in animal models of status epilepticus (Terunuma et al. 2008). 
Apart from kinases endocytosis is also modulated by phosphatases. For instance, PP1 
dephosphorylates 3 subunit at the AP2 interaction site promoting its endocytosis (Terunuma et 
al. 2004).  
After their endocytosis, GABAARs can be either recycled or degraded. Approximately 70% of the 
GABAARs are reinserted into the membrane in an hour after endocytosis. The other 30% are 
targeted to endosomes for degradation in a process that takes about 6 hours (Kittler et al. 2004). 
The decision of whether endocyted GABAARs undergo recycling or degradation is modulated by 
the interaction between  subunits and huntingtin-associated protein 1 (HAP1) through the 
cytoplasmic loop of the  subunit in a manner that when both proteins interact, there is a decrease 
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in the degradation of GABAARs and an enhancement of their recycling (Kittler et al. 2004). In 
fact, it is believed that the neurodegenerative effects observed in Huntington’s disease are, in part, 
due to a reduced expression and function of the GABAARs (Twelvetrees et al. 2010). Those 
GABAARs that fail to be recycled are ubiquitinated at lysine residues within the intracellular 
domain and further degraded at the lysosomes. Consistently, the blockade of lysosomal 
degradation results in an increase in the number of GABAARs at the synapse and the consequent 
increase in the efficacy of the GABAergic inhibition (Arancibia-Cárcamo et al. 2009). In relation 
to 3 subunit, Saliba and co-workers showed that the ubiquitination of the 3 subunit is activity-
dependent and proposed this targeting for proteasomal degradation as a mechanism to regulate the 
synaptic inhibition (Saliba et al. 2007).  
Different studies (Thomas et al. 2005; Bogdanov et al. 2006) suggest that GABAARs are 
exclusively inserted into or removed from extrasynaptic sites of the plasma membrane. In this 
manner, the lateral mobility of the receptors is necessary so that GABAAR can be found at 
postsynaptic densities. Embedded proteins can move laterally in the membrane thanks to its 
physical properties of lipid bilayer as far as they are not stuck by intracellular interactors or they 
face obstacles. The final localization of the receptor depends on both the subunit composition of 
the receptor and the interaction of the receptor’s subunits with scaffold proteins of the 
postsynaptic neuron such as gephyrin (Tretter et al. 2012) and radixin (Hausrat et al. 2015). 
Gephyrin is a subsynaptic scaffold protein that stabilizes GABAARs at synapses. When the 
expression of gephyrin is downregulated in mouse cultured neurons, there is a selective reduction 
in the number of GABAARs at the synapses. By contrast, radixin serves for the anchoring of 5-
containing receptors extrasynaptically, which prevents thir accumulation at the synapses 
(Loebrich et al. 2006). However, after disruption of radixin-5 interaction, 5-containing 
GABAARs remain completely functional in mediating tonic current inhibition (Loebrich et al. 
2006).  
Besides, the neuronal activity is also important in adjusting the number of GABAARs at synapses 
during synaptic plasticity (Choquet and Triller 2013) and in fact, after repetitive stimulation, 
desensitized GABAARs laterally diffuse at neighboring GABAergic synapses where they decrease 
the amplitude of GABA-related synaptic currents (de Luca et al. 2017).  
1.3.7. GABAA receptor function 
In studies with heterologously expressed receptors, subsequent to GABA binding the  and  
subunits rotate asymmetrically promoting the opening of the ion channel (Horenstein et al. 2001). 
Once opened, the GABAAR-associated channel is selectively permeable to several anions that can 
flux in both directions (Sakmann and Fassberg 1987). Chloride is the principal anion passing 
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through the channel although other anions such as bicarbonate can also move through the 
GABAAR-associated channel (Kaila 1994). In most cases, the opening of the GABAAR-channel 
leads to the entrance of Cl- into the cell, generating membrane hyperpolarization and neuronal 
inhibition. Still, if the intracellular Cl- concentrations are higher, there is an efflux of Cl- anion 
thus depolarizing the membrane. This phenomenon has been identified in the developing brain 
(Obata et al. 1978) and in primary afferent neurons (Barker et al. 1975).  
The neural response upon GABAAR activation by GABA binding depends on the electrochemical 
driving force for Cl-, which is fixed by the Cl- equilibrium (ECl). ECl  is determined by the relative 
expression of KCC2 (potassium chloride cotransporter 2) and NKCC1 (Na-K-Cl cotransporter) 
which varies during animal development and neural differentiation (Andäng and Lendahl 2008). 
KCC2 is a neuron-specific chloride potassium symporter thus mediating the synaptic inhibition 
and synaptic plasticity. During mammalian development, when neural networks are still being 
established, KCC2 levels remain low and they are upregulated during postnatal development 
(Kaila et al. 2014). On the other hand, NKCC1 is a cotransporter of sodium potassium and 
chloride. It is expressed widely throughout the body and importantly in many regions of the brain 
during development but not in adulthood (Dzhala et al. 2005). When NKCC1 is expressed, the 
internal chloride concentrations rise. In that manner, when the GABAAR-associated channel 
opens there is an outflux of chloride anion thereby depolarizing the cell membrane. Altogether, 
the switch in KCC2 and NKCC1 expression levels are thought to be responsible for the alteration 
of the GABAergic responses from excitatory (early neural development) to inhibitory (maturity). 
This shift in the function of GABAARs is essential for structural and functional maturation of 
neurons (Tozuka et al. 2005; Ge et al. 2006; Cancedda et al. 2007) as well as for termination of 
interneuron migration in the developing neocortex (Bortone and Polleux 2009).  
1.3.7.1. Phasic and tonic inhibition 
As mentioned above, GABAARs mediate two distinct forms of inhibition. It is the subunit 
composition of GABAARs that dictates their localization not only between brain regions but also 
within a neuron, which in turn determines the functional properties of the receptor. In that sense, 
receptors found in the postsynaptic density (1-3) have EC50 (half maximal Effective 
Concentration) of 6-14 M whereas for peri- and extrasynaptic receptors (4, 5, 6)  
the EC50 is approximately 0.5 M. Hence, synaptic receptors mediate phasic inhibition (fast 
IPSPs) and extrasynaptic receptors that are continuously exposed to low concentrations of 
residual GABA, generate persistent tonic inhibition (Farrant and Nusser 2005).  
Phasic activation of GABAARs at the postsynaptic density is generated in response to action 
potential (AP)-induced and spontaneous quantal GABA release. That is, upon the arrival of an AP 
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at the nerve terminal, there is an influx of Ca2+  that triggers the fusion of synaptic vesicles with 
the presynaptic membrane and the consequent release of tens of thousands of GABA molecules 
into the synaptic cleft, thus generating a peak of GABA concentration in the millimolar range 
(Mody et al. 1994). On the other site of the synapse, at the postsynaptic density, a small number of 
receptors (from ten to few hundred) are clustered together (Edwards et al. 1990; Mody et al. 1994; 
Nusser et al. 1997; Brickley et al. 1999). These receptors undergo saturation even if only one 
neurotransmitter vesicle is released from the presynaptic neuron. For this reason, the amplitudes 
of IPSCs (Inhibitory Postsynaptic Currents) depend more on the number of GABAAR available 
for activation rather than on the amount of GABA release. Often multiple GABA vesicles are 
released from the presynaptic neuron in response to an AP generating spontaneous IPSC (sIPSC). 
However, sometimes single vesicles can be liberated without the need of an AP to generate 
miniature IPSC (mIPSC). The IPSC is finished within milliseconds due to the removal of GABA 
from the synapse by either diffusion or active transport. GABA that escapes from the synapse is 
further retaken by active transporters into neurons and astrocytes (Glykys and Mody 2007a). 
These transporters consist of high-affinity Na+/Cl- dependent membrane translocators of GABA 
and belong to the SLC6 family (Chen et al. 2004). Among them, the GABA transporter GAT-1 
(SLC6A1) is the most common in neurons (Glykys and Mody 2007a). Due to their intrinsic 
capacity of regulating ambient GABA concentrations, GAT transporters become relevant 
modulators of GABA tonic currents. A second factor that contributes to the short lasting of the 
IPSC is the desensitization of the GABAARs due to high agonist concentrations (MacDonald and 
Twyman 1992). In the state of desensitization, a GABAAR remains closed even when the agonist 
GABA is still bound. This phenomenon is important because of the high concentrations of GABA 
present at the synapses (Jones and Westbrook 1996). 
Notably, if multiple synapses are triggered at the same time or if there is a repeated AP firing, it is 
possible that there is a large increase in the amount of released GABA, promoting its diffusion to 
peri- and extrasynaptic spaces or even to neighboring synapses (Kullmann 2000; Farrant and 
Nusser 2005). This phenomenon is known as neurotransmitter “spillover” and it is important to 
remark that the currents resulting from GABA spillover must still be considered phasic since they 
are temporally related to the release event (Farrant and Nusser 2005).  
Residual GABA (100 nM – 2 M) at the extracellular space is able to activate peri- and 
extrasynaptic GABAAR generating tonic currents. Tonic inhibition is responsible for 75% of the 
total inhibition currents received by hippocampal neurons (Mody and Pearce 2004). Different 
studies have shown that GABA-mediated tonic currents exist in granule cells of the dentate gyrus 
(Nusser and Mody 2002), thalamocortical relay neurons of the ventral basal complex (Porcello et 
al. 2006), layer V pyramidal neurons in the somatosensory cortex (Yamada et al. 2007), CA1 
pyramidal cells and certain inhibitory interneurons in CA1 region of the hippocampus (Bai et al. 
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2001). However, the origin of the extracellular GABA is not well understood. Apart from GABA 
from spillover, Glykys and Mody showed that it could come from reversal of GATs (Glykys and 
Mody 2007b). Moreover, Liu et al. observed that GABA coming from astrocytes was also able to 
activate extrasynaptic currents since embryonic neurons co-cultured with astrocytes showed 
GABA tonic currents that were absent when no astrocytes were present (Liu et al. 2000).  
1.3.8. Regulation of the GABAA receptors and their relation to diseases  
1.3.8.1. Alterations in extrasynaptic GABAA receptors  
Major changes in the GABAAR subunit expression patterns occur during development (Laurie et 
al. 1992). Nevertheless, the adult brain can suffer several changes in the expression of receptor 
subunits. The subunit composition of GABAARs in each cell type, and as a consequence the 
function of the receptors, is determined by the expression levels of each subunit gene. Several 
physio- or pathological conditions can alter subunit levels.  
Neurosteroids are steroid derivates that can be synthesized either in neurons and glia or in gonads 
and adrenals. This family comprises THP (3-OH-5-pregnan-20-one, allopregnanolone), which 
can selectively modulate the activity of GABAARs, specifically extrasynaptic GABAARs. During 
puberty in female mice, there is an increase in 4 GABAAR subtype in CA1 pyramidal neurons 
promoted by the rising levels of 17-estradiol (E2) and the decline in hippocampal levels of THP 
(Keating et al. 2019). However, in stress situations there is a release of THP that in pubertal 
female mice generates anxiety whereas it has an anxiety-reducing effect in adults by a mechanism 
that involves the downregulation of 42 GABAARs (Shen et al. 2007). Besides, THP is able to 
reduce the learning diminution that takes place at the onset of puberty by inhibiting 42 
GABAARs (Shen et al. 2010). At the end of pregnancy, there is an increase in the expression of 
the  subunit of the GABAARs while the levels of 2 subunit decrease and 4 subunit levels 
remain constant in the rat hippocampus (Sanna et al. 2009). Additionally, there is an increase in 
4 subunit after delivery (Sanna et al. 2009). In a rat model of premenstrual syndrome, 42 
receptors are overexpressed at the hippocampus due to progesterone withdrawal. In this model, 
low doses of alcohol enhances GABAARs function and decreases neuronal excitability 
(Sundstrom-Poromaa et al. 2002). 
Ethanol is a depressant of the CNS that exerts behavioral effects similar to those promoted by 
other agonists of the GABAARs such as benzodiazepines and barbiturates. The effects of ethanol 
on GABAARs was reviewed by Davies and co-workers (Davies 2003). Extrasynaptic GABAAR 
are enhanced by ethanol concentrations lower than 30 mM (approximately the concentration 
achieved by social drinking) (Sundstrom-Poromaa et al. 2002; Wallner et al. 2003; Wei et al. 
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2004; Hanchar et al. 2005). Moreover, heterologous 4/6 plus  subunits containing GABAARs 
are potentiated by concentrations of ethanol of 1-3 mM, which corresponds to less than a half 
glass of wine (Sundstrom-Poromaa et al. 2002; Wallner et al. 2003). In contrast, mice deficient in 
 subunit of the GABAAR showed diminished potentiation of tonic inhibition promoted by 
ethanol (Wei et al. 2004).  
Besides, GABAARs expression is altered in several pathologies, including depression and 
epilepsy. In humans, different studies with postmortem brains have described significant changes 
in subunit gene expression in depressed patients and suicide victims (Klempan et al. 2009; 
Sequeira et al. 2009). Such changes result in an alteration in the composition of GABAARs which 
leads to the GABAergic deficit observed in major depression (Luscher et al. 2011). Epilepsy is a 
chronic disease characterized by seizures evoked by excessive electrical discharge of neurons in 
the brain (Hesdorffer et al. 2013). The term used to describe the complex process of acquired 
epilepsy development is termed “epileptogenesis” and pictures the plastic progression from a well 
neuronal excitation/inhibition balanced brain into a hyperexcitable brain. GABAARs have been 
largely studied in both epileptic patients and epileptic animal models. In that sense, prolonged 
seizures (status epilepticus or SE) result in alterations in the expression and membrane 
localization of several GABAAR subunits in hippocampus (Brooks-Kayal et al. 1998; Peng et al. 
2004; Zhang et al. 2007). Structural and functional changes on GABAARs have been described in 
neurons from surgically resected hippocampi from patients with intractable temporal lobe 
epilepsy (TLE) (Brooks-Kayal et al. 1998; Shumate et al. 1998; Loup et al. 2000). In addition, 
GABAARs from TLE neocortex present a marked GABA-induced current run-down upon 
repetitive stimulation with GABA (Goodkin et al. 2007), which reflects GABAARs instability and 
the desensitization of the receptor due to the shift of the GABAAR-associated channel from an 
open to a desensitized state (Sullivan 1992). This mechanism is inhibited by BDNF (Palma et al. 
2005) and phosphatase inhibitors (Palma et al. 2004). Further, Palma and co-workers 
demonstrated that this GABAA-current run-down can actually be blocked by the antiepileptic drug 
levetiracetam (Palma et al. 2007). Thus, these results suggest that targeting GABAAR activity 
could be a good strategy in the development of antiepileptic drugs.  
In a mouse model of TLE,  subunit expression decreases progressively after the pilocarpine-
induced SE, while the expression levels for 4 and 2 subunits increase over the same time course 
(Peng et al. 2004). This change in the expression pattern is thought to be due to the competition 
between  and 2 for their binding to 4 in the forebrain and with the 6 subunit in the 
cerebellum (Tretter et al. 2001). Notably, other studies done in experimental TLE found an 
increase in the expression of 3 4, and  subunits following the pilocarpine injection (Schwarzer 
et al. 1997; Brooks-Kayal et al. 1998; Fritschy et al. 1999). In a model of TLE in adult rats at the 
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time of the first pilocarpine-induced seizure, there is a significant reduction of the 1 subunit and 
increase in 4 subunit density that correlates with an enhancement of GABAA-current run-down 
(Mazzuferi et al. 2010). In the pilocarpine model of SE, GABAAR 1 subunit mRNA decreases 
while 4 subunit mRNA expression increases in dentate granule cells of the hippocampus and 
animals go on to develop epilepsy. These changes in subunit mRNA levels correlate with 
decreased presence of 12 containing receptors (Lund et al. 2008) and increased presence of 
42 containing receptors localized perisynaptically (Zhang et al. 2007; Lund et al. 2008; 
Rajasekaran et al. 2010). The change in receptor subtype from 12 to 42 may contribute to 
epileptogenesis, as 4 containing GABAARs have been shown to desensitize rapidly, especially 
when assembled with 3 subunit (Lagrange et al. 2007). In primary cultured hippocampal 
neurons, transcriptional up-regulation of the 4 subunit gene after seizure is regulated by the PKC 
pathway, more specifically through the binding of the inducible early growth response factor 
(Egr3), whose mRNA levels also increase (Roberts et al. 2005; Grabenstatter et al. 2014). 
Additionally, inferior colliculi of both Wistar audiogenic rats (WAR) and the genetic audiogenic 
seizure hamster (GASH:Sal) present higher Egr3 gene expression than control animals (intact 
Wistar rats and Syrian hamsters respectively).  
Different transgenic mice have been designed to bring about new insights on tonic inhibition. For 
instance, mice lacking the  subunit of the GABAAR was first introduced in 1999 (Mihalek et al. 
1999). GABAARs deficient in  subunit present lower affinity for the GABA agonist muscimol 
than WT mouse receptors. Moreover,  KO mice show decreased sensitivity for anesthetic and 
anxiolytic drugs and are more exposed to the chemoconvulsants seizures caused by GABAAR 
antagonist. Also, GABAARs without  subunits are less sensitive to the action of neurosteroids 
and this fact can count for their increased susceptibility to seizure (Mihalek et al. 1999; Spigelman 
et al. 2002; Porcello et al. 2003; Chandra et al. 2010). Furthermore, mice lacking 4 have also 
been designed. In global 4 KO mice, there is a reduction of the inhibitory tonic currents in 
thalamus and dentate gyrus, as well as decreased gaboxadol sensitivity (Chandra et al. 2006). 
Importantly, 4 KO mice have defective migration and altered dendritic maturation in adult 
hippocampal neurogenesis (Duveau et al. 2011). 3 KO mice, on the other side, exhibit 
abnormalities in social and exploratory behavior and deficits in non-selective attention along with 
cerebellar vermis hypoplasia, all of them features associated with autism spectrum disorder (ASD) 
Moreover, large maternal deletion from UBE3A to GABRB3 genes (located on chromosome 
15q11 and 15q13) causes impairments in motor function, learning and memory tasks related to the 
Angelman syndrome (Jiang et al. 2010).  
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1.3.8.2. Genetics of epilepsy 
The development of epilepsy is, in part, due to alterations in the composition and function of 
GABAARs that generate dysregulation of the neuronal activity. Genetic epilepsies are those 
caused by mutations in genes that modulate either activation or inhibition of the CNS. GABAAR 
subunits can suffer mutations and lead to epileptogenesis. Notably, mutations in the 1 subunit 
encoding gene (GABRA1) and the gene coding for the 3 subunit (GABRB3) are related to 
childhood absence epilepsy (CAE) and juvenile myoclonic epilepsy (JME). Otherwise, mutations 
in the genes encoding the 2 and  subunits (GABRG2 and GABRD respectively) are associated 
with febrile seizures (FSs), generalized epilepsy with FS plus and Dravet syndrome (DS) (Chuang 
and Reddy 2018). Mutations in the genes coding for both synaptic and extrasynaptic GABAARs 
subunits are reviewed by Galanopoulou, Chuang and Reddy (Galanopoulou 2010; Chuang and 
Reddy 2018). Here, we will focus on those mutations altering both GABRA4 or GABRB3 
expression and/or function. 
Concerning GABRB3 gene, 13 single nucleotide polymorphisms (SNP) are found in the promoter 
region causing diminished expression of the GABRB3 expression, a fact that has been related to 
CAE (Feucht et al. 1999; Urak et al. 2006; Lachance-Touchette et al. 2010). In exon 1, which 
codes for the signal peptide, two missense mutations (P11S and S15F) have been described 
(Tanaka et al. 2008) in families with remitting CAE. Another missense mutation in exon 2 
(G32R) has been detected in CAE patients. This mutation causes a shift from 32 receptors to 
3 and 3 receptors and a consequent decrease in GABAAR current density (Gurba et al. 2012). 
Experiments done with recombinant receptors containing these mutations suggest a possible 
mechanism because 3, when mutated is hyperglycosylated and that impedes the maturation and 
trafficking of the subunit thereby affecting GABAAR function (Tanaka et al. 2008). In regard to 
GABRA4 gene, a polymorphism (T320A) has been described in idiopathic generalized childhood 
absence epilepsy although this polymorphism has also been observed in control patients (Dibbens 
et al. 2009). Nevertheless, different SNPs of the GABRA4 gene have been described in autism 
patients (Ma et al. 2005; Collins et al. 2006) 
1.3.9. Regulation of GABAAR activity through phosphorylation 
The activity of GABAARs can be regulated by several post-translational modifications such as 
phosphorylation that alter not only the number and localization but also the functionality of the 
receptor (reviewed in Connelly et al. 2013; Nakamura et al. 2015). These phosphorylations 
mainly occur in the major intracellular loop between TM3 and TM4 of the GABAAR, which 
contains numerous consensus sites for tyrosine and serine/threonine (S/T) kinases. Although most 
phosphorylations target  and  subunits, in the last decade several phosphorylation sites have 
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been identified on  subunits. Different kinases are known to phosphorylate GABAAR subunits, 
including PKA, PKC and CaMKII.  
The S/T kinase PKA can either enhance or depress GABAAR function through the 
phosphorylation of its subunits. PKA is recruited by the A-kinase anchoring protein (AKAP) to 
GABAARs containing either 1 or 3 subunits. PKA can phosphorylate 1 subunit on S409 
inhibiting GABAAR function while the PKA phosphorylation of 3 subunits on S408 and S409 
potentiates the activity of the receptor. Accordingly, mutation of S408 to alanine (S408A) in 3 
subunit decreases GABAAR function at the same level as the 1 monophosphorylation on S409. 
By contrast, 2 subunit is not affected by PKA phosphorylation probably because it cannot bind 
AKAP. The effect of the 3 phosphorylation on the spontaneous activity of the extrasynaptic 
receptors is different depending on the subunit combination. Thus, the effect of PKA activation on 
43 is larger than for 432 receptors. Nevertheless, it seems that PKA can function both as 
an activator and as an inhibitor of GABAAR activity depending on the cell context. For instance, 
in hippocampal pyramidal cells, cultured cerebellar granule cells, neostriatal neurons, superior 
cervical neurons and spinal cord neurons, PKA activation is to decreases GABAARs function 
whereas in hippocampal dentate granule cells, cerebellar interneurons and olfactory bulb granule 
cells increases GABAARs activity. Specifically, the activation of the PKA increases spontaneous 
43 and 2 GABAAR currents (Tang et al. 2010). 
PKC also has different effects on the GABAARs depending on their subunit composition. PKC 
can phosphorylate S409/410 in 1-2 subunits, S408/409 in 3 subunit, S327 in 2S/2L subunits 
and S343 in 2L subunit. As noticed before the effect of the phosphorylation on the GABAAR can 
vary. Thus, in Xenopus oocytes the phosphorylation of 2 on S343 increased the activity of the 
receptor while in fibroblasts expressing 112L the constitutively activation of PKC results in a 
reduction of the GABAAR-mediated currents. Actually, mutating 2L S327 and S343 into alanine 
(S327A and S343A) prevents the enhancement of the GABAAR activity. In acute hippocampal 
slices, PKC inhibition leads to lower levels of 3-containing GABAARs at the cell surface and to 
diminished tonic currents attributed to the lower levels of 3 phosphorylation on S383 (Modgil et 
al. 2017). In hippocampal pyramidal cells, PKC has no influence on mIPSCs while in dentate 
gyrus granule cells PKC enhances mIPSC amplitude. Besides, PKC can also phosphorylate 4 
subunit on S443. Studies in COS7 cells show an enhancement of the 4 phosphorylation after 
phorphol 12-myristate 13-acetate (PMA)-induced PKC activation that results in an increase in the 
surface levels of 43 receptors. Consistently, the expression of the phosphomimetic mutant 
(S443E) showed that the accumulation of 43 was due to both increased stability and enhanced 
insertion levels at the cell surface. Opposing effects are observed in HEK293 cells expressing 
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heterologous 42 receptors in which the activation of PKC decreased the surface levels of 
GABAARs. This effect was accompanied by a reduction in GABA-mediated tonic inhibition. 
Tonic inhibition mediated by 42 GABAARs is modulated in a similar manner by PKC-
dependent phosphorylation in the hippocampus and in the thalamus while phasic inhibition seems 
to be insensitive (Bright and Smart 2013a). In hippocampal neurons, PKC inhibition prevents 4 
phosphorylation and surface expression of 4-containing receptors, apparently at odds with what 
happens at synaptic GABAARs (Connolly et al. 1999; Abramian et al. 2014). Reassuringly, PKC 
activators were not able to potentiate surface expression or currents in cell lines expressing an 4 
non-phosphorylatable mutant (S443A).  
CaMKII can phosphorylate 3 subunit on S383 and in neuroblastoma-glioma hybrid (NG108-15) 
cells expressing 13 and 132 receptors this phosphorylation potentiated GABA-evoked 
current amplitudes. Besides, the same group showed that the enhancement of GABA-evoked 
currents was also due to the phosphorylation of 2 subunit on residues Y365/Y367 by endogenous 
tyrosine kinases indicating that the activation of CaMKII enhances GABA-evoked currents not 
only by direct phosphorylation of 3 subunit but also through the activation of tyrosine kinases 
that phosphorylate 2 subunit. In hippocampal neurons, CaMKII phosphorylation of 3 on S383 
induces de rapid surface expression of GABAARs leading to an increase in the tonic currents 
(Saliba et al. 2012).  
1.3.9.1. GABAA receptor run-down regulation by phosphorylation 
The run-down of the GABA response is a phenomenon in which the repeated exposure of the 
receptor to GABA results in a gradual decrease of the resulting currents. In electrophysiology, 
GABA receptor run-down can be measured and it is used to evaluate the activity of the receptor.  
It is well known that the phosphorylation of receptor subunits influences in its activity, including 
receptor run-down (Kittler and Moss 2003). In HEK293, neurosteroids enhance the GABA-
mediated currents by promoting PKC phosphorylation of S443 in 4 subunit. This effect is also 
observed in hippocampal neurons, where the application of THDOC selectively enhances GABA-
mediated tonic currents (Abramian et al. 2014).  
Also, GABA run-down has been prevented or decreased by the inclusion of Mg-ATP or Mg-
ATPS in the intracellular solution of the whole-cell patch clamp recordings in pyramidal cells 
dissociated from the hippocampus of mature guinea-pigs, suggesting that receptor run-down may 
be a consequence of dephosphorylation of some targets closely associated with the GABAAR 
(Chen et al. 1990). 
INTRODUCTION 
| 30  
1.3.9.2. Dysregulation of GABAA receptor phosphorylation in epilepsy 
Epilepsy appears due to the imbalance between excitatory and inhibitory neuronal signaling. In 
that manner, alterations in GABAAR expression, trafficking and activity can lead to 
epileptogenesis. Since many GABAAR subtypes are regulated by phosphorylation, modifications 
in the phosphorylation pattern of the subunits are often related to epilepsy. Thus, in a model of 
pilocarpine-induced SE there is a decrease in the PKC-mediated 3 phosphorylation on S383, 
which is responsible for the loss of GABAARs via enhanced endocytosis. Also in pilocarpine-
treated rats, at the time of the first spontaneous seizure, there is an increased run-down in the 
hippocampus probably due to an increase in 4-containing receptors relative to 1-containing 
GABAARs.  
The efficiency of GABAARs in epileptic patients is often studied by injecting membranes from 
human nervous tissue into oocytes and then performing electrophysiological recordings are done. 
Results obtained with this model also show the relevance of GABAAR subunit phosphorylation in 
epilepsy since GABAARs from the TLE temporal neocortex exhibit a marked current run-down. 
Besides, Palma et al showed that the inhibition of phosphatases stabilizes the epileptic GABAAR 
and enhances GABA inhibition in oocytes injected with TLE membranes (Palma et al. 2004). In 
this study, these authors also demonstrate that okadaic acid inhibition of protein phosphatases 
results in hyperphosphorylation of the 3 subunit, yielding an enhanced activity of the GABAAR. 
In the same model, it was later demonstrated that GABAARs run-down is also prevented by 
BDNF (Palma et al. 2005).  
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2. HYPOTHESIS AND OBJECTIVES 
2.1 Hypothesis 
Ccnd1 is required for NGF-induced neurite outgrowth in PC12 pheochromocytoma cells, is 
detected in the cytoplasm of cortical neurons at 4 days of in vitro differentiation, and mice without 
Ccnd1 show neurological abnormalities. Moreover, CCND1 mRNA has been abundantly detected 
by in situ hybridization in the adult mouse brain, specifically enriched in the hipoccampus, as well 
as in the adult human brain in different regions by DNA microarray expression profiling. And in a 
two hybrid screen previously carried out in our lab, Ccnd1 was found to interact with the 4 
subunit of the GABA type A receptor. 
Hence our hypothesis is that Ccnd1 may have a role, likely a cytoplasmic function, both during 
the development of the central nervous system and in the normal physiology of the adult brain. 
More specifically we want to test in this study whether the process of neuritogenesis may be 
modulated by Ccnd1 and whether Ccnd1 may be involved in the regulation of the GABA 
receptors. 
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2.2 Objectives 
In order to elucidate the hypothesis, the study was divided in two main objectives These general 
objectives may be broken down into more specific ones. 
I. Study of the role of cytoplasmic Ccnd1 in neuritogenesis in embryonic cortical 
neurons. 
1. Evaluation of the overexpression of cytoplasmic Ccnd1 in neurite outgrowth in 
cultured cortical neurons. 
2. Analysis of the effect of endogenous Ccnd1 downregulation in neuritogenesis. 
3. If a role of Ccnd1 in neuritogenesis is uncovered, we will test paxillin as a 
possible downstream effector.  
II. Dissection of the role of cytoplasmic Ccnd1 in the regulation of GABAA receptors  
1. Defining the interaction between Ccnd1 and the 4 and 3 subunits of the 
GABAA receptor by in vitro and in vivo assays.  
2. Characterization of the 4 and 3 subunits of the GABAA receptor as 
phosphorylation substrates of Ccnd1-Cdk4. 
3. Examining functional effects mediated by cytoplasmic Ccnd1 on heterologously 
expressed GABAA receptors by electrophysiology in tsA201 cells. 
4. Analysis of functional effects mediated by the Ccnd-Cdk4/6 complex on GABA 
receptors by electrophysiology in rat hippocampal slices.  
5. Study of the regulation of 4 and 3 subunits trafficking and cell surface 
abundance by cytoplasmic Ccnd1. 
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3. MATERIALS AND METHODS 
3.1 Molecular biology techniques 
3.1.1. Plasmid constructions 
Coding sequences and fusion proteins of interest are cloned into pcDNA3, pCMV-SPORT6 or 
pNBM470 (as pcDNA3 but with N-terminal 6His-3HA epitopes). These vectors contain the CMV 
promoter, although sometimes this promoter is changed to the polyubiquitin C gene promoter 
(Ubi) (Table 1).  
Site-directed mutagenesis (PCR-SDM) follows a previous protocol (Weiner et al. 1994) with 
some modifications. We have developed a facile procedure for rapid PCR-based site-directed 
mutagenesis of double-stranded DNA. Increasing the initial template concentration and 
decreasing the PCR cycles to 5-10 allows us to reduce the rate of undesired second-site mutations 
and dramatically saves time. Following PCR, DpnI treatment is used to select against parental 
DNA molecules since DpnI only cuts methylated or hemimethylated DNA, which comes from 
bacteria. Pfu DNA polymerase is used, prior to intramolecular ligation of the linear product, to 
remove any bases extended onto the 3’ ends by the Taq DNA polymerase. The recircularized 
DNA vector incorporating the desired mutations is transformed into E. coli. This method can be 
used independently of any host strain and vector. When possible, a restriction site is generated at 
the mutation point so that it is possible to track the mutation and select the mutant clones. 
Both cyclin D1 wild type and the cyclin D1 K112E allele are fused to three copies of the FLAG or 
HA epitopes under the CMV promoter in pcDNA3. Cyclin D1 K112E is a point mutant of cyclin 
D1 that contains a lysine to glutamic acid substitution at amino acid position 112. This mutant 
binds Cdk4/6 with an affinity similar to that of wild type cyclin D1, but it is unable to activate the 
catalytic activity of the partner kinase and cannot transform primary rodent cells (Hinds et al. 
1994; Baker et al. 2005). To construct the variants of cyclin D1 associated to the membrane, the 
3’coding sequence of the K-Ras gene, which contains the CAAX motif (GGC TGT GTG AAA 
ATT AAA AAA TGC ATT ATA ATG TAA) is fused to the 3’ end of the coding sequence of 
either cyclin D1 or cyclin D1 K112E (Fusté et al. 2016).  
Mus musculus GABRA4 (IMAGE ID 6828002, BioScience) and Homo sapiens GABRB3 
(IMAGE ID 3871111, BioScience) are used to obtain a GST fusion protein in pGEX-KG 
(Clontech). Moreover, in some cases those proteins are tagged with either the FLAG or GFP 
epitope. GST-GABRA4 contains the full-length protein, while GST-C-terminus contains the 
sequence corresponding to amino acids 354 to 552.  
MATERIALS AND METHODS 
| 38 
GABRA4 cDNA is also cloned into the pEGFP-N1 mammalian expression vector to generate a 
GFP fusion protein. PCR-SDM is carried out to produce the non-phosphorylatable and the 
phosphomimetic mutants.  
For cyclin D1 downregulation with interference ARN, shRNA TRCN0000026883 cloned into 
pLKO.1-puro is purchased from Sigma- Aldrich.  
Plasmids are isolated from cultures of E.coli DH5 using a miniprep plasmid purification kit 
(Qiagen) according to manufacturer’s instructions and are outlined in Table 1. To test integrity, 
DNA is subjected to agarose gel electrophoresis and to ethidium bromide (EtBr) staining. DNA 
concentration is determined with a spectrophotometer NanoDrop ND-1000 (NanoDrop 
Technologies). Constructions are checked by restriction analysis and the expressed proteins are 
checked by Western blotting. Mutations created by PCR-SDM are also checked by DNA 
sequencing.  
Table 1. List of the plasmids used in this thesis. 
NAME PLASMID VECTOR DESCRIPTION 
pcDNA3 CMVp-3FLAG Expression vector with CMV promoter tagged with FLAG 
pNBM470 pcDNA3-6His-3HA-MCS 
Expression vector with CMV promoter tagged with 6His and 
3HA.  
pEGFP-N1 CMVp-EGFP GFP containing expression vector with CMV promoter  
pGEX-KG pGEX-2T derivate Bacterial expression plasmid containing GST. Tac promoter.  
pCYC193 
CMVp-pcDNA3-
FLAG5’-Ccnd1 
pcDNA3 vector containing Ccnd1 tagged with FLAG under 
CMV promoter.  
pCYC2057 3HA-Ccnd1-CAAX 
Mm Ccnd1-CAAX cloned into pNBM470 expression vector 
under CMV promoter. Tagged with 3HA 
pCYC2058 3HA-Ccnd1K112E-CAAX 
Ccnd1K112E-CAAX cloned into pNBM470 expression vector 
under CMV promoter. Tagged with 3HA 
pCYC2076 Ubip-3HA-Cdk4-CAAX 
MmCdk4-CAAX cloned into pPDSL. Contains Ubi promoter 
and 3-HA tag  
pCYC2111 shRNA SCR (scramble) Control vector shRNA SCR pLKO.1-puro (Sigma-Aldrich) 
pCYC2136 Ccnd1 shRNA83 
shRNA for Mus musculus cyclin D1 in pLKO.1-puro vector. 
TRCN0000026883 (Sigma- Aldrich) 
pCYC2084 3HA-CBP-Pxn 
Mm Pxn cloned into pPDSL. Contains Ubi promoter and 3HA 
and CBP tags 
pCYC2104 
3HA-CBP-Pxn (S83A; 
S178A; S244A) 
Non-phosphorylatable mutant of Pxn cloned into pPDSL. 
Contains Ubi promoter and 3HA and CBP tags 
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NAME PLASMID VECTOR DESCRIPTION 
GABRA4 Mm GABRA4 IMAGE ID 6828002, BioScience 
pCYC2123 GABRA4 in pGEX-KG 
Mm GABRA4 cloned into the pGEX-KG bacterial expression 
plasmid containing GST. Tac promoter 
pCYC2153 
GABRA4 T423A, S431A 
in pGEX-KG 
Mutant Mm GABRA4 cloned into the pGEX-KG bacterial 
expression plasmid containing GST. Tac promoter 
pCYC2155 
GABRA4 S456A S458A 
in pGEX-KG 
Mutant Mm GABRA4 cloned into the pGEX-KG bacterial 
expression plasmid containing GST. Tac promoter 
pCYC2157 
GABRA4 T500A in 
pGEX-KG 
Mutant Mm GABRA4 cloned into the pGEX-KG bacterial 
expression plasmid containing GST. Tac promoter 
pCYC2127 
Cterminal-GABRA4 in 
pGEX-KG 
C-terminal fragment of GABRA4 cloned into the pGEX-KG 
bacterial expression plasmid containing GST. Tac promoter 
pCYC2237 
GABRA4 C-terminal 
T423A S431A in pGEX-
KG 
Mutant Mm GABRA4 C-terminal fragment GABRA4 cloned 
into the pGEX-KA bacterial expression plasmid containing 
GST. Tac promoter 
pCYC2206 GABRA4 in FCIV1 
Mm GABRA4 into FCIV vector under Ubi-c promoter. Contains 
an IRES element driven venus protein 
pCYC2207 
GABRA4 T423A S431A 
in FCIV1  
Mutant Mm GABRA4 into FCIV vector under Ubi-c promoter. 
Contains an IRES element driven venus protein 
pCYC2224 
GABRA4 T423E S431E 
in FCIV1 
Mutant Mm GABRA4 into FCIV vector under Ubi-c promoter. 
Contains an IRES element driven venus protein 
pCYC2121 GABRA4 in EGFP-N1 
Mm GABRA4 cloned into pEGFP-N1. Contains GFP and CMV 
promoter 
pCYC2183 
Mm GABRA4 T423A, 
S431A in EGFP-N1 
Mutant Mm GABRA4 cloned into pEGFP-N1. Contains GFP 
and CMV promoter 
pCYC2261 
Mm GABRA4 T423E, 
S431E in EGFP-N1 
Mutant Mm GABRA4 cloned into pEGFP-N1. Contains GFP 
and CMV promoter 
pCYC2213 
GABRB3-FLAG in pBI-
EGFP 
Hs GABRB3 cloned into pBI-EGFP. Contains FLAG tag 
GABRB3 Hs GABRB3 IMAGE ID 3871111, BioScience 
pCYC2181 GABRB3 in pGEX-KG 
Hs GABRB3 cloned into the pGEX-KG bacterial expression 
plasmid containing GST. Tac promoter 
pCYC2275 Hs GABRB3 in EGFP-N1 
Hs GABRB3 cloned into pEGFP-N1. Contains GFP and CMV 
promoter 
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3.1.2. RNA extraction and RT-qPCR  
Ccnd1 mRNA levels are analyzed by performing an mRNA extraction protocol from mice 
embryonic cortical neurons followed by RT-qPCR. To this end, cortical neurons are obtained as 
described in 3.2.2 and collected at different time points (0 hours, 4 hours, 1 day or 3 days) of in 
vitro differentiation in RLT buffer of the RNeasy Mini Kit (QIAGEN) containing -
mercaptoethanol. Samples are stored at -80ºC until RNA extraction is carried out using this kit 
and following the manufacturer’s instructions. Afterwards, samples are treated with the On-
Column DNase I Digestion Set from Sigma. RNA integrity and purity are measured by agarose 
gel electrophoresis and NanoDrop ND-1000 spectrophotometry (NanoDrop Technologies). For 
retrotranscription, up to 5 g of RNA are converted into cDNA with the SuperScript Reverse 
Transcriptase (Thermofisher) using random hexamers as oligonucleotides. The reaction is 
performed according to manufacturer’s instructions. This cDNA obtained is used for qPCR. In 
this case, samples are added to a SYBR Green master mix (Applied Biosystems™ SYBR™, 
Thermofisher) together with both the forward and reverse primers (see Table 2). As an internal 
control, the house keeping gene GAPDH is amplified and quantified. qPCR is performed in the 
C1000 Thermal Cycler CFX96 Real-Time System from Bio-Rad Laboratories. A scheme of the 
conditions used for the qPCR is shown in Figure 6. 
 
Figure 6: Scheme of the conditions used for qPCR.  
Table 2: Primers used in qPCR. 
TARGET DIRECTION DESCRIPTION 
SEQUENCE (5’ – 
3’) 
CCND1 
Forward 
To amplify Mm CCND1 (183bp). Tm: 62.5 (exon1-
2) 
GCGTACCCTGAC
ACCAATCTC 
Reverse To amplify Mm CCND1. Tm: 62.4 (exon1-2) 
CTCCTCTTCGCAC
TTCTGCTC 
GAPDH 
Forward 
To amplify Mm GAPDH (123bp). Tm: 62.6 
(exon1-2) 
AGGTCGGTGTGA
ACGGATTTG 
Reverse To amplify Mm GAPDH. Tm: 60.2 (exon1-2) 
TGTAGACCATGT
AGTTGAGGTCA 
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3.2 Cellular biology techniques 
The different cell types, both primary and cultured lines, used in this thesis are listed in Table 3.  
Table 3: Mammalian cell types used in this study. 
Cell type Description Obtained from Use 
HEK293T 
Human Embryonic 
Kidney cells  
American Type 
Culture Collection 
(ATCC) 
Used for virus production, 
immunoprecipitation assays 
and immunofluorescence 
HEK tsA201 
Human Embryonic 
Kidney SV40 
transformed cells 
Dr. David Soto’s 
lab 
Whole-cell patch clamp 
studies 
MEFs 
(immortalized) 
Immortalized Mouse 
Embryonic Fibroblasts  
Dr. Sicinsky’s lab Used for shRNA testing 
Cortical neurons 
Primary cortical neurons 
from mice E15.5 
embryos 
Mice embryos 
(E15.5) 
Neuritogenesis studies and 
immunofluorescence 
Hippocampal slices 
Organotypic 
hippocampal slices  
Newborn rats (P5-
7) 
Whole-cell patch-clamp 
recordings and western blot 
Hippocampal cells Whole hippocampus  Adult female mice Immunoprecipitation 
 
All centrifugations at 4 ºC are done using the F45-24-11 rotor (Eppendorf), centrifugations of cell 
cultures are done using the S-4-72 rotor (Eppendorf). For bacterial cultures centrifugation, the A-
4-81 rotor (Eppendorf) is used.  
3.2.1. Growing and harvesting cells 
HEK and MEFs cells are sub-cultured when a cell density greater than 80% confluence is 
reached, every 3-4 days, cells are sub-cultured. In brief, the medium is aspirated and cells are 
washed in pre-warmed phosphate-buffered saline (PBS). To detach the cells from the plate, cells 
are then incubated with trypsin (Sigma) at 37ºC for 5 min. To inactivate trypsin, a 3-volume 
aliquot of pre-warmed medium is added. Cells are then collected and centrifuged at 1000 rpm for 
5 min. Pelleted cells are resuspended in 1 ml medium and then a Neubauer chamber is used for 
cell counting when an accurate cell number for seeding is necessary. Alternatively, a 1:10 or 1:20 
dilution (depending on cell type) is directly used. Cells are maintained in a wet atmosphere with 
5% CO2 at 37ºC. Mycoplasma detection tests are performed with PlasmoTest (Invivogen, code: 
rep-pt1) 
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For cell freezing, cells are harvested at 1000 rpm after trypsinization, and resuspended in 1 ml 
freezing medium (90% FBS+ 10% DMSO). Aliquots of approximately 1-2·106 cells are stored in 
2 ml polypropylene vials, first at least 24 hours at -80ºC and then permanently in the gas phase of 
a liquid nitrogen vessel (at -180ºC). To unfreeze cells, they are rapidly thawed at 37ºC and then 
mixed with 9 ml DMEM (supplemented with 10% FBS + P/S). They are centrifuged at 1000 rpm 
for 5 min and resuspended in 1 ml medium. The whole aliquot is added to a 100 mm plate 
containing 9 ml DMEM (with 10% FBS, P/S), and incubated at 37ºC, 5% CO2.  
3.2.2. Primary culture of cortical neurons 
Timed-pregnant females are killed by cervical dislocation, and embryos are removed at the 
appropriate age (embryonic day E15.5) and placed on ice-cold HBSS-MHPS (Hank's Balanced 
Salt Solution, 10 mM MgSO4, 10 mM HEPES pH 7.2 adjusted with NaOH) and 104 U/L P/S. The 
E15.5 age is chosen because most cortical neurons are forming while the appearance of glial cells 
can be avoided (Sciarretta and Minichiello 2010). All the dissection protocol is done on ice in 
order to preserve the cells. The embryo heads are collected in fresh ice-cold HBSS-MHPS 
medium and then cortexes are obtained with the help of a magnifying glass (Leica Microsystems). 
Briefly, skulls are opened laterally, the two cortexes dissected and meninges removed. Dissected 
cortexes are placed in 10 ml Falcon tubes (maximum 8 hemicortexes per tube) containing 4 ml 
ice-cold HBSS-MHPS. After removing the medium, 1.5 ml freshly-prepared filtered papain 
solution (1 mg/ml papain in HBSS-MHPS) is added to each tube. We prepare a papain (Sigma-
Aldrich) stock solution at 10 mg/ml in water and store it at 4ºC. For proper digestion and protein 
hydrolysis, tissue is incubated in a water bath at 37 ºC for 23 min. During the enzymatic 
digestion, two Pasteur pipettes are prepared to the flame for further triturating the tissue: one with 
the round rim (pipette A) and the other with the round rim but with smaller diameter (pipette B). 
After the incubation with papain, the enzyme is inhibited by washing the tissue three times with 1 
ml of 10 mg/ml trypsin inhibitor (ThermoFisher) in HBSS-MHPS (filtered). Additionally, one 
more wash is done with 1 ml neurobasal medium supplemented with B27 (1:50), 2 mM Glutamax 
and 1 mM sodium piruvate (NB27, ThermoFisher) at room temperature. Another milliliter is 
added to each tube and tissue is triturated by passing it through the two pipettes (A and B) no 
more than 10 times each. After the mechanical disgregation, the supernatant of 1 min incubation 
containing mostly single cells is transferred to a Falcon tube with 9 ml NB27 medium and 
centrifuged at 650 rpm for 4 min. Next, the pellet is resuspended in 1 ml NB27 using the pipette B 
no more than 5 times.  
If needed, cells are counted in a Neubauer chamber. Trypan Blue (1:1) is used to stain dead cells 
so that only living cells are counted. For biochemical studies as well as for transfections, high 
density cultures are needed. Given so, approximately 5.5·104 cells/cm2 are seeded. On the other 
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hand, for conditioned medium production, low density cultures (3 cortexes in a 100 mm plate) are 
needed since they must be in the incubator for 7-10 days without refreshing the media. Following 
the incubation, the medium is filtered and stored at -20ºC.  
For the seeding of the primary cortical neuron culture, Neurobasal medium with B27 supplements 
(1:50), 2 mM Glutamax and 1 mM sodium piruvate is used. However, when cells are transfected, 
NB27 medium is diluted 1:1 with conditioned media. 
3.2.2.1. Genotyping and protein extraction from wild type and cyclin D1 knockout 
mice 
CCND1 knockout mice were obtained from P. Sicinski (Sicinski et al. 1995) (Figure 7A). 
Transgenic mice are maintained in a mixed background of C57BL/6 and SV129. Ccnd1 KO 
embryos are obtained from the crossing of two heterozygotes of Ccnd1. In order to process all 
embryos of the same genotype together, it is necessary to differentiate between KO and WT 
embryos prior to the primary cortical neurons culture. To that end, embryo’s tails are collected 
and warmed at 54 ºC in a solution containing genotyping buffer (100 mM Tris-HCl pH8.0, 50 
mM EDTA pH8.0, 1% SDS, 500 mM NaCl) and proteinase K (20 mg/ml) for 20 minutes while 
shaking at 950 rpm with a Thermo-Shaker (Eppendorf). Dissolved tails are then centrifuged for 5 
minutes at 10000 rpm. Supernatant is collected and heated at 65 ºC to inactivate the proteinase K. 
Next, DNA is precipitated with isopropyl alcohol, washed with 70% ethanol, and eventually 
resuspended in water.  
Genotyping is performed by PCR using genomic DNA extracted from the tail (as described 
above) and three different primers: one hybridizes with a sequence of CCND1 gene present in 
both WT and KO mice (1) (5’-TAGCAGAGAGCTACAGACTTCG-3’) (Integrated DNA 
Technologies); a second primer is targeted to the gene region removed in the knockout construct, 
hence it uniquely hybridizes with the WT gene sequence (2) (5’-
CTCCGTCTTGAGCATGGCTC-3’) and the third primer hybridizes with the neomycin-gen 
introduced during knockout construction (3) (5’-CTAGTGAGACGTGCTACTTC-3’) (Sicinski et 
al. 1995). PCR is performed in a Thermal Cycler (T100 Bio-Rad) with the program showed in 
Figure 7C. PCR products are analyzed in a 1.5 % agarose gel. After running, gel is stained in an 
EtBr solution for 10 min and visualized with a UV light transilluminator. The expected band 
pattern for WT (224 bp), heterozygous (224 and 391 bp) and KO (391 bp) animals is shown in 
Figure 7B. 
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94 ºC à 3’
94 ºC à 30’’
62 ºC à45’
72 ºC à 2’
38x
 
Figure 7: Disruption of CCND1 gene. A) Restriction map of Mm CCND1 and the structure of the mutated 
locus by homologous recombination. Black boxes show the coding exons numbered; open box represent the 
noncoding portion of the first exon. Arrows denote PCR primers (1, 2 and 3) used for genotyping the 
animals. B) PCR amplification products of DNA extracted from mouse tails. The sizes of amplification 
products of either WT or KO alleles are shown. The genotypes of the animals are represented above the 
lanes. Extracted from (Sicinski et al. 1995). C) Scheme of the conditions used for the PCR.  
Moreover, Ccnd1 protein expression is confirmed by Western Blot. Protein extraction in this case, 
is performed from a paw of the animal which is introduced in 15 l of urea with glass beads and 
50 l of 1x SR (2% SDS and 0.125 M Tris-HCl, pH adjusted to 6.8). The mix is vortexed and 
boiled at 95 ºC for 3 minutes. After that, sample is homogenized at high speed twice for one 
minute so that cells are broken (Minibead-beater-24, BioSpec). Finally, 25 l of 1x SR are added 
and the supernatant is collected. The recovered volume (~40 l) is mixed with 4xSS (20% sucrose 
and 0.02% bromophenol blue, 0.1% sodium azide) and 1% -mercaptoethanol. Cyclin D1 levels 
in samples are analyzed by Western blot with a Ccnd1 antibody (see Table 5).  
3.2.2.2. Plate coating for primary neuronal culture with poly-D-lysine and laminin 
For the primary cortical neuron culture, it is necessary to coat the plates with filtered poly-D-
lysine 0.5 mg/ml in borate buffer pH 8.4. After incubation at 37 ºC overnight (O/N), plates are 
washed three times with distilled water. For neuron transfections, plates are additionally coated 
with laminin (5 mg/ml in DPBS - Dulbecco's phosphate-buffered saline, Gibco). These plates are 
incubated at 37 ºC for at least 2 hours, and then they are washed three times with DPBS (Gibco) 
avoiding that the bottom of the plate dries up. Finally, 1:1 NB27 conditioned medium is added 
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and plates are left in an incubator until the moment of seeding the cells. In this way, a proper 
matrix is generated allowing the adherence of the cells.  
3.2.3. Organotypic hippocampal slices preparation 
Organotypic hippocampal slice cultures are prepared as previously described (Gähwiler et al, 
1997) and shown in Figure 8. Briefly, newborn rats (postnatal days 5-7) are decapitated, and 
whole brains are dissected and placed in ice-cold Ca2+-free dissection solution (10 mM D-glucose, 
4 mM KCl, 26 mM NaHCO3, 8% sucrose, 5 mM MgCl2, 1:1000 Phenol Red) saturated with 5% 
CO2 / 95% O2, enabling the brain to chill for 1 min. Hippocampi are then isolated with the help of 
a magnifying glass, cut in slices (400 m) in the same solution using a tissue chopper (Stoelting), 
and maintained at 35.5ºC in culture on semipermeable membranes in a medium containing 20% 
horse serum, 1 mM CaCl2, 2 mM MgSO4, 1 mg/l insulin, 0.0012% ascorbic acid, 30 mM Hepes, 
13 mM D-glucose, and 5.2 mM NaHCO3. Culture medium is replaced with fresh one every 2-3 
days. The slices are used at 4-8 days in vitro.  
 
 
Figure 8: Scheme of the workflow followed for hippocampal slice preparation for whole-cell 
recordings. 
3.2.4. Cell transfection 
3.2.4.1. Lipofectamine 2000 
For transient transfection of plasmid vectors, Lipofectamine 2000 (Invitrogen) transfection 
reagent is used. The day prior to transfection, cells are seeded in either 4-well plates (16 mm), 6-
well dishes (35 mm), 60 mm or 100 mm plates. For HEK293T cells, plates are coated with 100 
g/ml collagen in 0.02 M acetic acid. Cells are transfected at ~70% confluency. For the amount of 
reagents, we follow manufacturer’s recommendations (Table 4). The appropriate volume of Opti-
MEM medium (GIBCO-Invitrogen) is mixed with DNA. Concurrently, Opti-MEM is mixed with 
Lipofectamine 2000 and incubated at room temperature for 5 min. Then, Lipofectamine mixture is 
added to the DNA mixture, gently mixed and left for 20 min at room temperature. During this 
time, cells are washed with Opti-MEM. The DNA – Lipofectamine mixture is then added to the 
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cells in a dropwise manner and gently swirled to mix. Cells are incubated at 37 ºC, 5% CO2 for 15 
min. Finally, transfection mixture is removed and DMEM (10% FBS, P/S) is added. Cells are 
grown at 37ºC, 5% CO2 with humidity for a further 24 to 48 hours.  
Lipofectamine 2000 reagent is also used for the “in tube” transfection of primary cortical neurons 
as long as this method guarantees a more efficient DNA entry to the cells (Halterman et al. 2009). 
In this case, 400 ng of DNA and 0.5 l of Lipofectamine are mixed with 50 l Opti-MEM for 
every 2·105 dissociated cortical neurons in 100 l Neurobasal medium. Incubating times are the 
same as in HEK293 transfection, but cells must be incubated with the DNA – Lipofectamine mix 
for 40 min at room temperature prior to seeding. Plates are incubated 24 hours at 37 ºC and then 
used for different analyses. 
3.2.4.2. Polyethylenimine  
Polyethylenimine (PEI, Sigma-Aldrich) consists of a stable cationic polymer that is used to 
introduce DNA into a host cell, since it condenses the DNA into positively charged particles that 
bind to anionic cell surfaces (Boussif et al. 1995). As a consequence, the DNA:PEI complex is 
endocytosed by the cells and DNA is released into the cytoplasm.  
Conditions prior to transfection are as described above for Lipofectamine 2000 in all respects. For 
the transfection procedure, 10 M PEI and DNA are diluted separately in Opti-MEM (Table 4). 
After 5 min incubation, the diluted PEI is added to the diluted DNA and the mixture is incubated 
for 15 min at room temperature. During this time, cells are washed once with pre-warmed Opti-
MEM and then, the PEI-DNA mixture is gently added to the cells. Plates are incubated for 1 hour 
at 37 ºC in the incubator. After this time, PEI-DNA mixture is removed from the cells and pre-
warmed fresh medium (DMEM 10% FBS, P/S) is added. Finally, plates are placed at the 5% CO2 
incubator O/N. After 24-48 hours, cells are harvested and used for different analyses.  
Table 4: Volumes of DNA, Opti-MEM, lipofectamine 2000 and PEI used for cell transfection in this 
thesis 
PLATE (Ø) DNA + Opti-MEM Lipofectamine + Opti-MEM PEI + Opti-MEM 
16 mm 0.8 g + 50 l OPT 2 l + 50 l OPT  
23 mm 1,6 g + 100 l OPT 4 l + 100 l OPT  
35 mm 4 g + 250 l OPT 10 l + 250 l OPT  
60 mm 8 g + 500 l OPT 20 l + 500 l OPT 80 l + 420 l OPT 
100 mm 24 g + 1.5 ml OPT  240 l + 1.26 ml OPT 
150 mm 50 g + 3.4 ml OPT  540 l + 2.84 ml OPT 
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3.2.4.3. tsA201 cells transfection for electrophysiology 
All electrophysiological experiments are done with mycoplasma-free tsA201 cells. This cell line 
(also known as HEK293T cells) is a transformed human kidney cell (HEK293) line stably 
expressing an SV40 temperature-sensitive T antigen, which produce high levels of recombinant 
proteins. tsA201 cells are kindly provided by Prof. F. Ciruela (Universitat de Barcelona) and 
purchased from the American Type Culture Collection (ATCC, CRL-3216, RRID: CVCL_0063). 
Mycoplasma detection tests are performed with PlasmoTest (Invivogen, code: rep-pt1). 
Cells are transiently co-transfected with 1 μg total cDNA using polyethylenimine (PEI) 
transfection reagent (1 mg/ml) in a 3:1 ratio (PEI:DNA). In all transfections the DNA ratio used is 
1:1:2 (plasmid A : plasmid B : plasmid C), where A is α4 or α4(T423E,S431E), B is β3: and C is 
CAAX or CAAX-Ccnd1 codifying plasmid. Cells are re-plated on poly-D-lysine coated glass 
coverslips to allow optimal density with isolated cells. All experiments are performed 48 h after 
transfection. 
3.2.4.4. Electroporation 
For faster expression, nucleofection is used. It applies an electrical pulse that allows DNA to enter 
directly into the nucleus. Specifically, for cortical neurons program 005-O of the Amaxa 
Nucleofector is used with its convenient electroporation solution (Ingenio, Mirus).  
In the case of electroporation, 2·106 cells are centrifuged at 650 rpm for 4 min. Medium is 
removed, cells resuspended in 100 l of electroporation solution, and 2 g DNA added. This mix 
is then transferred to an electroporation cuvette and submitted to an electrical pulse. After that, 
500 l NB27 (37ºC) are added and cells collected and seeded in 4-well plates at a density of 105 
cells/well (2 cm2 area) and incubated at 37 ºC, 5 % CO2 for 2 hours. Afterwards, transfection 
solution is removed and fresh medium at 37 ºC (1:1 conditioned medium: NB27) is added. 
3.2.5. Competent cells transformation 
Escherichia coli DH5 cells are thawed on ice and 1-50 ng DNA is added. Cells are incubated 30 
for 30 min on ice. Subsequently, a heat-pulse at 42 ºC is done in a preheated water bath for 20 
seconds. Reactions are then incubated on ice for 2 minutes and further 900 l LB (Luria-Bertani 
medium) medium are added and incubated 1 hour at 37 ºC. Finally, using a sterile spreader, 
transformed cells are spread onto LB agar plates containing the appropriate antibiotic.  
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3.3 Microscopy techniques 
3.3.1. Immunofluorescence 
For protein detection by immunofluorescence, cells are fixed in the primary cortical neuron plate 
so that both the cellular and subcellular architecture are maintained. All solutions are filtered 
before use. First, cells are washed with cold PBS-MC (1 mM MgCl2; 0.1 mM CaCl2), and fixed 
by adding 4% PFA and 4% sucrose in PBS for 15 min (500 l mix for a 2 cm2 area well). Later, 
cells are washed with PBS and permeabilized with 0.1% Triton in PBS (300 l mix for a 2 cm2 
area well) for 3 min. This step allows the entrance of the antibody into the cell. Subsequently, 
cells are washed with PBS and blocked with 3% Bovine Serum Albumin (BSA) for 30 min. This 
blocking step reduces the non-specific binding of the antibody. Primary antibody in 0.3% BSA in 
PBS is added to the sample and incubated at 4 ºC O/N at the concentrations indicated in the Table 
5. The following day, wells are washed three times with PBS to remove unbound or weakly 
bound antibody. Primary antibodies are combined with the corresponding secondary antibodies 
labeled with Alexa488 or Alexa594 (Molecular Probes) diluted 1:1000 in 0.3% BSA in PBS, and 
incubated together with Hoechst (1:10000 Sigma-Aldrich) to stain the nuclei for 45 min at room 
temperature in the dark. Epifluorescence images are obtained with the objectives 10x and 20x of 
an inverted Olympus IX71 microscope and its Controller software. Confocal images are obtained 
with 40x and 60x objectives of the confocal microscope FV1000i (Olympus) and its Olympus 
Fluoview FV10-ASW4.1 Viewer. Table 5 lists primary antibodies. For neurite and axon length 
quantification, the NeuronJ plugin of the ImageJ software is used. 
3.4 Biochemical analyses  
3.4.1. Antibodies 
Different antibodies have been used in several techniques such as immunofluorescence or 
Western blot. All primary and secondary antibodies used are listed in Table 5 and Table 6, 
respectively.  
Table 5. List of primary antibodies employed and their experimental conditions in 
immunofluorescence, immunoprecipitation and western blot techniques. 
ANTIGEN 
BIOLOGICAL 
SOURCE 
REFERENCE 
CONCENTRATION OF USE 
WESTERN 
BLOT 
IMMUNO- 
FLUORESCENCE 
-Tubulin 
Mouse 
monoclonal 
Clone B-5-1-2, Sigma-
Aldrich #T5168 
1:10000 - 
-Actin 
Mouse 
monoclonal 
 
Clone AC-15, Sigma-Aldrich 
#A1978 
1:4000 - 
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ANTIGEN 
BIOLOGICAL 
SOURCE 
REFERENCE 
WESTERN 
BLOT 
IMMUNO-
FLUORESCENCE 
Cyclin D1 
Mouse 
monoclonal 
Clone DCS-6, BD Pharmigen 
#556470 
1:500 - 
Cyclin D1 
Rabbit 
monoclonal 
Clone EP12, Dako #M3642 1:500 - 
Cdk4 Rabbit polyclonal 
Clone C-22, Santa Cruz 
Biotecnology #sc260 
1:250 - 
FLAG 
Mouse 
monoclonal 
Clone M2, Sigma-Aldrich 
#F3165 
1:1000 - 
FLAG Rabbit polyclonal Invitrogen #11508721 1:500 - 
GABRA4 Rabbit polyclonal AB5459, Sigma-Aldrich 1:1000  
GFP 
Mouse 
monoclonal 
Clone 13.1; Roche 
#11811460001 
1:1000  
GFP 
Mouse 
monoclonal 
Clone 3E6, Invitrogen 
#A11120 
- 1:200 
GST Goat polyclonal 
GE Healthcare Life Sciences 
#27-4577 
1:2000 - 
HA Rat monoclonal 
Clone 3F10, Roche 
#11867431001 
1:2000 1:200 
Pxn 
Mouse 
monoclonal 
Clone 349; BD Transduction 
laboratories #610051 
1:1000 - 
Pxn 
phospho-
Ser83 
Rabbit polyclonal ECM Biosciences #PP1341 1:500 - 
Pxn 
phospho-
Ser178 
Rabbit polyclonal Calbiochem #ST1069 1:500 - 
TFRC 
Mouse 
monoclonal 
Clone H68.4; Invitrogen #13-
6800 
1:1000 - 
Ubiquitin 
Mouse 
monoclonal 
Santa Cruz Biotecnology 
#sc8017 
1:200 - 
 
Table 6: List of secondary antibodies used in this thesis. 
IMMUNOGEN BIOLOGICAL SOURCE REFERENCE APPLICATION 
Mouse IgG 
HRP-linked whole Ab (from 
sheep) 
GE Healthcare Western blotting (1:10000) 
Rabbit IgG 
HRP-linked whole Ab (from 
donkey) 
GE Healthcare Western blotting (1:10000) 
Rat IgG 
HRP-linked whole Ab (from 
goat) 
GE Healthcare Western blotting (1:10000) 
Mouse IgG 
Alexa Fluor 488 conjugated 
antibody (from rabbit) 
Thermo Fisher 
Scientific 
Immunofluorescence 
(1:1000) 
Rat IgG 
Alexa Fluor 594 conjugated 
antibody (from rabbit) 
Thermo Fisher 
Scientific 
Immunofluorescence 
(1:1000) 
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3.4.2. Protein extraction and immunodetection by western blot 
Immunodetection by western blot is used to study the expression pattern of expression of different 
proteins. For protein extraction from a cell culture, medium is removed and cells washed with 
cold 1x PBS. This step is important in order to avoid detection of proteins from the medium in the 
western blot. Then, cells are collected in 1x SR buffer (2% SDS, 0.125 M Tris-HCl pH 6.8) and 
sonicated (Soniprep 150 MSE) in short bursts of high-frequency sound waves (15’’ at power 8). If 
needed, protein quantification is carried out with the Lowry method (Bio-Rad). Next, a mixture of 
4x SS (20% sucrose, 0.02% bromophenol blue, 0.1% sodium azide) and 1% -mercaptoethanol is 
added. Samples are boiled for 5 min at 95 ºC, spun and either stored at -20 ºC or used 
immediately. 
In order to extract protein from hippocampal slices, 3-5 slices are collected in 80 l 1x SR buffer 
and homogenized 2x 10 seconds with a Pellet Mixer (VWR ®Radnor). Protein is quantified by 
the Bradford method (Bio-Rad). Finally, 4x SS and 1% -mercaptoethanol are added and samples 
boiled for 5 min at 95 ºC. 
3.4.3. Electrophoresis (SDS-PAGE) 
Denaturing electrophoresis (SDS-PAGE) is achieved using different concentrations of 
acrylamide/bisacrylamide (37.5:1, Bio-rad) are used depending on the molecular weight of the 
protein of interest, this ranging from 7.5% to 15%. Stacking gels to deposit the samples are 5% 
acrylamide/bisacrylamide. To determine protein size, 5 µL of a molecular weight marker 
(PageRuler prestained protein ladder, ThermoFisher) are loaded into each gel. The electrophoretic 
separation is performed in electrophoresis cells from BioRad (Mini-PROTEAN II, #165-2940) 
filled with a buffer solution (25 mM TRIS, 1.44%, 0.1% SDS) and applying constant amperage of 
20 mA/gel for 1 hour approximately. 
3.4.4. Electroblotting 
After electrophoretic protein separation, proteins are transferred to a PVDF (polyvinilide 
difluoride) membrane (Immobilon-P, #IPVH00010, Millipore) previously activated by incubation 
with methanol for 5 seconds and equilibrated with transfer buffer (25 mM TRIS, 192 mM glycine, 
20% methanol). The separating gel is in touch with the PVDF membrane inside a sandwich 
system for a semidry transfer in a Hoefer TE77XP semidry system. The amperage applied was 
constant at 60 mA per membrane for 75 min. 
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3.4.5. Membrane blocking 
Once proteins are transferred, the chemically active groups in the PVDF membrane are blocked to 
avoid non-specific binding of antibodies. Two different blocking solutions are used depending on 
the primary antibody: 3% BSA in PBS-T (phosphate buffered-saline 10 mM, Tween-20 0.05%) 
for phosphorylation-antibodies or 5% skimmed milk in PBS-T for the rest. Membranes are 
blocked for 1 hour at room temperature or O/N at 4 ºC, then washed for 5 min with PBS-T in 
order to remove excess of blocking solution. 
3.4.6. Immunodetection 
Membranes are incubated with the primary antibody in 0.25% milk in PBS-T or in 0.3% BSA in 
PBS-T overnight at 4 ºC and mild shaking. Primary antibodies used in this work are summarized 
in Table 5. After incubation with the primary antibody, three washes of 10 min each are 
performed with PBS-T and then membranes are incubated with the appropriate secondary 
antibody linked to horseradish peroxidase (GE Healthcare) (Table 5 and Table 6) in 0.3% BSA or 
0.5% milk and incubated for 1 hour with mild shaking at room temperature. Afterwards, 
membranes are washed three times for 10 min each with PBS-T. 
3.4.7. Chemiluminescent detection and data analysis 
For detection, PVDF membranes are incubated at room temperature for 5 min with a 
chemiluminescent substrate (LuminolTM Western Chemiluminescent HRP Substrate, Millipore). 
The luminescent emission is detected with a ChemiDocTM MP imaging System from Bio-Rad and 
analyzed with the Image Lab v4.0 software (Bio-Rad). The amount of luminescence is directly 
proportional to the amount of protein in the membrane, when this is not overexposed. Usually, the 
level of a protein is relativized to a loading control: actin or Coomassie Blue staining.  
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3.5 Protein interaction assays 
3.5.1. Immunoprecipitation using anti FLAG M2 agarose beads 
Flag tagged proteins are recognized and bound by the anti-FLAG-M2 antibody (Table 5) and 
efficiently pulled-down using anti-FLAG-M2-conjugated agarose beads.  
For heterologous expression of proteins, HEK293 cells are transfected with the plasmid of 
interest. After 24 h, cells are placed on ice and washed with ice-cold PBS. Cells are collected by 
scraping them in ice-cold lysis RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 
0.1% Na·Deoxycolate, 0.1% SDS, 5 mM EDTA, 1x protease and phosphatase inhibitor mix). 
Collected cells are transferred to a pre-cooled microcentrifuge tube, rolled for 30 min at 4 ºC and 
then centrifuged at 4 ºC, 300 g for 5 min. After centrifugation, supernatant is transferred to a fresh 
tube kept on ice; the pellet containing cell debris and membranes is discarded.  
An aliquot of the supernatant is stored as input. The remaining is then incubated for 3 hours at 4 
ºC with the agarose beads conjugated with the FLAG-M2 antibody. Next, beads bound to the 
antigen are washed 3 times with ice-cold lysis buffer and bound proteins are eluted in 1x SR (2% 
SDS, 0.125 M Tris-HCl pH 6.8) at 37ºC for 5 min. Afterwards, eluate is taken and mixed with 
4xSS (20% sucrose, 0.02% bromophenol blue, 0.1% sodium azide) and -mecaptoethanol, and 
further boiled at 95ºC for 5 min. Samples are then stored at -20 ºC or analyzed by western blot. 
Anti-ubiquitin antibody is used to detect ubiquitylated proteins.  
3.5.2. Immunoprecipitation of endogenous cyclin D1 in adult hippocampus 
For the immunoprecipitation of endogenous Ccnd1 in adult hippocampus, three hippocampi from 
adult females are taken, lysed in 1 ml RIPA buffer, and homogenized with 20x strokes in a 
douncer. Then, 2 ml RIPA buffer are added and samples are rolled for one hour at 4 ºC. After 
that, samples are centrifuged 5 min at 5000 rpm, 4 ºC. Supernatant is then incubated for 30 min at 
4 ºC with 20 l of pre-washed protein A magnetic beads (Dynabeads, Invitrogen) for a 
preclearing step to remove proteins that bind non-specifically to beads. Afterwards, beads are 
removed and the sample is divided into two tubes and one is incubated overnight at 4 ºC with 3 
g rabbit -FLAG antibody and the other with rabbit -cyclin D1. The following day, and prior 
to the incubation with the sample, 40 l protein A dynabeads per sample are washed twice with 
RIPA buffer (without SDS). These washed dynabeads are incubated 2 hours at 4 ºC with the 
antigen-antibody sample. Finally, three washes are carried out with RIPA buffer (without SDS) 
and bound proteins are eluted from the beads with 1x SR (2% SDS, 0.125 M Tris-HCl pH 6.8) for 
5 min at 37ºC. Eluate is taken and mixed with 4xSS (20% sucrose, 0.02% bromophenol blue, 
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0.1% sodium azide) and -mecaptoethanol and further boiled at 95ºC for 5 min. Samples are then 
analyzed by western blot. 
3.5.3. Affinity purification of GST-4  
Mus musculus GABRA4 (Image ID 6828002, BioScience) and C-terminus of GABRA4 (amino 
acids 354-552) are amplified by PCR and cloned into the expression vector pGEX-KG, which 
allows the fusion with the glutathione-S-transferase (GST) encoding gene. The resulting fusion 
proteins are able to bind to glutathione beads, and therefore these constructions allow us to 
express and purify from bacteria the fusion proteins for in vitro interaction analyses or in vitro 
kinase assays. To this end, Escherichia coli BL21 is transformed with either the GST-GABRA4 
or GST-C-terminus GABRA4 vectors (see 3.2.5).  
Vector-bearing bacteria are grown in 10 ml LB medium with 50 g/ml ampicillin overnight at 37 
ºC. The next day, culture is diluted into a new LB + ampicillin + 10% glycerol solution to an 
OD600 ~0.05 – 0.1 and cells are grown at 37 ºC for 2-3 hours. When the culture reaches an OD600 
of 0.5, the expression of the fusion proteins is induced with 1 mM IPTG (Isopropyl - D -1- 
thiogalactopyranoside) for 4 hours at 30 ºC until OD600 reaches 2-3. At this point, the culture is 
placed on ice for 30 min and then centrifuged at 700 rpm for 10 min at 4 ºC. The resulting pellet 
is resuspended in 2 ml cold distilled H2O, divided into two tubes with 50 OD600 equivalents each, 
centrifuged at 10000 rpm for 5 min at 4 ºC. The resulting pellets are frozen and maintained at -80 
ºC.  
For protein purification, the pellet is resuspended in 1 ml lysis buffer (50 mM HEPES pH7.5, 150 
mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol and a mix of protease and phosphatase 
inhibitors) with 0.5 mg/ml lysozyme and rolled at 4 ºC for 30 min. Then, to help dissolve the 
membranes, 0.5% Triton-X100 is added and incubated on ice for 5 min. Cell extract is sonicated 
three times for 10 seconds at power 6 (Soniprep 150 MSE) and centrifuged at 15000 rpm for 10 
min at 4 ºC. At this time, an aliquot of the supernatant is taken as the soluble extract fraction and 
the rest is incubated with previously washed Glutathione-Sepharose 4B beads (GE, Healthcare 
Bio-sciences) rolling for 2 hours at 4 ºC. Afterwards, protein-bound beads are washed three times 
with lysis buffer containing 0.1% Triton-X100 and once with kinase buffer or binding buffer. 
Then, glycerol is added and samples are kept at –80 ºC. An aliquot of this purified protein 
together with the soluble extract is collected for a further analysis by SDS-PAGE. The gel is 
stained with Coomassie brilliant blue (EZblueTN Gel Staining Reagent, Sigma- Aldrich). The final 
concentration and purity of the isolates are estimated by comparison with protein standards.  
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3.5.4. In vitro protein interaction assay 
FLAG-Ccnd1 (pCYC193) is amplified by PCR (forward primer: 
CGCGCTAATACGACTCACTATAGGGAGACCCAAGCCCATGGGATCAC; reverse primer: 
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTGGCTGATCAGCGAGCTCTAG, transcribed in 
vitro with the T7 RNA polymerase (New England Biolabs), and in vitro translated with a rabbit 
reticulocyte lysate system (Promega). For the in vitro protein interaction assay, 400 ng of GST-4 
or GST-4-C-terminal purified from E. coli and immobilized on Glutathione-Sepharose 4B beads 
(GE, Healthcare Bio-sciences) are incubated together with FLAG-Ccnd1 in binding buffer (20 
mM HEPES-KOH pH7.5, 150 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 0.1% NP-40, 1mM DTT, 
1 mM PMSF, 10% glycerol and a mix of protease and phosphatase inhibitors) for 30 min at room 
temperature. After four washes in binding buffer, 50 l 2xSSR is added and the samples are 
analyzed by SDS-PAGE and Western blotting (GST and Rabbit anti-Ccnd1 antibodies, see Table 
5).  
3.6 Kinase reaction assays 
3.6.1. In vitro kinase assay 
For kinase reactions, 0.2-0.5 g substrate (GST-fusion proteins obtained in 3.5.3) are mixed with 
10 M cold ATP, 10 Ci -32P-ATP (PerkinElmer, 3000 Ci/mmol) and 1.5 l of the Ccnd1–Cdk4 
active complex purified from baculovirus (C0620, Sigma- Aldrich) in 20 l kinase buffer (50 mM 
Tris-HCl pH7.5, 10 mM MgCl2, 0.5 mM DTT, 1 mM EGTA, 2.5 mM -glycerophosphate). 
Either the kinase complex inhibitor palbociclib (S1116, Selleckchem) at 2 M or DMSO as a 
control is added to the reaction mix. This mix is incubated for 20 min at 30 ºC and the reaction is 
stopped by adding 2xSSR (4% SDS, 0.25 M Tris-HCl pH6.8, 10% sucrose, 2% -
mercaptoethanol and 0.01% bromophenol blue) and boiling the samples for 5 min at 95 ºC. 
Proteins are loaded into a gel and separated by SDS-PAGE electrophoresis. After that, the gel is 
dried and exposed to a film at -80 ºC. Phosphorylated proteins are visualized by autoradiography 
in the automatic film processor OPTIMAX from PROTEC®.  
3.6.2. Mass spectrometry (HPLC-MSMS) 
Mass spectrometry experiments are performed with the GST-4 or GST-4-C-terminal obtained 
in 3.5.3 after an in vitro kinase assay as in 3.6 but with non-radioactive ATP or without ATP 
(control). After the kinase reaction, samples are run in a SDS-PAGE gel and stained with Oriole 
Fluorescent Gel Staining (BioRad). Detected bands are purified and prepared to be analyzed by 
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mass spectrometry (HPLC-MSMS) in the Proteomic Unit of the Institut d’Investigació Biomèdica 
de Bellvitge (IDIBELL). 
3.7 Electrophysiology 
3.7.1. Whole-cell currents measurements in tsA201 cells 
The measurements of GABA-evoked whole-cell currents in tsA201, a human embryonic kidney 
cell line, were done in the laboratory of Dr. David Soto (Universitat de Barcelona). Cells are 
visualized with an inverted microscope (AxioVert A.1, Carl Zeiss) and maintained in extracellular 
flowing solution at a rate of 60 ml/h. The extracellular solution contains (in mM): 140 NaCl, 5 
KCl, 10 HEPES, 11 glucose, 2.5 CaCl2, 1.2 MgCl2 (pH = 7.4 with NaOH; osmolarity 305 
mOsm/Kg adjusted with sorbitol). Electrodes are fabricated from borosilicate glass (1.50 mm 
O.D., 1.16 I.D., Harvard Apparatus) pulled with a P-97 horizontal puller (Sutter Instruments) and 
polished with a forge (MF-830, Narishige) to a final resistance of 2–5 MΩ. The intracellular 
solution contains (in mM): 140 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 1.1 EGTA, 2 Mg ATP (pH = 
7.2 with KOH; osmolarity 295 mOsm/Kg adjusted with sorbitol). 
Macroscopic GABAA-mediated currents are recorded at room temperature (22-25˚C) in the 
whole-cell configuration from cells positive for venus and mCherry fluorescence at a holding 
membrane potential of -60 mV. Currents are recorded with Axopatch 200B amplifier, filtered at 
2kHz and digitized at 5kHz using Digidata 1440A interface with pClamp 10 software (Molecular 
Devices Corporation). Series resistance is typically 5–20 MΩ, and is monitored at the beginning 
and at the end of the experiment. Cells that showed a change in series resistance greater than 20% 
are rejected. 
Rapid application of the agonist GABA (1-2 ms exchange) is applied by switching between a 
continuously flowing control solution (extracellular solution diluted by 5%) and a GABA-
containing solution (1 μM GABA and 2.5mg/ml of sucrose diluted in extracellular solution). 
Solution switching is achieved by piezoelectric translation of a theta-barrel application tool made 
from borosilicate glass (1.5 mm O.D.; Sutter Instruments) mounted on a piezoelectric translator 
(P-601.30; Physik Instrumente). Agonist is applied at 2 minutes interval and the magnitude of the 
peak current is measured (IGABA). Electrophysiological recordings are analyzed using IGOR Pro 
(Wavemetrics Inc.) with NeuroMatic (Jason Rothman, UCL).  
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3.7.2. Whole-cell recordings in organotypic hippocampal slices 
3.7.2.1. GABA tonic currents  
Whole-cell voltage clamp is used to measure GABA tonic currents in cultured hippocampal 
slices. Prior to the electrophysiological recordings, slices are treated for 2 hours with either 
DMSO (control solution) or 2.5 M Palbociclib (Cdk4/6 inhibitor) (Selleckchem). After that, 
slices are placed in a chamber and perfused with artificial cerebrospinal fluid [aCSF: 119 mM 
NaCl, 2.5 mM KCl, 1 mM NaH2PO4, 26 mM NaHCO3, 11 mM glucose, 1.2 mM MgCl2, 2.5 mM 
CaCl2; osmolarity adjusted to 290 mOsm; pH7.5] supplemented with 100 M AP5 (NMDA 
receptor antagonist), 10 M CNQX (AMPA receptor antagonist), 1 M strychnine (glycine 
antagonist), 4 M 2-chloroadenosine (to stabilize the evoked neural response) and DMSO or 
Palbociclib as external solution gassed with 5% CO2 at 29 ºC in the electrophysiology set-up. 
Patch recording pipettes (4-6 M) are pulled from thin-walled borosilicate capillary glass (World 
Precision Instruments [WPI], Sarasota, FL) on a P-2000 laser electrode puller (Sutter Instrument, 
San Rafael, CA) and filled with high chloride internal solution (178 mM CsCl, 10 mM Hepes, 2.5 
mM MgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP, 10 mM sodium phosphocreatine, 0.6 mM EGTA; 
pH adjusted to 7.2, osmolarity adjusted to 290 mOsm). The pipette potential is held at -60 mV 
during recordings. GABA inhibitory post synaptic currents are evoked with single voltage pulses 
(200 s, <30 V) delivered through a bipolar electrode Axopatch 200B amplifier (Molecular 
Devices, Union City, CA) placed on Schaffer collaterals, and tonic currents are recorded from 
CA1 pyramidal neurons. At least 10 min of stable baseline synaptic responses and holding 
currents (HC) are recorded. The tonic GABAA R-mediated current is measured as an outward 
shift in holding current following application of picrotoxin (100 M). For quantifications, each 
cell contributed with a holding current value obtained as a mean of one minute HC recording once 
the synaptic response was almost inhibited by picrotoxin action (Figure 9). 
3.7.2.2. Miniature inhibitory postsynaptic currents  
Recordings of miniature responses (mIPSC) are performed from hippocampal slices from P5-7 
rats at -60 mV in the presence of 10 M CNQX, 100 M AP5, 1 M strychnine and 1 M 
tetrodotoxin (action potentials blocker). As for the GABA tonic current recordings, slices are 
treated for 2 hours with 2.5 M Palbociclib or DMSO. These recordings are obtained with the 
gap-free program of pClamp. All electrophysiological data are collected with pCLAMP software 
(Molecular Devices). Data analysis is performed with pClamp software (miniature currents) or 
custom-mode Excel (Microsoft) macros (GABA tonic currents).  
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Figure 9: Representative examples of recordings of GABA tonic currents. A) Rat hippocampal slices 
are used for whole-cell patch clamp recordings performed at -60 mV. Recordings are aligned by the 
moment of 100 M picrotoxin addition. The grey rectangle shows the selected minute in which the holding 
current (HC) for that cell is obtained. Baseline holding current is considered as the average of the HC 
during 3 minutes of stability. The shift in the HC is represented as the HC at the moment minus the baseline 
HC. B) Percentage of the intensity (I amplitude) of the evoked synaptic response. The amplitude of the 
response during the baseline is considered as 100%. The fall of the synaptic response is used as a control for 
picrotoxin activity. C) Serial resistance of each cell is followed as a control for cell viability and stability. 
3.8 Surface biotinylation assay 
A cell surface biotinylation assay provides a way to study trafficking of cell-surface proteins by 
their labelling with a biotin variant (EZ-link sulfo-nhs-SS-biotin, Fisher Scientific). In other 
words, the aim of this protocol is to analyze the processes of endocytosis and further destruction 
or “recycling” that contribute to the regulation of the amount of a specific protein in the 
membrane.  
The biotin variant used in this assay is a small water-soluble molecule consisting of a charged 
sulfo group, a reactive N-hydroxysuccinimide ester group, a cleavable disulfide bond and biotin. 
Due to the strong charge imparted by the sulfo group, this biotin variant is membrane 
impermeable.  
3.8.1. Biotin labeling of membrane proteins 
Cells (2·106 cells in a 100mm plate) are washed twice with ice-cold PBS. Then, 1 mg/ml of sulfo-
NHS-SS-biotin in PBS is added and incubated on ice for 15 min. Low temperature restricts 
endocytosis, thus the NHS group of the reagent reacts covalently only with primary amines on 
surface proteins. After the treatment, cells are washed twice with TBS (Tris-buffered saline: 150 
mM NaCl, 50 mM Tris-HCl, pH 7.6) in order to quench the non-conjugated biotin. Next, cells are 
lysed in RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 
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0.1% SDS, 5 mM EDTA, 40 mM NaF, 1 mM Na3VO4 and 1x EDTA-free protease inhibitor 
cocktail) and centrifuged at 1800 rpm, 5 min at 4ºC. Supernatants are collected as cell lysates.  
Biotinylated proteins are isolated by adding the cell lysates to streptavidin-coated synthetic beads 
(Neutravidin agarose beads, Fisher Scientific). To use the same amount of protein per condition, 
protein concentration of each cell lysate is measured with the Bio-Rad DCTM Protein assay kit. 
Then, cell lysates and Streptavidin-agarose beads are incubated together overnight at 4ºC on an 
orbital shaker and washed three times with RIPA buffer the next day. A final elution step in 
2xSSR is performed to release bound proteins. The target proteins are then analyzed by Western 
blotting.  
3.8.2. Receptor internalization assay using biotin labeling 
Cells (2·106 cells in a 100mm plate) are washed with PBS and labeled with 1 mg/ml of sulfo-
NHS-SS-biotin in PBS on ice for 15 min. Next, two washes with TBS are carried out, and time 0 
samples are collected. The other plates are placed at a 37 ºC incubator for 15 min with medium 
containing the lysosomal inhibitor leupeptin at 100 g/ml to prevent lysosomal proteolysis of 
internalized proteins. Afterwards, cells are incubated twice for 15 min each with cleavage buffer 
(50 mM glutathione, 75 mM NaCl, 10 mM EDTA, 1% BSA, 0.075 N NaOH) on ice in orther to 
cleave biotin labels in cell-surface proteins (it breaks the disulfide bridge of the EZ-link sulfo-nhs-
SS-biotin). Subsequently, cells are washed with PBS containing 5 mg/ml iodoacetamide, an 
alkylating reagent, and TBS. Finally, cells are lysed with RIPA buffer and a pull-down with 
Streptavidin-agarose beads is performed as in 3.8.1. Samples are analyzed by Western blot 
3.8.3. Assessment of receptor insertion into the membrane by biotin labeling 
Receptor insertion into the membrane is assessed by biotin labeling. First, cell-surface proteins are 
labeled with 1 mg/ml of sulfo-NHS-SS-biotin in PBS on ice for 15 min. After that, all labels are 
cleaved by incubation with cleavage buffer (50 mM glutathione, 75 mM NaCl, 10 mM EDTA, 
1% BSA, 0.075 N NaOH) on ice twice for 15 min. Time 0 samples are collected at this moment. 
Then, cells are placed on an incubator at 37 ºC with fresh medium for 2 hours. Subsequently, cells 
are incubated again with biotin for newly inserted surface protein labeling, lysed with RIPA 
buffer and a pull-down with Streptavidin-agarose beads is carried out as in 3.8.1. Samples are 
analyzed by Western blot.  
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3.9 Statistical analysis 
Different statistical analyses are used in this work. In every analysis, the minimum level of 
statistical significance is a p-value equal to 0.05. The significance level is represented in each 
graph as indicated. 
In order to evaluate possible differences between two experimental groups a t-test is performed. 
When there is a multiple comparison, one-way ANOVA with a post-hoc test (Tukey) is 
performed. In whole-cell recordings in ts201A cells, comparisons between groups are done using 
the parametric student’s t-test. For tonic currents comparison, Wilcoxon test is performed and in 
mIPSC amplitude and frequency, Mann-Whitney test is done. Microsoft Excel and GraphPad 
Prism v5.0 (GraphPad) are used for statistical analysis and graphical representation. 
3.10 Ethical considerations  
All procedures with animals follow the protocols approved by the Institutional Committee of Care 
and Use of Animals (Comitè Institucional de Cura i Ús d’Animals), and experiments are approved 
by the Ethics Committee of the University of Lleida (EAEC 18-01 / 12). Animals are housed and 
maintained in the animal facility of the University of Lleida with 12h:12h light/dark cycle and 
food/water available ad libitum. All efforts are made to minimize the number of animals and their 
suffering.  
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4. RESULTS 
4.1 Role of cytoplasmic cyclin D1 in neuritogenesis 
Several studies point to a role for Ccnd1 in normal development of the nervous system. Ccnd1 
KO mice show neurological abnormalities (Sicinski et al. 1995), Ccnd1is required for NGF-
induced neurite outgrowth in PC12 pheochromocytoma cells (Marampon et al. 2008), and is also 
detected in the cytoplasm of cortical neurons at 4 DIV (days in vitro) (Sumrejkanchanakij et al. 
2003). All together these observations led us to consider a role -likely a cytoplasmic function- for 
Ccnd1 in neuritogenesis. We wanted to study this possibility by electroporating an HA-Ccnd1 
construct in cortical neurons, but this caused nuclear Ccnd1 accumulation and apoptosis, detected 
by cleaved caspase 3 labeling and pyknotic nuclei (Figure 10). To prevent neuronal apoptosis due 
to nuclear Ccnd1 accumulation, HA-Ccnd1 was fused to CAAX, a farnesylatable motif that 
targets the protein to cell membranes, thus avoiding entrance to the nucleus (Fusté 2016). After 
electroporation of HA-Ccnd1-CAAX in cortical neurons, Ccnd1 localizes in the cytoplasm, 
cleaved caspase-3 labeling and pyknotic nuclei disappear, and apoptotic death is prevented. 
Therefore, the HA-Ccnd1-CAAX construct allows us to study the effects of cytoplasmic Ccnd1 in 
neurons. 
HA-CycD1
Caspase-3HA-CycD1 Nuclei
HA-CycD1-CAAX
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Figure 10. Cytoplasmic localization of cyclin D1 avoids apoptotic neuronal death. Mouse cortical 
neurons from E15.5 embryos are electroporated with HA-Ccnd1 or HA-Ccnd1-CAAX and cultured until 4 
DIV. At 4 DIV, apoptosis is assessed by immunofluorescence. Representative images showing HA positive 
cells (red), pyknotic nuclei (Hoechst) and cleaved caspase-3 (green). Arrowheads show electroporated cells. 
Scale bar 10 m 
In consequence, to study the role of cytoplasmic HA-Ccnd1-CAAX in neuritogenesis in primary 
cortical neurons, we co-electroporated them with HA-Ccnd1-CAAX and GFP. GFP is used to 
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observe cell morphology under fluorescence. Neurite number and length are quantified with the 
NeuronJ plugin of ImageJ. The mean of each condition is obtained and normalized to a GFP 
control in each experiment. Then, the mean of the ratios is represented.  
In these experiments, HA-Ccnd1-CAAX promoted an increase of both axon and neurite lengths 
(1.5-fold and 1.4-fold increase respect to a control vector, respectively) at 4 DIV. Also, neurite 
number per cell was increased when HA-Ccnd1-CAAX was overexpressed (from an average of 
5.9 neurites per cell to 6.5 neurites per cell). Hence, overexpression of cytoplasmic Ccnd1 
significantly induces neuritogenesis in cortical neurons at 4 DIV when compared to control cells 
(Figure 11).  
 
Figure 11: Cytoplasmic cyclin D1 induces neuritogenesis in cortical neurons at 4 DIV. A) 
Representative images of cortical neurons electroporated with GFP and HA-Ccnd1–CAAX, HA-
Ccnd1K112E-CAAX or a control vector. At 4 DIV, cells are observed by immunofluorescence against GFP 
(green) and HA (red). Scale bar 10 m. B) Quantifications of axon length, neurite length and number of 
neurites per neuron of the experiments in A. Data obtained with the NeuronJ plugin of ImageJ. Values are 
expressed as meanSEM (n=3 independent experiments, at least 25 cells per condition in each experiment). 
Statistical significance is determined by one way ANOVA and Tukey-HSD post-test (*p<0.05; **p<0.01, 
compared to control). 
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Furthermore, this effect is kinase-dependent since the overexpression of a Ccnd1 mutant (HA-
Ccnd1K112E-CAAX) that does not form an active complex with CDKs does not significantly 
increment either the number of neurites per cell or the lengths of neurites or axons (1.0-fold and 
1.1-fold increase respect to control, respectively). Hence, we conclude that overexpression of 
cytoplasmic Ccnd1 induces axon and neurite outgrowth and increases neurite number per cell in a 
kinase-dependent manner. 
Since the effect of cytoplasmic Ccnd1 observed in neurons at 4 DIV was dependent on the kinase 
activity, we reasoned that overexpressing Cdk4, the CDK partner of Ccnd1, might also elicit a 
similar effect. Therefore, HA-Cdk4 fused to CAAX was electroporated into primary cortical 
neurons. Indeed, overexpression of this membrane-targeted HA-Cdk4-CAAX construct in cortical 
neurons at 4 DIV also causes a significant increase (1.4-fold) of both axon and neurite lengths 
compared to a control group, neurons electroporated with a GFP and a control vector. Also, 
neurite number per cell was increased when HA-Cdk4-CAAX was overexpressed (from an 
average of 5.47 neurites per cell to 6.6 neurites per cell) (Figure 12). 
 
Figure 12: Cytoplasmic Cdk4 induced neuritogenesis in cortical neurons at 4 DIV. A) Representative 
images of cortical neurons electroporated with GFP and either HA-Cdk4-CAAX or a control vector. At 4 
DIV, cells are observed by immunofluorescence against GFP (green) and HA (red). Scale bar 10 m. B) 
Quantifications of axon length, neurite length and neurite number of experiments in A. Data obtained with 
the NeuronJ plugin of ImageJ. Values are expressed as meanSEM (n=3 independent experiments, at least 
25 cells per condition in each experiment). (*p<0.05; **p<0.01, t-test).  
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Because the overexpression of cytoplasmic Ccnd1 in mouse cortical neurons induces an 
increment in the length of both axons and neurites, we wanted to study the role of endogenous 
Ccnd1 in neurite outgrowth. To this aim, cortical neurons were isolated from E15.5 mouse 
embryos and cultured for 0 hours, 4 h, 1 DIV and 3 DIV, and then CCND1 mRNA was quantified 
by qRT-PCR. Endogenous CCND1 mRNA levels decrease significantly after 1 DIV and become 
very low at 3 DIV in comparison with 0 h and 4 h of in vitro differentiation (Figure 13).  
 
Figure 13: Cyclin D1 mRNA level drops at 1 DIV and continues to decrease at 3 DIV. CCND1 and 
GAPDH mRNAs expression are analyzed by qRT-PCR at different time points in cultured cortical neurons. 
CCND1 mRNA levels relative to GAPDH mRNA levels are represented. For all plots, values are expressed 
as mean  S.E.M. Statistical significance is determined by one way ANOVA and Tukey-HSD post-test 
(***p<0.001, compared to time 0h). 
Since downregulation of Ccnd1 in PC12 cells results in a diminution of neurite outgrowth 
(Marampon et al. 2008), we used interference RNA (shCcnd1) to downregulate the expression of 
Ccnd1 in cortical neurons. The efficiency of the shRNA was tested in MEFs (Figure 14A). 
Afterwards, cortical neurons were transfected before seeding with GFP along with a scramble 
control or with shCcnd1, seeded and cultured for 1 DIV. Next, cells were fixed and observed by 
immunofluorescence against GFP to allow quantifications (Figure 14B). Both axon and neurite 
lengths are significantly reduced (23% and 20% respectively) when Ccnd1 is downregulated, 
which also significantly decreases the neurite number per cell, from an average of 4.95 neurites 
per cell in the WT to 4.34 in shCcnd1-expressing neurons. Therefore, downregulation of 
endogenous Ccnd1 significantly affects neuritogenesis. 
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Figure 14: Downregulation of cyclin D1 affects neuritogenesis in cortical neurons at early stages of 
differentiation. A) Ccnd1 knockdown by interference RNA in MEFs. Immunoblot showing Ccnd1 protein 
levels (Dcs6 antibody) in control (Scr) and knockdown cells. Actin levels are used as a loading control. B) 
Cortical neurons are co-transfected with GFP and either a scramble shRNA or shCcnd1. Neurons are fixed 
at 1 DIV and observed by immunofluorescence against GFP. Scale bar 10 m. C) Axon length, neurite 
length and neurite number per cell are quantified using the NeuronJ plugin of ImageJ. For all plots, values 
are expressed as mean  S.E.M (n=3 independent experiments, at least 25 cells per condition in each 
experiment). Statistical significance is determined by t-test (*p<0.05; **p<0.01). 
In addition, axon and neurite lengths and neurite number were determined for cortical neurons 
obtained from E15.5 WT and Ccnd1 KO mice (Figure 15). Prior to seeding, neurons were 
electroporated with GFP in order to follow neurites for quantification. Cells were cultured for 1 
DIV, fixed and observed by immunofluorescence against GFP. Multiple images were taken and 
the axon length, the neurite lengths and the neurite number per cell quantified. Neurons lacking 
Ccnd1 had shorter axons (by 18%) and neurites (by 26%) in comparison with neurons obtained 
from WT mice. We do not find a statistically significant difference between the number of 
neurites in WT (3.09 average) vs Ccnd1 KO neurons (2.99 average).  
All in all, apoptotic neuronal death induced by the overexpression of Ccnd1 is prevented by 
targeting the protein to the cytoplasm. We have shown a role of cytoplasmic Ccnd1 in 
neuritogenesis in a manner that depends on the kinase activity of Ccnd1-Cdk complex. This effect 
of Ccnd1 on neuritogenesis is seen under overexpression conditions and importantly also under 
endogenous conditions by downregulation of Ccnd1 with RNA interference and in Ccnd1 KO 
neurons.  
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Figure 15: Cyclin D1 deficient cortical neurons have shorter axons and neurites at 1 DIV. Cortical 
neurons from Ccnd1 KO mouse embryos (n=6) and WT controls siblings (n=6) were electroporated with 
GFP and cultured for 1 DIV. A) Ccnd1 levels from paw of PCR-genotyped Ccnd1 KO embryos and sibling 
controls were analyzed by WB using Dcs6 antibody. B) Representative images of 1 DIV-cultured cortical 
neurons. Cells are fixed and observed by immunofluorescence against GFP. Scale bar 10 m. C) 
Quantifications of axon length, neurite length and neurite number of the experiments in B using the 
NeuronJ plugin of ImageJ. For all plots, values are expressed as mean  S.E.M (n=3 independent 
experiments, at least 25 cells per condition in each experiment). Statistical significance is determined by t-
test (*p<0.05). 
4.2 Effect of paxillin phosphorylation at S83 and S178 in 
neuritogenesis 
Because Pxn phosphorylation at serine 83 (S83) and serine 178 (S178) is important for 
neuritogenesis in PC12 cells (Huang et al. 2004; Yamauchi et al. 2006) and Ccnd1 controls cell 
spreading and invasion through the phosphorylation of Pxn at serine 83 (S83) and serine 178 
(S178) (Fusté et al. 2016), we wondered whether Pxn could be a downstream target of Ccnd1 in 
the control of neurite outgrowth. Hence, we tested the level of phosphorylated Pxn in cortical 
neurons from E15.5 mouse embryos. These neurons were cultured for 1 or 4 DIV and collected 
for the analysis of phosphorylated S83 (pS83), phosphorylated S178 (pS178) and total Pxn levels 
(Figure 16A). WB quantifications are shown in Figure 16B as a ratio between phosphorylated Pxn 
and total Pxn. pS83 Pxn/Pxn decreases up to 54% and pS178/Pxn drops 52% when 4 DIV is 
compared to 1 DIV. These results are in accordance with CCND1 mRNA levels in cultured 
cortical neurons, i.e, there is a correlation between CCND1 mRNA levels and Pxn 
phosphorylation at S83 and S178 during differentiation.  
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Figure 16: Paxillin phosphorylation at serines 83 and 178 is lower at 4 DIV in comparison to 1DIV. 
A) Endogenous levels of total Pxn and phosphorylated Pxn pS83 and pS178 in cortical neurons are 
analyzed at 1 DIV and 4 DIV by WB. B) Quantification of pS83 Pxn and pS178 Pxn versus total Pxn 
levels. Values are expressed as mean  SEM (n=6). Statistical significance is determined by t-test 
(**p<0.01).  
Paxillin can be phosphorylated in vitro by Ccnd1-Cdk4 at S83, S178 and S244 (Fusté et al. 2016). 
Next, we wanted to test whether these Pxn phosphorylations were important for neurite 
outgrowth. For this reason, cortical neurons were electroporated with GFP and either HA-Pxn or 
the triple non-phosphorylatable mutant PxnS83A, S178A, S244A (HA–PxnTM) and cultured for 1 DIV. 
For this experiment, we chose to culture the cells for 1 DIV because at this time we can observe 
effects of endogenous Ccnd1 on neurite outgrowth (Figure 14B and Figure 15C) and there are 
good levels of Pxn phosphorylation at S83 and S178 (Figure 16A). After 1 DIV, neurons were 
fixed and observed by immunofluorescence against GFP and HA. Figure 17 shows the 
quantification of both axon and neurites lengths for HA-Pxn and for the mutant HA– PxnTM. This 
non-phosphorylatable mutant of Pxn causes a decrease of 18% in axon length and a decrease of 
16% in total neurite length compared to control neurons electroporated with WT Pxn. Besides, 
neurite number per cell in the triple mutant (3.21 average) is lower than in the control (4.05 
average). Hence, Pxn phosphorylation at S83, S178 and S244 significantly affects neuritogenesis 
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in cortical neurons at 1 DIV suggesting that Pxn could act as a downstream effector of Ccnd1 in 
the control of neurite outgrowth.  
 
Figure 17: Phosphorylation of paxillin at serines 83, 178 and S244 is involved in early neuritogenesis 
control. A) Representative images of cortical neurons from E15.5 embryos electroporated with GFP and 
either HA–Pxn or a triple non-phosphorylatable mutant HA–PxnTM at 1 DIV. Neurons are fixed and 
observed by immunofluorescence against GFP (green) and HA (red). Scale bar 10 m. B) Axon and neurite 
lengths are quantified using the NeuronJ plugin of ImageJ. Values are expressed as mean  SEM (n=5 
independent experiments, at least 25 cells per condition in each experiment). Statistical significance is 
determined by t-test (*p<0.05; **p<0.01). 
4.3 Cyclin D1 effects on GABAA receptors 
4.3.1. Interaction between cyclin D1 and 4 subunit of the GABAA receptor  
Looking for Ccnd1 interactors in the brain, a yeast two hybrid screening had previously been 
carried out in our lab with Ccnd1 as a bait and an adult mouse brain cDNA library as prey. An 
interaction between Ccnd1 and the alpha 4 subunit of the type A GABA receptor (4) was 
detected. Specifically, Ccnd1 interacted with three independent clones that contained the 
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intracellular loop found between the TM3 and TM4 domains of the 4 subunit (from amino acid 
354 to 552) (Figure 24).  
In order to confirm the interaction between Ccnd1 and 4, we performed both pull-down and 
immunoprecipitations (IP) experiments. In the GST pull-down assay, in vitro transcribed and 
translated FLAG-Ccnd1 directly and specifically interacts with both recombinant full-length 
GST-4 and the C-terminus fragment isolated from the cDNA library (GST-4-C-terminus) 
corresponding to the intracellular loop and TM4 (Figure 18). This interaction is further tested in 
vivo in HEK 293 cells transfected with HA-4-C-terminus together with FLAG-Ccnd1. IP of 
FLAG-Ccnd1 specifically co-IP HA-4-C-terminus (Figure 19).  
 
Figure 18: Ccnd1 interacts in vitro with the C-terminus of the 4 subunit of the GABAA receptor. 
GST, GST-4 or GST-4-C-terminus are purified from E. coli and immobilized on glutathione agarose 
beads, followed by incubation with in vitro transcribed and translated FLAG-tagged Ccnd1.Five separate 
reactions with the indicated components were set up. WBs using antibodies against GST and Ccnd1 before 
and after the pull-down are shown.  
Therefore, these assays confirmed that Ccnd1 interacts with 4 through its C-terminal region that 
contains the intracellular loop between TM3 and TM4. 
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Figure 19: Heterologous Ccnd1 interacts with the C-terminus of 4 subunit of the type A GABA 
receptor. HEK 293 cells are co-transfected with HA-4-C-terminus together with either FLAG-Ccnd1 or a 
control vector. After 24 h in culture, cells are collected for IPs with antiFLAG agarose beads. Cell extracts 
are collected before the addition of the antibody (inputs). WB of inputs and IP, antibodies used are listed on 
the left of the blot.  
We wanted to study in a relevant model whether Ccnd1 and 4 co-localize. Detection of the 
endogenous proteins was precluded because the antibodies that were available did not work for 
immunofluorescence. Our goal was to use cortical neurons electroporated with Ccnd1 and 4. 
However, expression of Ccnd1 in these cells induces apoptosis (see Figure 10), consequently we 
had to use a Ccnd1-CAAX construct. Nonetheless, as a previous test, we checked the co-
localization of overexpressed GFP-tagged 4 and HA-Ccnd1-CAAX in HEK293 cells by 
immunofluorescence and confocal microscopy (Figure 20). In this model, we observed mainly a 
cytoplasmic distribution of both proteins, which co-localized conspicuously at the cell boundary, 
presumably at the cell membrane.  
 
Figure 20: Cyclin D1-CAAX and 4 co-localize in HEK293T transfected cells. HEK 293 cells are co-
transfected with 4-GFP and HA-Ccnd1-CAAX, fixed and labeled for immunofluorescence with anti-GFP 
(green) and anti-HA (red) antibodies. Co-localization can be seen as yellow color in the merge. Scale bar 10 
m. Images obtained by confocal microscopy.  
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Next, we used the same GFP-tagged 4 and HA-Ccnd1-CAAX to electroporate cortical neurons 
that were seeded, and fixed after 1 DIV. By immunofluorescence and confocal microscopy, both 
proteins co-localize in the soma as well as in the neurites (Figure 21). Thus, we can conclude that 
heterologously expressed 4-GFP and Ccnd1-CAAX co-localize in the cytoplasm, particularly in 
membranous regions, in both HEK293 cells and primary cortical neurons.  
 
Figure 21: Heterologous 4 and Ccnd1-CAAX co-localize in primary cortical neurons. Mice cortical 
neurons are isolated from E15.5 mouse embryos and electroporated with HA-Ccnd1-CAAX and 4-GFP. 
At 1 DIV, cells are fixed and labeled with anti-GFP (green) and anti-HA (red) antibodies. Co-localization 
can be seen as yellow color in the merge. Scale bar 10 m. Images obtained by confocal microscopy. 
Finally, we wanted to detect the interaction between endogenous Ccnd1 and 4 to highlight its 
physiological significance. Hence, we looked at mRNA expression levels for 4 and Ccnd1 at the 
Allen brain atlas (Allen institute for brain science), and we realized that the two genes were highly 
expressed in the hippocampus of P56 adult mice (Figure 22).  
Thus, we obtained hippocampi from adult female mice and performed an IP against Ccnd1 with a 
rabbit polyclonal antibody. As a control, we performed an IP in parallel with a rabbit polyclonal 
antibody against the FLAG epitope. In this experiment, we observed faint but specific co-IP of 
endogenous 4 with Ccnd1 (Figure 23).  
Formerly, we have demonstrated not only the interaction between Ccnd1 and 4 subunit through 
the 4 intracellular loop, but also that both proteins co-localize at the cytoplasm and membranous 
regions when they are heterologously expressed in HEK293 cells and cortical neurons. 
Endogenously, we have detected the interaction between Ccnd1 and the 4 subunit of the 
GABAAR in the hippocampus of adult mice.  
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Figure 22: 4 subunit and CCND1 mRNA expression patterns in mouse adult brain. In situ 
hybridization results obtained for 4 (A) and CCND1 (B) in P56 mouse brain. Image credit: Allen brain 
atlas (Allen institute for brain science).  
 
Figure 23: Endogenous Ccnd1 and 4 interact in adult hippocampus. Ccnd1 IP with a rabbit polyclonal 
antibody from an extract of adult mouse hippocampi. Whole cell extracts (WCE) are collected before the 
addition of the antibody for the IP. Lane IP Flag: control IP with rabbit polyclonal FLAG antibody. Lane IP 
Ccnd1: IP with rabbit polyclonal Ccnd1 antibody. WBs using antibodies against Ccnd1 and 4, before and 
after the immunoprecipitation are shown.  
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4.3.2. The alpha 4 subunit of the GABAA receptor as a phosphorylation target 
for cyclin D1-Cdk4 complex 
The 4 subunit, as well as other GABAA receptor subunits, contains a large N-terminal 
extracellular loop, four transmembrane domains and an intracellular loop between TM3 and TM4 
which is susceptible to phosphorylation (Figure 4A, Figure 24 and (Abramian et al. 2010)). 4 
contains seven putative Cdk phosphorylation sites (serine-proline; threonine-proline), five of them 
located at the large intracellular loop between TM3-4 (Figure 24).  
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Figure 24: Mus musculus GABAA receptor α4 subunit amino acidic sequence. In bold, putative Cdk 
phosphorylation sites. In italics and underlined, four TM domains; framed, intracellular loop between TM3 
and TM4. Between arrows, the C-terminal fragment from amino acid 354 to amino acid 552 found to 
interact with Ccnd1 in the yeast two hybrid assay.  
Thus, we wondered whether Ccnd1-Cdk4 complex is able to phosphorylate this subunit of the 
GABAA receptor. For this, we carried out an in vitro kinase assay with a commercially available 
Ccnd1-Cdk4 complex purified from insect cells (Sigma) and a GST-4 fusion protein purified 
from E. coli and -32P-ATP. In this assay, we observed phosphorylation of GST-4 that is 
dependent on the CDK complex and that is inhibited by Palbociclib, a specific inhibitor of Ccnd-
Cdk4/6 complexes (Figure 25). Because Ccnd1-Cdk4 does not phosphorylate GST alone or fused 
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to a number of other proteins, we conclude that this CDK complex must phosphorylate 4 in 
vitro. To determine the precise 4 residues involved in the phosphorylation by the Ccnd1-Cdk4 
complex different alleles of 4 were constructed by mutating the threonines and serines that are 
candidates to be targets of the complex in the intracellular loop. We changed threonines and 
serines for alanines resulting in non-phosphorylatable residues. Three different mutants were 
made: a double mutant T423 and S431 (T423A-S431A), another double mutant S456 and S458 
(S456A-S458A) and a single mutant T500 (T500A). 
 
Figure 25: 4 is phosphorylated in vitro by the Ccnd1-Cdk4 complex. Ccnd1-Cdk4 complex (Sigma) is 
used in a kinase assay in the presence of -32P-ATP to test the phosphorylation of GST-4 purified from E. 
coli. The Cdk4/6 inhibitor Palbociclib (2 M) is used to show that phosphorylation depends on Ccnd1-Cdk4 
complex. Coomassie staining of 4 is shown in lower stripe (Input) as a loading control.  
As shown in Figure 26, T423A-S431A results in a significant reduction of 4 phosphorylation in 
the kinase assay, while the other mutants display the same level of phosphorylation as WT.  
 
Figure 26: 4 T423A-S431A mutant has reduced phosphorylation by Ccnd1-Cdk4 complex. A) 
Ccnd1-Cdk4 complex (Sigma) is used in an in vitro kinase assay to detect the phosphorylation sites of 4. 
Three different non-phosphorylatable mutants of 4 are tested. Coomassie staining of the gel is shown in 
the lower stripe (Input) as a loading control. B) Quantifications of three independent experiments. Values 
are expressed as mean  S.E.M. Statistical significance is determined by t-test (*p<0.05). 
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Moreover, the capacity of the Ccnd1-Cdk4 complex to phosphorylate the C-terminus region of 4 
is tested in vitro (Figure 27). We found that the complex does phosphorylate 4 at the C-terminus 
(amino acids 354 to 552) and that there is a significant diminution in the phosphorylation levels 
when mutating T423 and S431 into non-phosphorylatable amino acids in two different clones. 
 
Figure 27: Residues T423 and S431 in the C-terminus of 4 are phosphorylated by Ccnd1-Cdk4 
complex. A) Schematic representation of the Ccnd1-Cdk4 complex phosphorylation sites on 4 subunit of 
GABAARs. Note their location at the intracellular loop. B) In vitro kinase assay performed with Ccnd1-
Cdk4 complex (Sigma) using both GST-fused 4-C-terminus and two independent clones of GST-4-
CterminusT423A-S431A non-phosphorylatable mutant. C) Quantifications of two independent experiments. 
Values are expressed as mean  S.E.M. Statistical significance is determined by t-test (*p<0.05). 
Furthermore, a non-radioactive kinase assay using GST-4 C-terminus and Ccnd1-Cdk4 complex 
was analyzed by mass spectrometry (HPLC-MSMS). In this study (Table 7) only phosphorylation 
at T423 and S431 was detected. As a control, no phosphopeptides appeared when no ATP was 
added to the assay. Hence, all in all, we can conclude that residues T423 and S431 are the main, if 
not the only, phosphorylation targets of Ccnd1-Cdk4 in the 4 subunit of the GABAAR. 
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Table 7: Mass spectrometry results of 4 phosphorylation by Cdk4-Ccnd1. Mass spectrometry of the 
peptides containing the different Cdk putative phosphosites in the presence (up) or absence (down) of ATP. 
Grey highlights show the phosphorylation of the threonine and the serine that correspond to those detected 
by the kinase assay. This phosphorylation is not observed when ATP is not present in the kinase reaction.  
ID Description Score Coverage Proteins 
Unique 
Peptides 
Peptides 
MW 
[kDa] 
Q9D6F4 
Gamma-
aminobutyric acid 
receptor 
309.37 33.70 1 16 17 60.8 
Sample 
ATP 
Peptide sequence Modifications 
phoSite 
Probab 
q-Value 
M+H+ 
[Da] 
M 
[ppm] 
RT 
[min] 
 
TSAVQESSEAT
PK 
  0.002 1334.64 -1.09 15.99 
 
TSAVQESSEAT
PK 
T11 (Phospho) 
T(11): 
100.0 
0.012 1414.61 -1.91 15.92 
 
AHLASSPNPFS
R 
  0.038 1283.64 -3.28 19.81 
 
AHLASSPNPFS
R 
S6 (Phospho) 
S(6): 
98.3 
0.131 1363.61 -5.17 20.50 
        
Sample 
no ATP 
Peptide sequence Modifications 
phoSite 
Probab 
q-Value 
MH+ 
[Da] 
M 
[ppm] 
RT 
[min] 
 
TSAVQESSEAT
PK 
  0.0000 1334.64 -0.91 16.33 
 AHLASSPNPFS   0.0000 1283.64 -3.57 20.01 
M+H+: proton adduct; M: mass difference; RT: retention time; q-value: adjusted p-value. 
4.3.3. Functional effects of the 4 phosphorylation by cytoplasmic Ccnd1-
Cdk4 complex by whole-cell patch clamp in HEK tsA201 cells 
Once we knew that Ccnd1-Cdk4 complex is able to phosphorylate the alpha4 subunit, we wanted 
to study if the GABAAR functionality is affected by this phosphorylation. One way to study the 
GABAAR functionality is by electrophysiology, measuring their run-down by whole-cell patch 
clamp. For this reason, we have collaborated with Dr. David Soto (Institut de Neurociències, 
Universitat de Barcelona), who has expertise in electrophysiology.  
The run-down of the GABA response consists in a gradual loss of GABA-induced currents due to 
the repetitive GABA stimulation of GABAARs. To examine the run-down of GABA-mediated 
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currents by whole-cell patch clamp recordings, 1 M GABA was applied to the cells once every 2 
min (Figure 28). 
 
Figure 28: Cytoplasmic cyclin D1 or mimicking phosphorylation of the alpha 4 subunit of GABAA 
receptor prevent GABA receptor’s run-down. A) Representative examples of whole-cell currents evoked 
by rapid application of 1 M GABA (solid line above the trace) to tsA201 cells expressing WT 43 
GABAAR plus a control vector. The GABA evoked current at the beginning of the recording (time 0 min) is 
shown on the left and the response after 14 min is shown on the right. Dashed line denotes the zero current. 
Holding potential is held at -60 mV. B) Same as A, but co-expressing WT 43 GABAAR plus Ccnd1-
CAAX. C) Same as A, but co-expressing phosphomimetic GABAA receptor 4T423E, S431E 3 plus a control 
vector. D) Time dependence relationship for GABAAR-mediated currents for WT receptor alone (grey 
circles), together with Ccnd1 (red circles) or for phosphomimetic GABAAR (blue circles). *p<0.05, 43 
vs. 43 + Ccnd1-CAAX and 4T423E, S431E 3. E) Bar graph showing the mean  S.E.M of the relative 
current at t=12 minutes compared with current at time=0 for cells expressing wild type 43 (n=7), 43 + 
Ccnd1-CAAX (n=5) or for 4T423E, S431E 3 GABAARs (n=6). Open circles denote single experiment values.  
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To study the physiological effects of cytoplasmic Ccnd1 on GABAAR, HEK tsA201 cells are 
transfected with 4 and 3 subunits of the receptor together with Ccnd1-CAAX or a control 
plasmid. The transient expression of 43 receptors resulted in functional channels that generated 
GABA-evoked currents (Figure 28A and Abramian et al. 2010). When 43 receptors are 
expressed together with the control vector, GABA-mediated current amplitude decreased over 
time after 12 min of repetitive GABA stimulation (Figure 28A). By comparison, when 43 
receptors are co-expressed with Ccnd1-CAAX, the response intensity after 12 min of GABAAR 
stimulation with its agonist was closer to the initial response (Figure 28B). Hence, the loss of 
function of the 43 receptors measured as a diminution in their responses after 10 to 14 min of 
stimulation is significantly prevented by the overexpression of Ccnd1-CAAX.  
Besides, the heterologous expression of a phosphomimetic mutant of the alpha4 subunit (4T423E, 
S431E) together with the 3 subunit prevents the run-down observed in the WT 43 GABAAR 
(Figure 28C). In fact, the overexpression of this phosphomimetic mutant averts the receptor run-
down more efficiently than the overexpression of Ccnd1-CAAX (Figure 28D, E). 
Therefore, cytoplasmic Ccnd1 or the phosphomimetic allele of 4 subunit maintains efficacy of 
43 receptors. 
4.3.4. Cyclin D-Cdk4/6 complex effect on the functionality of GABAA 
receptors in rat hippocampal slices. 
Next, we wanted to study the effects of Ccnd1-Cdk4 complex on GABAAR in a physiological 
context. As mentioned before and according to in situ hybridization data available on the brain 
atlas (Allen institute for brain science) mRNA of both Ccnd1 and 4 are expressed at the 
hippocampus of adult mice (Figure 22). For this reason, we used rat hippocampal slices (P5-7) to 
measure GABA tonic currents and mIPSC. To evaluate the influence of 4 phosphorylation by 
Ccnd1-Cdk4, we inhibited Ccnd-Cdk4/6 complex by the addition of 2.5 M Palbociclib. The 
following results were obtained in collaboration with Dr. José Antonio Esteban (CBMSO-UAM).  
4.3.5. Cyclin D1-Cdk4/6 complex inhibition with Palbociclib 
The inhibition of Ccnd1-Cdk4/6 is achieved by means of 2.5 M Palbociclib for 2 h. The 
specificity of this drug at this dose has been described previously (Fry et al. 2004). However, we 
wanted to confirm the effect of Palbociclib in 400 m hippocampal slices obtained from postnatal 
rats (P5-7).  
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For that, hippocampal slices are treated with either 2.5 M Palbociclib or DMSO for 2 h, samples 
are collected and the activity of the complex is analyzed by measuring the levels of 
phosphorylation of the known Ccnd1-Cdk4 substrate Pxn in a WB (Figure 29). 
 
Figure 29: Inhibition of Cyclin D-Cdk4/6 complexes by 2.5 M Palbociclib significantly reduces the 
phosphorylation state of paxillin at serine 83 in hippocampal slices. A). Phosphorylation of Pxn S83 is 
measured in 400 m hippocampal slices previously treated with either 2.5 M Palbociclib or DMSO during 
2h. Immunoblot using a specific Pxn S83 antibody. Ccnd1 (Dcs6 antibody) levels are assessed and actin is 
used as a loading control. Lane 1: Palbociclib treated slices. Lane 2: DMSO treated slices are used as a 
control. B) Quantification of Ccnd1 normalized to actin levels. C) Quantification of P-Pxn S83 normalized 
to actin levels. Values are expressed as mean  SEM (n=3). Statistical significance is determined by t-test 
(*p<0.05).  
Since Pxn S83 is a phosphorylation target for Ccnd1-Cdk4 complex (Fusté et al. 2016), we tested 
the phosphorylation status of PaxS83 in both Palbociclib and DMSO treated samples. As it is 
seen, the treatment of hippocampal slices for 2 hours with Palbociclib, significantly reduces the 
Pxn phosphorylation at S83. Furthermore, the inactivation of the Ccnd-Cdk4/6 complex leads to 
an increment of Ccnd1. This is likely due to Ccnd1-Cdk4/6 inhibition by preventing its 
autophosphorylation and subsequent degradation.  
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4.3.6. Cdk4/6 role in GABA tonic currents 
Once we have shown that 2.5 M treatment with Palbociclib is capable of inhibiting Ccnd-Cdk4/6 
complex in hippocampal slices, we aimed to study the effect of this inhibitor on GABAAR-
mediated tonic currents. Inhibitory tonic currents are usually measured applying a saturating 
specific GABAAR antagonist, such as picrotoxin. This drug causes a shift in the holding current 
related to a decrease in the operative GABAA channels (Bright and Smart 2013b). Briefly, rat 
hippocampal slices are treated with either 2.5 M Palbociclib or DMSO for 2 h and placed into 
the patch clamp set-up with continuous perfusion of an external solution containing in addition to 
DMSO or 2,5 M Palbociclib, AMPA receptor blocker (CNQX), NMDA receptor blocker (AP-
V), glycine receptor antagonist (Strychnine) and 2-chloroadenosine. Cells are held at – 60mV 
during the recording. To measure inhibitory events at this voltage, high chloride concentrations in 
the internal solutions are used. Then CA3 to CA1 synapses are evoked by Schaffer collateral 
stimulation (Figure 30A). Once both the holding current and the peak amplitude of the synaptic 
response are stabilized (baseline), picrotoxin 100 M is added (t= 0 min). Picrotoxin, an 
antagonist of synaptic GABAAR, takes about 2 min to inhibit the synaptic response. For each cell, 
GABA tonic current is defined by the outward shift of the base-line current after the application 
of the antagonist picrotoxin (100 M), once the synaptic response is mostly abolished (average of 
the holding current during one minute). Figure 30B shows the shift in the holding current 
produced by the picrotoxin addition. Each point represents the mean values of holding current at a 
specific time for 10 cells. While the holding current in DMSO treated cells diminishes 21.39  
3.81 pA, the holding current in Palbociclib treated cells diminishes 9.11  2.92 pA (Figure 30C). 
Therefore, cyclin D-Cdk4/6 inhibition by acute Palbociclib application causes a significant 
diminution in the GABAAR tonic current. 
4.3.7. Cdk4/6 role in GABA mIPSC 
Because Ccnd-Cdk4/6 inhibition with 2.5 M Palbociclib significantly reduced GABA tonic 
currents in hippocampal slices, we decided to test whether this acute Ccnd inhibition may in turn 
affect synaptic function given that 4 subunit can form synaptic receptors when clustered together 
with x2 subunits. To this end, organotypic cultures are treated with either DMSO or 2.5 M 
Palbociclib for 2 h and placed at the electrophysiology set-up with continuous perfusion of 
external solution containing aCSF supplemented with either DMSO or 2.5 M Palbociclib, plus 
pharmacological inhibitors of the excitatory neurotransmitters’ receptors (CNQX and AP-V) and 
the glycine receptor antagonist (Strychnine). When measuring mIPSCs the addition of TTX to 
inhibit the generation of spontaneous action potentials is also necessary. mIPSCs are recorded at -
60 mV using whole-cell configuration in the gap-free mode. 
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Figure 30: Cyclin D-Cdk4/6 inhibition with Palbociclib significantly reduces GABA tonic currents in 
hippocampal slices. A) Schematic representation of the experimental configuration for GABA tonic 
currents recordings in CA1 neurons. B) Effects of picrotoxin (100 M) on holding currents recorded in 
DMSO (grey rounds) or Palbociclib (red squares) (2,5 M, 2 hours) treated hippocampal slices. Tonic 
currents are reduced in Palbociclib treated slices compared to vehicle (n=10 for each). Recordings are 
aligned by the time of drug addition (t=0). C) Quantification of results in A represented in a scatter dot plot 
shows mean values  S.E.M (*p<0.05, Wilcoxon-Mann-Whitney test). 
To measure inhibitory events at this voltage, high chloride concentrations in the internal solutions 
are used. Thus, by inhibiting the generation of action potentials and not evoking GABA 
responses, one is able to measure the spontaneous release of GABA vesicles and the consequent 
response generated at postsynaptic GABAAR, that is the mIPSC. Under these conditions, we 
observed that both the amplitude and frequency of the spontaneous response are reduced after 
Ccnd-Cdk4/6 inhibitor treatment (Figure 31). Specifically, the addition of Palbociclib to the cells 
significantly reduces mIPSC amplitude (-105.87  20.30 pA for DMSO vs -50.78  5.08 pA for 
Palbociclib). Besides, the frequency of mIPSC in Palbociclib-treated slices is lower than for 
controls (0.9  0.51 Hz vs 0.48  0.17 Hz respectively) although the difference is not statistically 
significant.  
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Figure 31: Palbociclib treatment decreases both mIPSC amplitude and frequency in organotypic 
hippocampal slices. A) Representative traces of miniature inhibitory post-synaptic currents of DMSO or 
2.5 M Palbociclib treated cells. Bars: (horizontal) 10 ms; (vertical) 50 pA. B) Scatter dot plot showing 
mIPSC amplitude quantifications of DMSO (n=9) and Palbociclib (2.5 M, 2 hours) treated cells (n=8). 
Bars show mean values  S.E.M. *p<0.05, Wilcoxon-Mann-Whitney test. C) Cumulative distribution of 
mIPSC amplitude from CA1 pyramidal neurons treated with either Palbociclib or control vehicle, as 
indicated. “n” represents number of miniature responses recorded from nine (DMSO) and eight 
(Palbociclib) cells. D) Similar to C for mIPSC frequencies. “n” represents number of miniature frequencies 
recorded from eight (DMSO) and five (Palbociclib) cells. The frequency of the two groups is compared 
using Wilcoxon-Mann-Whitney test. 
Put together, all electrophysiological experiments show that Ccnd1 enhances GABAARs function 
presumably through 4 phosphorylation.  
4.4 Cytoplasmic cyclin D1 role in the assembly of 43 
containing GABAA receptors. 
4.4.1. Cyclin D1 interaction with 3 subunit of the GABAA receptor 
Once we had characterized the interaction of Ccnd1 and 4 subunit, we wondered whether Ccnd1 
was also interacting directly with the 3 subunit. For this, a pull-down assay was performed using 
GST-3 and flag-tagged Ccnd1 as described before for 4 (Figure 18). Under these conditions, 
we also detect a directed and specific interaction between 3 and Ccnd1 (Figure 32).  
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Figure 32: Cyclin D1 interacts with 3 in vitro. In vitro GST pull-down assay showing a direct interaction 
between 3 and Ccnd1. GST or GST-3 purified from E. coli are immobilized on glutathione beads, 
followed by incubation with FLAG-tagged Ccnd1 obtained by in vitro transcription and translation in 
reticulocyte lysate system (Promega). WB showing the input and pull-down samples. GST and GST-3 
were detected with an anti-GST antibody; Ccnd1 was detected with a rabbit anti-Ccnd1 antibody. 
Further, this interaction is tested in HEK293 cells by heterologous co-expression of flag-tagged 
3 and HA-Ccnd1-CAAX, and then immunoprecipitating 3-FLAG. As Figure 33 shows, HA-
Ccnd1-CAAX co-immunoprecipitates with 3-FLAG in this assay. Hence, not only can Ccnd1 
interact with 4 but also with the 3 subunit of GABAARs in vitro and in vivo.  
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Figure 33: Heterologous HA-Ccnd1-CAAX interacts with 3-FLAG. HEK 293 cells are co-transfected 
with HA-Ccnd 1-CAAX and either 3-FLAG or a control vector. After 24 hours in culture, cells are 
collected for IP with M2-FLAG beads. WB of the cell extract and immunoprecipitation (IP) is shown. 
Antibodies used for protein detection are indicated on the left of the blot.  
As for other subunits, 3 sequence contains a large cys-loop extracellular domain at the N-
terminal, four helical TM and two cytoplasmic domains (Figure 34). Although the large 
intracellular loop between TM3-4 is phosphorylated by other kinases, 3 does not have any 
putative CDK phosphorylation site (serine-proline; threonine-proline). 
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Figure 34: Human GABAA receptor 3 subunit amino acidic sequence. Underlined and in italics, four 
TM domains; framed, intracellular loop between TM3 and TM4. Note that nor S-P neither T-P putative 
phosphorylation sites for CDKs are found.  
Although 3 does not have any putative Cdk phosphorylation site, we tested the capacity of the 
Ccnd1-Cdk4 complex to phosphorylate 3 in an in vitro assay. As expected, Ccnd1-Cdk4 purified 
from insect cells (Sigma) does not phosphorylate GST-3 recovered from heterologous 
expression in E. coli (Figure 35).  
 
Figure 35: 3 is not an in vitro substrate of Cyclin D1-Cdk4 complex. Ccnd1-Cdk4 complex (Sigma) is 
used in a kinase assay in the presence of -32P-ATP to test the phosphorylation of GST-3 purified from E.  
coli. Coomassie staining of the gel is shown in the lower stripe (input) as a loading control.  
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4.4.2. Cytoplasmic cyclin D1 effect on 4 and 3 surface levels 
Abramian and collaborators have shown that 4 phosphorylation at the intracellular loop (S443) 
by PKC enhances 4 subunit levels at the cell surface of HEK293 cells expressing heterologous 
43 receptors (Abramian et al. 2010). Moreover, this increment in 4 levels at the cell surface 
prevents GABAAR run-down. Because Ccnd1-Cdk4 phosphorylates 4 in vitro and cytoplasmic 
Ccnd1 affects GABAAR run-down in tsA201 cells, we wanted to investigate whether Ccnd1 is 
modulating the surface levels of 4 and 3 subunits.  
For this reason, HEK293 were co-transfected with 3-FLAG and 4 plus either a control vector, 
HA-Ccnd1-CAAX, or HA-Ccnd1K112E-CAAX, and a surface biotinylation assay was carried out. 
Briefly, 24 h after transfection, cells were labeled with sulfo-NHS-SS-biotin which forms 
covalent bonds with primary amines on surface proteins. After washing, cells were lysed and 
biotin-labeled proteins were isolated with Streptavidin-agarose beads (Figure 36A). The 
expression levels of both 4 (Figure 36B) and 3 (Figure 36C) were normalized to transferrin 
receptor protein (TFRC) levels. As shown in Figure 36, neither cytoplasmic Ccnd1-CAAX nor 
Ccnd1K112E-CAAX alter the surface levels of the 4 subunit significantly. However, 4 surface 
levels tend to increase when Ccnd1-CAAX is present (19  12 %) but not with Ccnd1K112E-
CAAX. Contrary, 3 subunit surface levels are decreased due to the presence of Ccnd1-CAAX 
(29  5 %) and, to a less extend, of Ccnd1K112E-CAAX (12  8 %). Hence, cytoplasmic Ccnd1 
presence lightly increases the amount of 4 and significantly reduces 3 subunits at the cell 
surface. 
Moreover, and in order to understand the mechanism by which cytoplasmic Ccnd1 is affecting 4 
and 3 surface levels, further studies are done. We also designed an experiment to test whether 
the receptor endocytosis during its turnover was specifically affected by Ccnd1. The approach is 
similar to the one described above but with certain modifications.  
Transfected HEK293 are labelled with biotin, washed and incubated for 15 min at 37 ºC with 
medium to allow endocytosis of labelled proteins. After this, cells are incubated with a cleavage 
buffer containing glutathione, which breaks the disulfide bond between biotin and surface 
proteins, to eliminate the biotin labeling of remaining surface proteins. Subsequently, cells are 
collected and biotin-labelled proteins, which correspond to endocyted proteins, are pulled down 
with Streptavidin-agarose beads and analyzed by WB (Figure 37A). Quantifications are calculated 
as the fraction of protein endocyted (labeled 15’) compared to the surface levels at time 0 (0h). 
For 4 subunit, 41% and 40% of the initial protein at the cell surface was internalized in control 
conditions (pNBM470) or in the presence of cytoplasmic Ccnd1, respectively (Figure 37B). 
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Figure 36: Cyclin D1-CAAX presence diminishes surface levels of 3, but not 4, subunit. A) HEK293 
are co-transfected with 3-FLAG and 4 plus either HA-Ccnd1-CAAX or HA-Ccnd1K112E-CAAX or a 
control vector. A biotinylation assay is used to purify cell surface proteins. TFRC is used to normalize 4 
and 3 levels. WB shows cell extract and surface proteins. Antibodies used for protein detection are 
indicated on the left of the blot. B and C) Quantifications of the experiment in A as a ratio surface:CE. Bars 
show mean values  S.E.M (n=4 independent experiments) of the ratio surface vs total protein levels. 
*p<0.05; ***p<0.001 (t-test, compared to control).  
For the 3 subunit, these values were 34% and 39%, respectively (Figure 37C). Hence, 
overexpression of HA-Ccnd1-CAAX does not result in any significant change in the endocytosis 
process of neither 4 nor 3 subunits.  
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Figure 37: Endocytosis process of the 4 and 3 subunits is not affected by cytoplasmic cyclin D1 in 
HEK293 cells. Heterologous 4 and 3-FLAG with or without HA-Ccnd1-CAAX are expressed in 
HEK293 cells. Endocytosis is assessed by biotin labelling of surface proteins followed by 15 min DMEM 
incubation to allow endocytosis, and cleavage of the biotin bound to the remaining surface proteins. Biotin-
labelled fractions are purified with streptavidin-agarose beads. A) Western blot analysis of samples taken at 
time 0h (total surface proteins) and after 15’ of endocytosis. Antibodies are indicated on the left of the blots. 
B) Quantification of 4 levels. Results are shown as a ratio of the amount of protein endocyted for 15 min 
compared to the initial levels (0h). C) Quantification of 3 levels as just mentioned for 4. 
Next, we tested whether the receptor insertion into the membrane is affected by the presence of 
cytoplasmic Ccnd1. Again, HEK293 are transfected with 4 and 3 subunits together with HA-
Ccnd1-CAAX or pNBM470 as a control vector. Cell surface proteins are labelled with biotin and 
further cleaved with cleavage buffer containing glutathione, as described above, and cells are 
collected at this point (t=0h) or incubated with medium for 2 h at 37 ºC, so that new receptors are 
inserted into the membrane, and can be subjected to a new round of biotin labelling (t=2h) (Figure 
38). 
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Figure 38: Cytoplasmic cyclin D1 decreases the insertion of 3 to the cell surface in HEK293. A) 
Heterologous 4 and 3-FLAG subunits are expressed in HEK293 cells in the presence (lanes 3 and 4) or 
not (lanes 1 and 2) of HA-Ccnd1-CAAX. Cells are subjected to biotinylation, cleavage and 2 hours of 
incubation with medium at 37 ºC followed by biotin labelling. Cell surface fractions are purified with 
streptadivin-agarose beads. WBs are immunoblotted with the antibodies indicated on the left of the blot. 
The insertion rate for each 4 and 3 is measured by comparing the labelling at time 0h and time 2h. B and 
C) Quantification of 4 and 3 levels normalized to TFRC. Results are shown as a ratio of the amount of 
protein at 2h compared to the initial levels (0h). *p<0.05 (t-test).  
As it is seen in Figure 38B, in control conditions, after the cleavage and the incubation with 
DMEM for 2 hours, there are slightly higher levels of 4/TFRC at the cell surface (1.2 times). 
This same effect is seen when Ccnd1 is present with an increment of 1.3 times of 4/TFRC at the 
cell surface. On the other hand, Figure 38C shows the effects observed for 3. There is a 
significant increase in the amount of 3/TFRC at the cell surface (1.6 times) in control conditions. 
Contrary, the presence of cytoplasmic Ccnd1 avoids the insertion of the 3 subunit at the cell 
surface after 2 hours of incubation. Hence, the co-transfection of HA-Ccnd1-CAAX with the 4 
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and 3 subunits in HEK293 cells results in a lowering of the insertion rate of the 3, but not 4, 
subunit at the cell surface. Henceforth, cytoplasmic Ccnd1 diminishes 3 subunit levels at the cell 
surface by hindering its insertion to the membrane, but not its endocytosis.   
Finally, since 3 stability and levels at the cell surface are affected by its ubiquitination (Saliba et 
al. 2007, 2008), the role of Ccnd1 on 3 in this process is tested. The ubiquitination assay is 
performed in HEK293 co-transfected with 4 and 3-FLAG together with pNBM470 (control 
plasmid), HA-Ccnd1-CAAX or the kinase inactive allele HA-Ccnd K112E-CAAX. We then carried 
out an IP of 3-FLAG with FLAG antibody and used a ubiquitin antibody to detect ubiquitinated 
forms of 3 by WB (Figure 39A).  
 
Figure 39: Cyclin D1-CAAX promotes ubiquitination of 3 in HEK293. A) Heterologous 3-FLAG is 
immunoprecipitated with FLAG antibody-conjugated beads. The levels of ubiquitination are evaluated in 
samples containing control vector (Lane 2), HA-Ccnd1-CAAX (Lane 3) or the kinase mutant HA-
Ccnd1K112E-CAAX (Lane 4). The specificity of the immunoprecipitation is checked in lane 1 (no 3-FLAG 
present). Antibodies used are indicated on the left of the blot. B) Quantification of 3 ubiquitination levels 
normalized to total 3. *p<0.05 (t-test compared to control).  
Overexpression of HA-Ccnd1-CAAX significantly increases 3 ubiquitination (3.23  0.67 fold 
increase) compared to control (pNBM470 vector). Moreover, this effect is kinase- dependent 
since the overexpression of HA-Ccnd K112E-CAAX does not increase the ubiquitination of 3 (1.08 
 0.39 fold increase). All together these results suggest that Ccnd1 is decreasing the surface levels 
of the 3 subunit by hindering its insertion into the membrane and increasing 3 ubiquitination in 
a kinase-dependent manner. 
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5. DISCUSSION 
5.1 Cytoplasmic cyclin D1-Cdk4/6 complexes induce 
neuritogenesis in cortical neurons 
Pointed up by previous observations (Sicinski et al. 1995; Sumrejkanchanakij et al. 2003; 
Marampon et al. 2008), in this thesis we have studied whether Ccnd1 plays a role in 
neuritogenesis. Overexpression of Ccnd1 in cortical neurons led to apoptotic cell death, 
presumably by its nuclear accumulation in agreement with a previous report (Sumrejkanchanakij 
et al. 2003). To circumvent this problem, we have used a Ccnd1 version with a CAAX motif at its 
C-terminus, which seemingly becomes farnesylated and targets the protein to cell membranes 
avoiding its nuclear entry (Fusté et al. 2016). Overexpression of this cytoplasmic Ccnd1 in 
cortical neurons in vitro results in roughly 50% increase in both axon and neurite length. 
Furthermore, this effect is dependent on the kinase activity of Ccnd1-Cdk4 because when we use 
a kinase-dead mutant (Ccnd1K112E) that forms an inactive complex with CDKs (Baker et al. 2005) 
no difference in length is obtained. Similar to Ccnd1, overexpressing a membrane-targeted 
version of Cdk4 (Cdk4-CAAX) also produces an increase in axon and neurite lengths. This effect 
is seen after four days of in vitro differentiation when the levels of the endogenous CCND1 
mRNA are very low. We propose several alternatives to account for this apparent contradiction. 
One possibility is that Ccnd1-Cdk4 complexes operate earlier in the differentiation process but we 
observe their effects with some delay. Alternatively, cyclins other than Ccnd1 may partner with 
Cdk4 and contribute to the observed effects. 
To study a putative role of the endogenous Ccnd1 in neuritogenesis we have followed two 
approaches. First, we downregulated the levels of Ccnd1 by RNA interference in cortical neurons 
in vitro. In agreement with a previous study in PC12 cells (Marampon et al. 2008), we have 
observed a significant (20-25%) reduction in the lengths of both axons and neurites as well as a 
decrease in the number of neurites per cell. Second, we have compared neurite outgrowth in 
cortical neurons isolated from wild type and CCND1 KO animals. Similarly, cells lacking Ccnd1 
developed shorter axons and neurites and reduced number of neurites per cell than their WT 
counterparts. This difference was more obvious just after one day of in vitro differentiation in 
consonance with the progressive decline in CCND1 mRNA levels, and suggests that Ccnd1 plays 
a role in the early stages of neuritogenesis. These findings agree with the fact that E13.5 mouse 
brains electroporated with Ccnd1 presents higher percentage of multipolar cells at high cortical 
plate than control or Ccnd1K112E electroporated brains (Rocandio 2018). Marampon and co-
workers have proposed that this effect of Ccnd1 on neuritogenesis could be due to the regulation 
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of several transcription factors by Ccnd1 (Marampon et al. 2008). By contrast, our results with 
Ccnd1-CAAX point toward of a cytoplasmic function of Ccnd1. Hence, we propose that 
cytoplasmic sequestration of Ccnd1 in postmitotic neurons not only avoids apoptotic neuronal 
death as previously suggested (Sumrejkanchanakij et al. 2003), but also plays a role in 
neuritogenesis.  
5.2 Paxillin phosphorylation at S83, S178 and S244 promotes 
neurite outgrowth 
Differentiating neurons assemble the nervous system by projecting axons and dendrites. FA 
proteins facilitate the signaling across the membrane to facilitate cell migration and axon 
pathfinding. Pxn, together with other FA proteins, localizes to the neuronal growth cone. Because 
cytoplasmic Ccnd1-Cdk4 complex controls cell spreading, invasion and metastasis through the 
phosphorylation of Pxn at S83 and S178 (Fusté et al. 2016), we have studied Pxn as a target of 
Ccnd1 in the control of neuritogenesis. Pxn phosphorylation at S83 and S178 was assessed at 
different time points during differentiation, and as we expected, Pxn phosphorylation at both 
serines decreases at 4 DIV in comparison to 1 DIV coinciding with the decrease of CCND1 
mRNA levels. As Ccnd1-Cdk4 is able to phosphorylate S83, S178 and S244 in vitro (Fusté et al. 
2016), we studied neurite outgrowth in the presence of a non-phosphorylatable mutant of Pxn 
(PxnTM; S83A, S178A and S244A). As compared to WT Pxn, overexpression of the PxnTM in 
cortical neurons promotes a shortening in both axon (18%) and neurite (16%) length and also in 
neurite number (4.05 average vs 3.21 average) at 1 DIV. Hence, Pxn phosphorylation at S83, 
S178 and S244 is important for the neurite extension in E15.5 cortical neurons at 1 DIV, when 
Ccnd1 is regulating neuritogenesis. This result concurs with other studies that involved Pxn 
phosphorylation in neurite formation and outgrowth implicating different kinases and 
phosphorylation sites. In particular, p38MAPK at S85 (S83 in rats) (Huang et al. 2004), JNK at 
S178 (Yamauchi et al. 2006), GSK3 at S126 and ERK at S130 (Cai et al. 2006), and Nemo-like 
kinase at S126 (Ishitani et al. 2009). Because some kinases can phosphorylate Pxn at the same 
residues phosphorylated by Ccnd1-Cdk4, further studies should be done in order to confirm that 
the effect observed in mouse cortical neurons overexpressing the PaxTM mutant is actually due to 
a decreased phosphorylation by Ccnd1-Cdk4 complex and not by other kinases. For instance, we 
could test Pxn phosphorylation levels at WT and CCND1 KO cortical neurons and the 
overexpression of a triple phosphomimetic mutant of Pxn (PxnS83E, S178E, S244E) should be able to 
rescue the defect in neurite outgrowth observed in cortical neurons from CCND1 KO mice. 
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On the whole, we can propose a model in which cytoplasmic Ccnd1-Cdk4/6 complexes regulate 
neuronal morphology and neurite outgrowth through the phosphorylation of Pxn (Figure 40).  
In vivo studies connect Pxn phosphorylation state not only with neuritogenesis but also with 
migration (Chen et al. 2009; Rashid et al. 2017), complementary studies should be done to assess 
the role of the Ccnd1-Cdk4/6 complex in collaboration with Pxn in brain development and 
function. For example, studies concerning the ability of Ccnd1-Cdk4/6 complex through Pxn 
phosphorylation to promote axon outgrowth in regenerating systems could reveal a potential 
therapeutic target after neuronal injury or disease (Kuboyama et al. 2013). Furthermore, we could 
perform in utero electroporations with Pxn or PxnTM and analyze the organization of cortical 
layers and the lengths of leading processes.  
 
 
Figure 40: Proposed model whereby Ccnd1 promotes neurite outgrowth at early stages of 
development. Pxn, together with other FA proteins, localizes to the neuronal growth cone. Cytoplasmic 
Ccnd1-Cdk4/6 complex phosphorylates Pxn at S83, S178 and S244 thus promoting neuritogenesis.  
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5.3 Cytoplasmic cyclin D1 interacts with and phosphorylates 
the 4 subunit of GABAA receptors preventing their run-down  
A previous yeast two hybrid screen performed in our lab had detected an interaction between 
Ccnd1 and the 4 subunit of GABAAR. Specifically, Ccnd1 interacted with 3 independent clones 
of the C-terminus of the protein, containing the intracellular loop between TM3 and TM4. Here 
we have demonstrated this interaction between Ccnd1 and the intracellular loop of the 4 subunit 
in vitro. Moreover, we have also detected the interaction with overexpressed Ccnd1-CAAX and 
4 in HEK293 cells, as well as colocalization by immunofluorescence in HEK293 cells and 
cortical neurons. Inspection of mRNA expression patterns in the mouse brain at the brain Atlas 
database (Allen brain atlas), shows that both Ccnd1 and 4 subunit are found at the hippocampus 
of adult mice. Curiously, both proteins share a common pattern of expression that is lower at CA3 
and increases in CA1. Notably, we have observed endogenous interaction of Ccnd1 and 4 in the 
hippocampus of adult mice. Besides, among several CDK putative phosphorylation sites present 
in the intracellular loop, we have shown that the Ccnd1-Cdk4 complex phosphorylates in vitro 
the. 4 subunit at T423 and S431. As phosphorylation by PKC of another residue (S443) in the 
same intracellular region is known to regulate the GABAA receptor activity (Abramian et al. 2010, 
2014) we have explored the effect of T423 and S431 phosphorylation in GABAAR function. 
In collaboration with Dr. Soto from Hospital Clinic at the University of Barcelona, we have first 
studied the functional effects of cytoplasmic Ccnd1 overexpression in heterologous 43 WT 
receptors in tsA201 cells. Whole-cell recordings revealed that the presence of Ccnd1-CAAX, but 
not Ccnd1K112E-CAAX, significantly prevents GABAAR run-down. Besides, we have studied the 
consequences of 4 phosphorylation at T423 and S431 by the heterologous expression of 
receptors containing WT 3 subunits plus a phosphomimetic (4T423E,S431E ) mutant in tsA201 
cells. In this case, the mimicking of the 4 subunit into a “persistently phosphorylated” state 
results in a nearly zero loss of GABAAR function. Hence, our results suggest that the Ccnd1-
Cdk4/6 complex phosphorylation of 4 at T423 and S431 reduces the GABAAR run-down and 
that this phosphorylation can be performed in vivo by the Ccnd1-Cdk4 complex. The fact that 
4T423E,S431E mutant is more effective in preventing GABAAR run-down than Ccnd1-CAAX 
overexpression, could be explained by incomplete phosphorylation of all GABAARs, even under 
increased levels of Ccnd1. These may not be enough or there may be phosphatases at play. 
Consistently, PKC phosphorylation of 4 at another site in the intracellular loop, S443, also 
prevented GABA current run-down increasing the activity of the 43 WT receptor in HEK293 
cells (Abramian et al. 2010). Other kinases like PKA are also able to regulate GABAAR function 
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by phosphorylation. In particular, PKA phosphorylates 3 subunit at residues S408 and S409 
thereby enhancing receptor function (McDonald et al. 1998). Hence, we wondered whether the 
effects observed of Ccnd1 on GABAARs might also be via 3 phosphorylation. Nevertheless, 3 
subunit does not contain any Cdk phosphorylation site (SP or TP) and we have been unable to 
detect phosphorylation of the 3 subunit by Ccnd1-Cdk4 in vitro. Therefore, we propose that 
Ccnd1 enchances GABAARs function through 4 phosphorylation on residues T423 and S431.  
Epilepsy is caused by the abnormal regulation of the neuronal excitability by GABAARs. 
GABAAR run-down is more pronounced in epileptogenic tissue, in part because GABAARs in 
TLE tissue present decreased affinity for GABA compared to control tissue (Ragozzino et al. 
2005) or because the replacement of 1 for 4 subunit (Mazzuferi et al. 2010). The 
phosphorylation status of the GABAAR subunits is important for receptor function, both 
physiologically and in disease. This is consistent with experiments that use phosphatase inhibitors 
to attenuate the run-down of GABAARs (Palma et al. 2004) and other that prevent the run-down 
of the GABA response by the addition of Mg-ATP or Mg-ATPS (Chen et al. 1990). We have 
observed that cytoplasmic Ccnd1-Cdk4 as well as the phosphomimetic 4 when expressed in 
HEK tsA201 cells prevent 43 GABAAR run-down. Hence, it would be interesting to compare 
Ccnd1 levels in brain slices from epileptic patients and control individuals. Similarly, using an 
antibody that recognizes 4 (T423, S431) phosphosites, we could test if in epileptic patients’ 
samples or in an epileptic mouse model there is a reduction in the phosphorylation levels of 4 at 
these residues. Also, in animal models of induced epileptogenesis, we could compare if there are 
changes in Ccnd1 expression levels before and after the induction of epilepsy. Besides, it would 
be relevant to know whether CCND1 KO mice are more vulnerable to develop epilepsy than their 
WT littermates. Finally, since 4 KO mice have impaired adult hippocampal neurogenesis and 
reduced dendritic growth and complexity (Duveau et al. 2011), we should test adult hippocampal 
neurogenesis in CCND1 KO mice as well as in an 4S423AT431A knockin mouse.  
In this work, we have not explored the possible interaction between Ccnd1 and other GABAARs 
subunits. However, by sequence alignment, we have observed that the most variable region 
between  (1-6) subunits is actually the intracellular domain which is susceptible to 
phosphorylation. Although other  subunits also contain putative Cdk phosphorylation sites (SP 
or TP), there is not any conserved region in the intracellular loop that contains these SP or TP 
sites among  subunits. In fact, 4 is the subunit with the larger intracellular loop and interacts 
with Ccnd1 through it. When comparing human and mouse 4 sequences, we can observe that SP 
and TP sites are conserved even though there are variations in the nearby amino acids. 
Interestingly, 4 and 3 present less homology than for other  subunits. The intracellular loop of 
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3 subunit is shorter and does not contain any Cdk phosphorylation site. Hence, it could be 
interesting to further test the interaction of Ccnd1 with other GABAARs subunits and reveal new 
targets for Ccnd1 in the control of the CNS function.  
5.4 Cyclin D-Cdk4/6 complex modulates GABA tonic currents 
and mIPSCs in hippocampal slices 
Since the 4 subunit is mainly localized extrasynaptically contributing to tonic inhibition, we 
have intended to study the effect of Ccnd-Cdk4/6 complexes in the modulation of GABA tonic 
currents in collaboration with Dr. Esteban from the Centro de Biología Molecular Severo Ochoa 
in Madrid. To that aim, we have inhibited the Ccnd-Cdk4/6 complex with Palbociclib, a specific 
Cdk4/6 inhibitor (Fry et al. 2004), in rat (P5-7) hippocampal slices, and measured GABA tonic 
currents in CA1 pyramidal neurons. Whole-cell recordings show that the inhibition of the Ccnd-
Cdk4/6 complex significantly reduces GABA tonic currents in this model, suggesting that Cdk4/6 
activity promotes the extrasynaptic GABAAR function through the phosphorylation of the 4 
subunit. This result is in accordance with the diminished GABAAR run-down produced by Ccnd1-
CAAX and the phosphomimetic version of 4 that we have observe in tsA201 cells and with the 
fact that neurosteroids promote GABA tonic currents via PKC phosphorylation of 4 subunit at 
S443 in hippocampal neurons (Abramian et al. 2010, 2014). Nonetheless, whether the effect on 
tonic currents we observe with Palbociclib is via phosphorylation of 4 at T423 and S431 or not 
remains to be investigated with future experiments. Recordings should be done in hippocampal 
slices infected with viruses to express Ccnd1-CAAX, Ccnd1K112E-CAAX and 4 mutants 
(phosphomimetic and non-phosphorylatable). We would expect that Ccnd1-CAAX enhances 
GABA tonic currents while the kinase-inactive mutant Ccnd1K112E-CAAX does not. Similarly, the 
expression of the non-phosphorylatable mutant of 4 should behave as Ccnd1K112E-CAAX or 
Palbociclib-treated cells. On the contrary, the expression of the phosphomimetic mutant of 4 
should be able to revert the effects of Palbociclib treatment on GABA tonic currents.  
Phosphorylation of GABAAR subunits often promotes GABA tonic currents, and the imbalance 
between neuronal excitation and inhibition can lead to epilepsy; specifically the 4 subunit has 
been related to this disease. Since Ccnd1-Cdk4 phosphorylates 4 at T423 and S431 in vitro and 
Ccnd1-Cdk4/6 inhibition decreases GABA tonic currents in hippocampal slices, further studies 
should be carried out in order to explore the potential relationship of this phosphorylation with 
epilepsy. First, if we had a specific antibody against phosphorylated T423 and S431 residues, we 
could compare the phosphorylation state of the 4 subunit in both CCND1 KO and WT mice. 
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Second, it would be interesting to compare GABA tonic currents in a CCND1 KO vs a WT 
animal. In such experiments, one would expect that mice lacking Ccnd1 present diminished tonic 
inhibition. If this is the case, the expression by in utero electroporation or slice infection of either 
cytoplasmic Ccnd1 or the phosphomimetic 4 mutant (4T423E,S431E ) in CCND1 KO mice should 
be able to rescue the defect in GABA tonic currents. Also, we should test whether the CCND1 
KO mice present more susceptibility to develop epilepsy under convulsant kainate or pilocarpine 
injection.  
Even though 4 is mostly extrasynaptical, it can also form synaptic GABAARs when assembled 
with 2. For this reason, we have assessed the effect of Palbociclib on mIPSC of hippocampal 
neurons using mIPSCs of CA1 pyramidal neurons as functional indicators of the inhibitory 
synapse’s efficacy. We have observed that the inhibition of Ccnd-Cdk4/6 complexes causes a 
decrease in both the amplitude and the frequency of mIPSCs. Thus, not only the tonic currents are 
affected by Ccnd1-Cdk4/6 inhibition, but also the mIPSCs. These results imply that Ccnd-Cdk4/6 
complex is somehow modulating the spontaneous release of GABA neurotransmitter (decreased 
mIPSC frequency) and also affecting the activation of the postsynaptic GABAAR (decreased 
mIPSC amplitude). Regarding a putative role of Ccnd1 in the release of GABA vesicles, we can 
speculate that Ccnd-Cdk4/6 might exert its action through the small GTPases Ral A/B to regulate 
the exocyst complex. Indeed, Ccnd1 interacts with exocyst components (Sec6) and RalA and B 
small GTPases, which regulate the exocyst (Fernández et al. 2011; Fernández-Hernández et al. 
2013). In neurons, the exocyst (also known as Sec6/8 complex) is highly expressed in regions 
undergoing neurite outgrowth, vesicle targeting and synapse formation (Vega and Hsu 2001). 
Hence, it seems pausible that blocking Ccnd-Cdk4/6 activity also affects the formation and/or the 
release of new GABA vesicles through exocyst alteration.  
Concerning mIPSC amplitude, it is feasible that phosphorylation of 4 by Ccnd-Cdk4/6 
complexes is still promoting its activity also when the 4 subunit is forming 4x2 receptors at 
the synapse (Wafford et al. 1996). This would mean that 4 phosphorylation by Ccnd-Cdk4/6 has 
the same effect irrespective of whether the receptor localizes synaptically or extrasynaptically. By 
contrast, 4-containing synaptic and extrasynaptic receptors show different modulation by PKA 
and PKC phosphorylation. PKA activation decreases synaptic 4 expression while decreases 
extrasynaptic 4. Activation of PKC instead promotes 4 expression at the synapse and has no 
effect extrasynaptically (Bohnsack et al. 2016).  
The 4 containing receptors have been involved in synaptic plasticity (Shen et al. 2010). 
Synaptic plasticity refers to the ability of individual synapses to modify their response to different 
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stimuli or environmental cues. When there is a persistent increase of the efficacy of synaptic 
transmission, it is called Long-Term Potentiation (LTP) whereas if the synaptic transmission 
efficacy is persistently decreased, it is called Long-Term Depression (LTD). A potential 
regulation system of synaptic plasticity is the balance between the phosphorylation and 
dephosphorylation of specific substrates (Soderling and Derkach 2000). Thus, the Ccnd-Cdk4/6 
complex might also induce inhibitory LTP (iLTP) by phosphorylating the 4 subunit of the 
GABAARs. This would not be a far-fetched idea since other similar cases have been reported such 
as the dephosphorylation of the 2 subunit by Calcineurin leading to inhibitory LTD (iLTD) 
(Wang et al. 2003) or the 3 phosphorylation by CaMKII promoting iLTP (Petrini et al. 2014). 
Nevertheless, future studies on this issue should be performed. For instance, it should be assessed 
whether there is a change in the number of 4-containing GABAARs at the cell surface in 
hippocampal organotypic slices in the presence or absence of Ccnd1. Moreover, specific 
experiments of iLTP should be carried out and possibly some memory and behavioral studies with 
both WT and CCND1 KO mice could reveal a role of Ccnd1 in synaptic plasticity.  
Synaptic pruning is the process of synapse removal that takes place naturally in the brain at 
puberty and early young adulthood. This is concurrent with the increase in the expression of the 
4 subunit of the GABAARs, and extrasynaptic 4 GABAARs play an important role in 
synaptic pruning at puberty through the impairment of NMDA receptor activation (Shen et al. 
2010; Afroz et al. 2016). Also, synaptic pruning of CA1 hippocampus is prevented in 4 KO 
adolescent female mice. Because of its effects on 4, we may expect Ccnd1 to have a role in 
synaptic pruning. Thus, it will be interesting to test spine density both pre- and post-puberty in the 
CCND1 KO mice, expecting that the lack of Ccnd1 leads to decreased 4 GABAARs activity 
and thus, decreased pruning.  
5.5 Cytoplasmic cyclin D1 regulates 43-containing GABAAR 
expression at the cell surface  
To understand the mechanism underlying the electrophysiological effects of cytoplasmic Ccnd1 
on 43 receptors, we have studied whether Ccnd1-CAAX affects the number and recycling of 
4 and 3 subunits at the cell surface. First of all, we tested if Ccnd1 also interacts with 3. We 
have observed co-immunoprecipitation of Ccnd1 and 3 in HEK293 cells and they directly 
interact in vitro. Nevertheless, 3 does not seem to be a phosphorylation target of the Ccnd1-Cdk4 
complex: it does not contain any putative CDK phosphorylation site and we did not observe 
phosphorylation of 3 in an in vitro kinase assay in which 4 was readily phosphorylated.  
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Expression of GABAARs at the cell surface is regulated by the phosphorylation of their subunits 
(see page 27). Thus, we have assessed the effect of Ccnd1-CAAX on 4 and 3 levels at the cell 
surface in HEK293 cells by biotin-labelling of surface proteins followed by precipitation with 
streptadivin. The presence of cytoplasmic Ccnd1 causes a small not-statistically-significant 
increase in the surface levels of 4. By contrast, PKC phosphorylation of 4 at S443 has been 
shown to enhance 4 expression at the cell surface in HEK293 (Abramian et al. 2010). Alike, 
THDOC induced phosphorylation via PKC of 4 leads to increased 4-containing receptors at the 
cell surface and this effect was prevented when the non-phosphorylatable mutant was 
overexpressed (Abramian et al. 2014). This increase in the surface levels of 4-containing 
GABAARs is connected with the decrease in loss of function of the GABAARs observed when 4 
is phosphorylated. Hence, it is possible that the decrease in the GABAAR run-down and the 
enhancement of both the GABA-tonic currents and mIPSCs adhered to cytoplasmic Ccnd1-
Cdk4/6 complex activity is due to the stabilization or expression triggering of 4 through 
phosphorylation. Conversely, surface levels of 3 are diminished in a kinase-dependent manner 
by Ccnd1. These reduced 3 surface levels may alter the 4/3 stoichiometry and lead to the 
generation of more 43 receptors instead of 3 homopentamers, which could increase GABAAR 
function.  
Further, to reveal the mechanism by which cytoplasmic Ccnd1 affects both 4 and 3 surface 
levels, we have studied the endocytosis process. However, neither the endocytosis of 4 nor 3 is 
altered by the presence of Ccnd1-CAAX. By contrast, the phosphorylation of residues in the 
intracellular loop of 3 and 2 subunits maintains the surface levels of GABAAR while 
dephosphorylation leads to the internalization of the receptor since this phosphorylation avoids 
the binding to AP2 protein, an adaptor protein involved in clathrin-mediated endocytosis (Kittler 
et al. 2005, 2008). Next, we measured the insertion rate of 4 and 3 subunits at the cell surface 
in HEK293 cells. In these experiments, the co-expression of Ccnd1-CAAX together with 4 and 
3 affected the insertion of the 3 subunit to the cell surface. Hence, cytoplasmic Ccnd1 seems to 
be diminishing 3 at the cell surface by hindering its insertion into the membrane.  
Because 3 is susceptible to activity-dependent ubiquitination (Saliba et al. 2012) and its 
interaction with Plic-1 stabilizes and increases 3-containing GABAARs into the neuronal cell 
surface (Saliba et al. 2008), it is conceivable that the reduction in the insertion rate of 3 observed 
in our experiments is due to an increased subunit degradation. We then tested 3 ubiquitination 
levels in HEK293 cells co-transfected with heterologous 43 receptors plus Ccnd1-CAAX or 
the Ccnd1K112E-CAAX mutant. Our results reflect that when cytoplasmic Ccnd1 is present, there is 
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an increase (3.23 fold) in the amount of 3 ubiquitination, and this effect is prevented by co-
expression of the Ccnd1K112E mutant. Therefore, we conclude that Ccnd1 is decreasing 3 
expression at the cell surface by altering its insertion to the membrane, increasing its 
ubiquitination and, perhaps, its proteasomal degradation in a kinase-dependent manner. All in all, 
we propose a model in which cytoplasmic Ccnd1-Cdk4/6 complexes modulate not only the 
number but also the function of 43 GABAARs (Figure 41).  
 
  
 
Figure 41: Model of the mechanism whereby Ccnd1 controls GABAA receptor expression and function proposed based on the results obtained in this thesis. 
Cytoplasmic Ccnd1 phosphorylates 4 at T423 and S431 promoting both phasic and tonic inhibition. Increased mIPSC frequency and amplitude suggest that Ccnd1 affect 
GABA vesicles release and postsynaptic GABAARs, respectively. Besides, cytoplasmic Ccnd1 promotes 3 ubiquitination and diminishes 3 insertion rate.  
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6. CONCLUSIONS 
First. Cyclin D1-Cdk4 promotes early neuritogenesis in cultured cortical neurons in a manner 
that depends on the kinase activity of the complex. 
 
Second. Paxillin is likely a downstream target of cyclin D1-Cdk4 in neuritogenesis. 
 
Third. Cyclin D1 directly interacts with the 4 and 3 subunits of GABAA receptors in vitro and 
endogenously with the α4 subunit at the hippocampus of adult mice. 
 
Fourth. Cyclin D1-Cdk4 complex phosphorylates α4 subunit at residues T423 and S431 in vitro. 
 
Fifth. Cyclin D1 or a phosphomimetic allele of 4 prevent GABAA receptor run-down. In vivo, 
cyclin D-Cdk4/6 complexes increase the efficacy of GABAA receptors.  
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